Home › Medical Devices
Medical Devices Market Research Reports & Consulting
Market Reports
| Title | Published | Price | TOC Available |
|---|---|---|---|
Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Leukopak (Mobilized, Non-Mobilized, Human Primary Cells), Application (Research, Therapeutic), End User (Hospitals, Research Institute) - Global Forecast to 2023The global leukapheresis products market is projected to reach USD 27.7 million by 2023 from USD 19.4 million in 2018, at a CAGR of 7.4%. Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes. The global leukopaks market is projected to reach USD 445.6 million by 2023, at a CAGR of 46.4%. Factors contributing to the growth of these markets include the increasing incidence and prevalence of leukemia, growing demand for leukopaks for research applications, and increasing blood donations. The report analyzes the global leukapheresis products market by type, application, end user, and region. Some prominent players in the leukopaks market are HemaCare (US), AllCells (US), StemExpress (US), PPA Research Group (US), Key Biologics (US), Caltag Medsystem (UK), ZenBio (US), Precision for Medicine (US), and BioIVT (US). |
August 2018 | $ 5650 |
|
Hemodynamic Monitoring Systems Market by Product (Disposables and Monitors), Type (Invasive, Minimally Invasive, and Non-invasive), End User (Hospitals, Clinics & Ambulatory Care Center, and Home Care Setting), and Region - Global Forecasts to 2023The global hemodynamic monitoring systems market is expected to reach USD 1,167.4 million by 2023 from USD 857.8 million in 2018, at a CAGR of 6.4% during the forecast period. The growth of this market is primarily driven by factors such as the technological advancements in hemodynamic monitoring systems, increasing research into hemodynamic monitoring systems, influx of VC funding, and the rising prevalence of cardiovascular diseases & diabetes. The key players in the global hemodynamic monitoring systems market are Edwards Lifesciences Corporation (US), PULSION Medical Systems SE (Germany), LiDCO Group plc (UK), Cheetah Medical (Israel), Deltex Medical Group Plc. (UK), ICU Medical (US), Osypka Medical GmbH (Germany), CareTaker Medical (US), CNSystems (Austria), NI Medical (Israel), and Uscom (Australia). |
August 2018 | $ 5650 |
|
Trocars Market by Product (Disposable, Reusable, Reposable), Tip (Bladeless Trocars, Bladed Trocars, Blunt Trocars, Optical), Application (General Surgery, Urology, Pediatric, Gynecological Surgery), End User (Hospitals) - Global Forecast to 2023The global trocars market is expected to reach USD 763.2 million by 2023 from USD 538.5 million in 2018, at a CAGR of 7.2%. The major factors driving the growth of this market are the increasing prevalence of cancer and hernia and growing preference for minimally invasive surgery. Key players in the trocars market include Medtronic (Ireland), Ethicon (US), B. Braun (Germany), Applied Medical (US), Cooper Companies (US), Teleflex (US), ConMed (US), LaproSurge (UK), Purple Surgical (UK), and GENICON (US). |
August 2018 | $ 5650 |
|
Hyperspectral Imaging System Market by Product (Camera, Accessories) & Application (Military, Remote Sensing, Environmental Monitoring, Agriculture, Mineral Map, Machine Vision/Optical Sorting, Life Sciences & Medical Diagnosis) - Global Forecast to 2023The global hyperspectral imaging systems market is projected to reach USD 21.33 billion by 2023 from USD 9.51 billion in 2018, at a CAGR of 17.5%. The growing industrial applications of hyperspectral imaging and increasing funding & investments are the major factors driving the growth of the global hyperspectral imaging systems market. The global hyperspectral imaging system market is highly competitive and fragmented. The prominent players operating in this market include Headwall Photonics (US), Applied Spectral Imaging (US), Corning Incorporated (US), Surface Optics Corporation (US), Norsk Elektro Optikk (Norway), Resonon (US), SPECIM (Finland), TELOPS (Canada), BaySpec (US), Cubert (Germany), and ChemImage (US). |
August 2018 | $ 5650 |
|
Breast Cancer Liquid Biopsy Market by Circulating Biomarkers, Region, End User, Investments, Market Dynamics, Platform Comparison (NGS, PCR), Competitive Landscape (Acquisition, Mergers, Collaboration, Competitive technology) - Global Forecasts to 2022The global breast cancer liquid biopsy market is projected to reach USD 411.1 million by 2022 from USD 145.4 million in 2017, at a CAGR of 23.1%. Factors such as increasing prevalence of breast cancer, increasing preference for noninvasive procedures, initiatives undertaken by government and global health organizations, technological advancements to augment market revenues, rising emphasis on personalized medicine in clinical practice, and increased funding for liquid biopsy R&D are driving the growth of the breast cancer liquid biopsy market. The key players in the global breast cancer liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDx Health SA (US). |
August 2018 | $ 5650 |
|
Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular diseases, Psoriasis, Migraine), Type (Disposable, and Reusable), End Users (Homecare, and Hospitals) - Global Forecast to 2023The global autoinjectors market is projected to reach USD 85.31 billion by 2023 from USD 28.91 billion in 2018 at a CAGR of 24.2% during the forecast period. The growth of this market is primarily driven by factors such as the growing prevalence of targeted therapies, rising incidence of anaphylaxis, increasing number of regulatory approvals, and the availability of generic versions of autoinjectors. The key players in the global autoinjectors market are Abbvie (US), Amgen (US), Teva (Israel), Biogen (US), Eli Lilly (US), and Mylan (US). The other prominent players in the market are J&J (US), Novartis (Switzerland), Bayer (Germany), Merck (Germany), Biogen (US), Ypsomed (Switzerland), SHL Group (Taiwan) Becton, Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), and Haselmeier (Switzerland). |
August 2018 | $ 5650 |
|
Medical Robots Market by Product (Instruments & Accessories, Medical Robotic Systems (Surgical Robots, Rehabilitation Robots, Non-invasive Radiosurgery Robots)), Application (Laparoscopy, Pharmaceutical Applications), and Region - Global Forecasts to 2023The medical robots market is projected to reach USD 16.74 billion by 2023 from an estimated USD 6.46 billion in 2018. The major influencing factors driving the growth of this market are technological advancements in medical robots, advantages offered by robot-assisted training in rehabilitation therapy, increase in funding for medical robot research, and the issuance of IPOs by medical robot companies. Intuitive Surgical (US), Stryker Corporation (US), and Mazor Robotics (Israel) are the key players in the medical robots market. Other players involved in this market include Hocoma (Switzerland), Hansen Medical (US), Accuray (US), Omnicell (US), ARxIUM (Canada), and Ekso Bionics Holdings (US). |
July 2018 | $ 5650 |
|
Medical Exoskeleton Market by Component (Hardware (Sensor, Actuator, Control System, Power Source), Software), Type (Powered, Passive), Extremities (Lower, Upper) & Mobility (Mobile, Stationary) - Global Forecast to 2023The global medical exoskeleton market is projected to reach USD 571.6 million by 2023 from USD 116.7 million in 2018, at a CAGR of 37.4% during the forecast period. Factors such as the increasing number of people with physical disabilities and subsequent growth in the demand for effective rehabilitation approaches and increasing insurance coverage for medical exoskeletons in several countries are driving the growth of the medical exoskeleton market. The report segments the market into component, type, mobility, extremity, and region. The medical exoskeleton market includes various players. Key players in this market include The major players in the market are Ekso Bionics Holdings, Inc. (US), ReWalk Robotics Ltd (Israel), Parker Hannifin Corp (US), Bionik Laboratories Corp (Canada), CYBERDYNE Inc. (Japan), Rex Bionics Ltd. (UK), B-TEMIA Inc. (Canada), Hocoma AG (A Subsidiary of DIH Technologies) (Switzerland), Wearable Robotics SRL (Italy), Gogoa Mobility Robots SL (Spain), and ExoAtlet, O.O.O. (Russia). |
July 2018 | $ 5650 |
|
Veterinary Diagnostics Market by Product (Instruments, Consumables),Technology (Clinical Biochemistry, Urinalysis, Immunodiagnostics, Hematology, Molecular Diagnostics), Animal (Dogs, Cats, Horses, Cattle, Pigs, Poultry), End User - Global Forecast to 2023The veterinary diagnostics market is projected to reach USD 4.00 billion by 2023 from USD 2.63 billion in 2018, at a CAGR of 8.8%. Factors such as growing companion animal population, growing prevalence of animal zoonotic diseases, rising demand for animal-derived food products, rising demand for pet insurance & growing animal health expenditure, and the increasing number of veterinary practitioners and income levels in developed economies are expected to drive the growth of the veterinary diagnostics market. However, the increasing pet care costs may restrain the growth of the market. The major players in the veterinary diagnostics market are IDEXX Laboratories, Inc. (US), Abaxis, Inc. (US), Heska Corporation (US), Zoetis, Inc. (US), Neogen Corporation (US), Thermo Fisher Scientific, Inc. (US), QIAGEN N.V. (Netherlands), Virbac (France), bioMérieux SA (France), IDvet (France), and Randox Laboratories Ltd. (UK). |
July 2018 | $ 5650 |
|
Bowel Management Systems Market by Product (Irrigation Systems, Nerve Modulation Devices, Colostomy Bags, and Accessories), Patient Type (Adult and Pediatric), End User (Home Care and Hospitals, Ambulatory Surgery Center) - Global Forecast to 2023The global bowel management systems market is projected to reach USD 2.07 billion by 2023 from USD 1.74 billion in 2018, at a CAGR of 3.5%. Growth in the bowel management systems market is mainly driven by factors such as the expanding target patient population, the rapidly growing geriatric population, availability of technologically advanced bowel management products, and the favorable reimbursement scenario in developed countries. Some of the major players operating in the bowel management systems market are Coloplast (Denmark), Medtronic (Ireland), 3M (US), B. Braun (Germany), C.R. Bard (US), Consure Medical (India), Cogentix Medical (US), Aquaflush Medical Limited (UK), Axonics Modulation Technologies (US), ConvaTec (UK), Hollister (US), MBH-International A/S (Denmark), Mederi Therapeutics Inc. (US), Welland Medical limited (UK), and Wellspect HealthCare (Sweden). |
July 2018 | $ 5650 |
|
Biosurgery Market by Product (Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitutes) Application (Orthopedic, Gynecology, Cardiovascular, Reconstructive) - Forecast to 2023The global biosurgery market is projected to reach USD 15.58 billion by 2023 from USD 11.36 billion in 2018, at a CAGR of 6.5%. The growth of this market is driven by the growing geriatric population and corresponding chronic diseases, increasing volume of surgeries and prevalence of severe trauma injuries, and rising need for effective blood loss management in patients. The key players in the global biosurgery market are Johnson & Johnson (US), Sanofi (France), Baxter (US), C.R. Bard (US), Integra LifeSciences (US), MAQUET (Sweden), Medtronic (Ireland), Cohera Medical (US), Hemostasis (US), Stryker(US), B.Braun (Germany), CSL (Australia), Pfizer (US), and CryoLife (US). |
July 2018 | $ 5650 |
|
Artificial Tendons and Ligaments Market by Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries, Spine Injuries, and Hip Injuries), and Region (North America, Europe, Asia Pacific, Rest of the World) - Global Forecast to 2023The global artificial tendons and ligaments market is projected to reach USD 35.0 million by 2023 from USD 18.5 million in 2018, at a CAGR of 13.6%. The growth of this market is primarily driven by factors such as the increasing incidence of sports injuries, growing number of initiatives to increase the awareness about artificial tendons and ligaments, increasing research activities on artificial tendons and ligaments, increasing preference for minimally invasive surgeries, benefits of artificial tendons and ligaments, and the issues related to the use of orthobiologics. The key players in the global artificial tendons and ligaments market are LARS (France), Neoligaments (UK), Cousin Biotech (France), Orthomed S.A.S. (France), FX Solutions (France), Shanghai PINE&POWER Biotech (China), and Mathys AG Bettlach (Switzerland). |
July 2018 | $ 5650 |
|
Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine & Saliva-based)), Mode of Purchase (OTC, Prescription), Application (Female, Male), End User (Home care, Fertility clinics, Hospital) - Global Forecast to 2023The global fertility test market is expected to reach 583.1 million by 2023 from USD 411.8 million in 2018, at a CAGR of 7.2%. Growth in the fertility test market can be attributed to factors, such as increasing first-time pregnancy age, launch of advanced, easy-to-use fertility monitors with high accuracy, and increasing awareness about fertility testing. The major players operating in the fertility test market include SPD Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), and Prestige Brands Holdings, Inc. (US), among others. |
July 2018 | $ 5650 |
|
Veterinary Endoscopy Market by Product Type (Flexible, Videoscope, Fibreoptic, Rigid), Procedure (Bronchoscopy, Laparoscopy, Gastroduodenoscopy, Colonoscopy, Rhinoscopy), Animal (Companion, Large), End User (Hospitals, Clinics) - Global Forecast to 2023The global veterinary endoscopy market is expected to reach USD 219.0 million by 2023 from USD 159.8 million in 2018, at a CAGR of 6.5%. The market growth is primarily driven by the growing pet population, increasing number of pet health insurance, and advanced applications of veterinary endoscopes. Key players in the veterinary endoscopy market include KARL STORZ (Germany), Olympus (Japan), Fujifilm (Japan), Eickemeyer (Germany), B. Braun (Germany), STERIS (UK), Endoscopy Support Services (US), Biovision Veterinary Endoscopy (US), Welch Allyn (US), and Dr. Fritz (Germany). |
July 2018 | $ 5650 |
|
Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Stem Cell), End User (Hospital) – Global Forecast to 2023The global transplant diagnostics market is projected to reach USD 4.91 billion by 2023 from USD 3.44 billion in 2018, at a CAGR of 7.4%. The growth witnessed by transplant diagnostics is mainly driven by the increasing public-private funding for target research activities, growing burden of infectious diseases, increasing number of transplant procedures, and technological advancements in the field of transplant diagnostics. Major players operating in the market include Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc. (US), and bioMérieux S.A. (France). Other prominent players present in this market are Immucor, Inc. (US), Illumina, Inc. (US), Luminex Corporation (US), CareDx (US), Becton, Dickinson and Company (US), Hologic (US), and GenDx (Netherlands). |
June 2018 | $ 5650 |
|
Microbiology Testing/Clinical Microbiology Market by Application (Pharma, Clinical, Manufacturing, Environment), Disease (Respiratory Disease, STD, UTI), Product (Instrument, Analyzer, Reagent), End User (Hospital, Diagnolab, Academia) - Global Forecast to 2023The global clinical microbiology market is expected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018, growing at a CAGR of 6.4%. The technological advancements in disease diagnostics, rising incidence of infectious diseases and growing outbreak of epidemics, and increased funding and public-private investments in the field of disease diagnosis are the key factors driving the growth of this market. The major players operating in the microbiology testing/clinical microbiology market include bioMérieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Bruker Corporation (US), Hologic, Inc. (US), QIAGEN N.V. (The Netherlands), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Shimadzu Corporation (Japan), 3M Company (US), and Neogen Corporation (US), among others. |
June 2018 | $ 5650 |
|
Dental 3D Printing Market by Product (Material (Plastic, Metal), Equipment (3D Printer, 3D Scanner), Service), Technology (Stereolithography, FDM, SLS, Polyjet), Application (Prosthodontics, Implantology, Orthodontic), End User - Global Forecast to 2023The global dental 3D printing market is projected to reach USD 5.06 billion by 2023 from USD 1.78 billion in 2018, at a CAGR of 23.2%. Market growth can be attributed to the increasing adoption of the dental 3D printers in dental hospitals and clinics, the significant increase in the geriatric population, and increasing disposable income is leading to the increased dental expenditure resulting in the utilization of digital dentistry. However, reimbursement scenario and stringent regulatory process for the approval of 3d printing equipment may hinder the growth of this market during the forecast period. The key players in the global dental 3D Systems (US), Stratasys (US/Israel), Renishaw (UK), Roland DG (Japan), SLM Solutions (Germany), EnvisionTEC (Germany), DENTSPLY Sirona (US), Straumann (Switzerland), Formlabs (US), Prodways Group (France), EOS (Germany), Rapid Shape (Germany), DWS (Italy), Planmeca (Finland), Kulzer GmbH (Germany), Ultimaker (Netherlands), Dental Wings (Canada), Carbon (US), and Asiga (Australia). |
June 2018 | $ 5650 |
|
Dental Sterilization Market by Product (Sterilization Equipment (high temperature, Low temperature), Ultrasonic Cleaner, Washer Disinfector, Surface Disinfectant, Instrument Disinfectant, Lubricant, Cleaning Solutions), End User - Global Forecast to 2023The global dental sterilization market is projected to reach USD 1.48 Billion by 2023 from USD 1.01 Billion in 2017 at a CAGR of 6.6% during the forecast period. Growth in the dental sterilization market is mainly driven by factors such as the increasing number of dental facilities and the growing pool of dental care personnel, growing prevalence of dental ailments, and increasing demand for cosmetic dentistry. The prominent players in the dental sterilization market are Getinge (Sweden), Midmark (US), SciCan (Canada), Tuttnauer (US), Planmeca (Finland), DENTSPLY Sirona (US), Danaher (US), Matachana (Spain), A-dec (US), W&H (Austria), Hu-Friedy (US), and NAKANISHI (Japan). New product launches and acquisitions were the major strategies adopted by these payers to maintain their positions in the dental sterilization market. |
June 2018 | $ 5650 |
|
Sinus Dilation Devices Market by Product (Balloon Dilation, Stents, Endoscope (Rhinoscopy, Sinoscopy), Handheld), Procedure (Standalone, Hybrid), Patient Type (Adult, Pediatric), Patient Care Setting (ENT, Clinic, Hospitals, ASC) - Global Forecast to 2023The global sinus dilation devices market is expected to reach USD 2.78 Billion by 2023 from USD 1.80 Billion in 2018, at a CAGR of 9.1% during the forecast period. Factors such as growing preference for minimally invasive procedures, benefits of balloon sinuplasty/sinus dilation over conventional sinus surgeries, favorable reimbursement scenario for sinus procedures in developed countries and high prevalence of chronic sinusitis are driving the growth of this market. The report segments the global sinus dilation devices market into product, type of procedure, patient care setting, type of patient, and region. The sinus dilation devices market includes various small and large players. Key players in this market include Entellus Medical Inc. (a subsidiary of Stryker) (US), Acclarent Inc. (a subsidiary of Johnson & Johnson) (US), Medtronic plc (Ireland), Smith & Nephew plc (UK), Intersect ENT Inc. (US), and Olympus Corporation (Japan). Other players in the market include Meril Life Sciences Pvt. Ltd. (India), SinuSys Corporation (US), InAccel (India), Jilin Coronado Medical Ltd. (China), and Creganna Medical (Ireland). |
June 2018 | $ 5650 |
|
Hematology Analyzers and Reagents Market by Products & Services (Hematology Analyzers (5 Parts, 6 Parts, 3 Part, PoC, Semi-Automated), Hemostasis, Immunohematology), Price Range (High, Low), End User (Government labs) - Global Forecast to 2023The hematology products market is projected to reach USD 4.98 Billion by 2023 from USD 3.31 Billion in 2018, at a CAGR of 8.5% during the forecast period. Factors such as the growth in blood donations, increasing incidence of blood disorder, and technological advancements in hematology analyzers and reagents are driving the growth of the market. The major players of the global hematology analyzers and reagents market are Sysmex (Japan), Danaher (US), Nihon Kohden (Japan), Siemens (Germany), Abbott Laboratories (US), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland). |
June 2018 | $ 5650 |
|
Dental Surgical Instruments Market by Product (Handheld Instruments, Laser, Dental Handpiece, Ultrasonic Instruments, Consumables), Therapeutic Area (Restorative Dentistry, Orthodontics), Patient Care Setting (Clinic, Hospital) - Global Forecast to 2023The global dental surgical instruments market is projected to reach USD 5.96 billion by 2023 from USD 4.48 billion in 2018, at a CAGR of 5.9%. Factors such as the rising incidence of dental diseases, growing demand for cosmetic dentistry, increasing number of dental practitioners and dental clinics, and growing dental expenditure are expected to drive market growth during the forecast period. The key players in the global dental surgical instruments market are DENTSPLY Sirona Inc. (US), Danaher Corporation (US), 3M Company (US), COLTENE Holding AG (Switzerland), Brasseler USA, A-dec, Inc. (US), Hu-Friedy Manufacturing Company, LLC (US), Integra LifeSciences Holdings Corporation (US), NAKANISHI Inc. (Japan), BIOLASE, Inc. (US), The Yoshida Dental Mfg. Co., Ltd. (Japan), Helmut Zepf Medizintechnik GmbH (Germany), Prima Dental Manufacturing Ltd. (UK), B. Braun Melsungen AG (Germany), AMD Lasers (US), and CAO Group, Inc. (US). |
June 2018 | $ 5650 |
|
Vascular Patches Market by Material (Biologic, Synthetic), Application (Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysms, Vascular Bypass Surgery), Patient Care Setting (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2023The global vascular patches market is expected to reach USD 525.8 Million by 2023 from USD 349.6 Million in 2018, at a CAGR of 8.5%. Growth in the vascular patches market is mainly driven by the rapidly growing geriatric population and the subsequent increase in the prevalence of vascular diseases, the increasing number of vascular surgeries performed, and the increasing adoption of biological patches. Major vendors who provide eDiscovery software and services include AccessData (US), Advanced Discovery (US), Catalyst (US), CloudNine (US), Commvault (US), Conduent (US), Deloitte (US), Driven (US), Epiq (US), FRONTEO (Japan), FTI (US), IBM (US), Ipro (US), KLDiscovery (US), Lighthouse (US), Logikcull (US), Micro Focus (UK), Microsoft (US), Nuix (Australia), OpenText (Canada), Relativity (US), Ricoh (Japan), Thomson Reuters (Canada), Veritas (US), and ZyLAB (Netherlands. |
June 2018 | $ 5650 |
|
Cold Pain Therapy Market by Product (OTC (Gels, Sprays, Patches, Cold Packs, Wraps, Pads, and Roll-Ons), Prescription-Based (Motorized, Non-Motorized Devices), Applications (Musculoskeletal Disorders, Post-Operative Therapy, Sports Medicine, and Post-Trauma Therapy) - Global Forecast to 2023The global cold pain therapy market is projected to reach USD 2.12 Billion by 2023 from USD 1.69 Billion in 2018, at a CAGR of 4.6%. The increasing incidence of sports injuries and rising emphasis on exercise and gym activities, growing number of hip and knee surgeries across the globe, and growing need for safer pain management modalities as opposed to oral drug therapy are expected to drive the demand for cold pain therapy products during the study period. As of 2017, the major players in the cold pain therapy market are Sanofi (France), DJO Finance (US), and Pfizer (US). Other players in this market include 3M (US), Hisamitsu Pharmaceutical (Japan), Johnson & Johnson (US), Medline Industries (US), Össur (Iceland), Performance Health (US), Beiersdorf (Germany) Rohto Pharmaceutical (US), Breg (US), Romsons Group of Industries (India), Custom Ice (US), and Unexo Life Sciences (India). |
June 2018 | $ 5650 |
|
Sterilization Equipment Market by Product & Service (Instrument (Heat, Filtration, Low Temperature), Consumables and Accessories (Detergents, Indicators), Services (E beam, Gamma)), End User (Hospitals, Pharmaceutical Companies) - Global Forecast to 2023The global sterilization equipment market is expected to reach USD 11.14 Billion by 2023 from USD 7.94 Billion in 2018, at a CAGR of 7.0%. The major factors driving the growth of this market are the rising incidence of hospital-acquired infections, increasing number of surgical procedures, rising focus on food sterilization and disinfection, technological advancements in sterilization equipment, and increasing number of hospitals in Asia. Key players in the sterilization equipment market include Steris Corporation (US), Getinge Group (Sweden), Advanced Sterilization Products (US), 3M Company (US), Belimed AG (Switzerland), Cantel Medical (US), and Sterigenics International, Inc. (US) |
June 2018 | $ 5650 |
|
Angiography Equipment Market by Product (Angiography Systems, Catheters, Guidewire, Balloons, Contrast Media), Technology (X-Ray, CT, MRA), Procedure (Coronary, Endo, Neuro), Application (Diagnostic, Therapeutic), Patient Care Setting - Global Forecast to 2023The angiography equipment market is projected to reach USD 13.06 Billion by 2023 from USD 10.26 Billion in 2018, at a CAGR of 5.0%. The growth in this market is attributed to the high prevalence of diseases such as cancer and CVDs, increasing product approvals for advanced angiography techniques in the market, the large number of ongoing research activities, growing government and public-private investments, increasing number of awareness programs, and rising adoption of angiography devices due to a large number of angiography procedures performed across the globe. The key players in the angiography equipment market are GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Canon Corporation (Japan), Boston Scientific Corporation (US), Cordis (a Cardinal Health Company, US), Shimadzu Corporation (Japan), Medtronic (Ireland), Angiodynamics (US), B. Braun Melsungen (Germany), and Abbott Laboratories (US). |
June 2018 | $ 5650 |
|
Lithotripsy Devices Market by Type (ESWL, Intracorporal (Laser, Electrohydraulic, Mechanical, Ultrasonic Lithotripsy)), Application (Kidney, Ureteral, Bile Duct & Pancreatic Stones), End User (Hospital), Procedures - Global Forecast to 2023The global lithotripsy devices market is expected to reach USD 1.76 Billion by 2023 from USD 1.41 Billion in 2018, at a CAGR of 4.5%. Growth in this market is propelled by the increasing incidence of urolithiasis and technological advancements in lithotripsy devices. Some of the major players in the lithotripsy devices market are Siemens AG (Germany), Boston Scientific (US), Dornier MedTech (Germany), Olympus America (Japan), DirexGroup (Germany), and Richard Wolf (Germany). Key companies in the lubricating oil additives market include Afton Chemical (US), Chevron Oronite (US), BASF (Germany), Evonik Industries (Germany), Lubrizol Corporation (US), and Lanxess (Germany). |
June 2018 | $ 5650 |
|
Wound Care Biologics Market by Product (Biological Skin Substitutes (Biosynthetic Products), Topical Agents), Wound Type (Diabetic Foot Ulcer, Pressure Ulcers, Surgical & Traumatic Wound), End User (Hospitals, Burn Centers) - Global Forecast to 2023The global wound care biologics market is expected to reach USD 2.26 Billion by 2023 from USD 1.42 Billion in 2018, at a CAGR of 9.8%. Market growth is mainly driven by factors such as the increasing incidence of diabetic foot ulcers, increasing geriatric population, and increasing burn injuries globally. On the other hand, the high cost of wound care biologics and the higher rejection rate associated with skin grafts & substitutes will restrain the growth of this market. Key players in the wound care biologics market include Smith & Nephew (UK), Mölnlycke Health Care AB (Sweden), Integra LifeSciences Corporation (US), Wright Medical (US), MiMedx Group (US), Vericel Corporation (US), Anika Therapeutics (US), Osiris Therapeutics (US), Organogenesis (US), Kerecis (Iceland), Solsys Medical (US), ACell (US), Lavior Inc. (US), and Marine Polymer Technologies, Inc. (US). |
June 2018 | $ 5650 |
|
Wound Debridement Market by Product (Gels, Ointments, Surgical, Ultrasonic Devices), Method (Autolytic, Enzymatic, Mechanical), Wound Type (Venous Leg, Diabetic Foot, Pressure Ulcers, Burns), End User (Hospitals, Clinics) - Global Forecast to 2023The global wound debridement market is expected to reach USD 1,041.0 Million by 2023 from USD 702.0 Million in 2018, at a CAGR of 8.2%. Factors such as rising incidence of diabetes & associated wounds, growing aging population, rising incidence of burn injuries, and growing awareness programs for wound care treatment and management are driving the growth of the wound debridement market. The major players in the wound debridement market include Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Coloplast (Denmark), Misonix (US), ConvaTec (UK), Lohmann & Rauscher (Germany), DeRoyal Industries (US), Medline Industries (US), Mölnlycke Health Care AB (Sweden), and Integra LifeSciences (US). |
May 2018 | $ 5650 |
|
Hernia Repair Market by Product (Mesh (Synthetic, Biologic), Mesh Fixation (Suture, Tack and Glue Applicator)), Surgery Type (Inguinal, Incisional/Ventral, Umbilical, Femoral), and Geography (America, Europe, Asia Pacific) - Forecast to 2023The hernia repair market is projected to reach USD 4.75 Billion by 2023 from USD 4.09 Billion in 2018, at a CAGR of 3.0% during the forecast period. The increasing adoption of mesh in hernia repair surgeries, rising geriatric population, new product developments, and efficient reimbursement system in developed countries are the major factors driving the growth of the hernia repair market during the forecast period. The major players in the hernia repair market profiled in this report are Covidien ( Part of Medtronic) (Ireland), Ethicon (Part of Johnson & Johnson) (US), B. Braun (Germany), C.R. Bard (Part of Becton Dickinson) (US), W. L. Gore (US), LifeCell (Part of Allergan) (Ireland), Maquet (Part of Getinge) (Sweden), Cook Medical (US), Integra (US), DIPROMED (Italy), FEG (Germany), Cousin Biotech (France), Herniamesh (Italy), Aspide Medical (France), TransEasy Medical (China), and Via Surgical (Israel). |
May 2018 | $ 5650 |
|
Molecular Diagnostics Market by Application (Infectious Disease (Hepatitis, HIV), Oncology, Genetic Testing), Technology (PCR, DNA Sequencing & NGS), End User (Hospital/Academic Laboratory), Product & Service (Reagent, Software) - Global Forecast to 2023The global molecular diagnostics market is projected to reach USD 11.54 Billion by 2023 from USD 7.10 Billion in 2017, at a CAGR of 8.4%. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023. Growth in this market is primarily driven by the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques. The key players in the global molecular diagnostics market are Roche (Switzerland), Hologic (US), QIAGEN (Netherlands), Abbott (US), and Danaher (US). |
May 2018 | $ 5650 |
|
Bariatric Surgery Devices Market by Type (Minimally Invasive (Stapling, Suturing), Non-Invasive), Procedure (Sleeve Gastrectomy, Gastric Bypass, Revision Surgery, Adjustable Gastric Banding, Mini Gastric Bypass) - Global Forecast to 2023The global bariatric surgery devices market is projected to reach USD 2.16 Billion by 2023 from USD 1.64 Billion in 2018, at a CAGR of 5.7% during the forecast period. The growth of this market is driven by factors such as the growing obese population, increasing number of bariatric surgeries, and increasing preference for minimally invasive procedures. Ethicon (US), Medtronic (Ireland), Intuitive Surgical (US), Apollo Endosurgery (US), and ReShape Lifesciences, (US) are the key players in the bariatric surgery devices market. Other players involved in this market are Aspire Bariatrics (US), Mediflex Surgical Products (US), Spatz FGIA (US), Cousin Biotech (France), and Olympus Corporation of the Americas (US). |
May 2018 | $ 5650 |
|
Patient Monitoring Device/System/Equipment Market by Product (EEG, EMG, MEG, TCD, Peak Flow Meter, Pulse Oximeter, Fetal Monitoring, Temperature Monitoring Devices, MCOT, ECG, Hemodynamic Monitoring System), End User (Home, Hospital) - Global Forecast to 2023The patient monitoring devices market is projected to reach USD 25.31 Billion by 2023 from USD 19.14 Billion in 2018, at a CAGR of 5.7%. Factors such as the easy availability of wireless monitoring devices and the rising incidence of lifestyle and chronic diseases are expected to drive market growth during the forecast period. The patient monitoring devices market is dominated by players such as Medtronic (Ireland), Abbott (US), Natus Medical (US), Nihon Kohden (Japan), GE Healthcare (US), and Philips Healthcare (Netherlands). |
May 2018 | $ 5650 |
|
Adhesion Barrier Market by Product (Regenerated Cellulose, Hyaluronic Acid, Polyethylene Glycol, Fibrin, Collagen & Protein), Type (Film, Gel, Liquid), Application (Abdominal, Orthopedic, Cardiovascular, Gynecological Surgery) - Global Forecast to 2023The global adhesion barrier market is projected to reach USD 806.4 Million by 2023 from USD 570.7 Million in 2018, at a CAGR of 7.2%. The growth of this market is driven by the growth in the geriatric population and corresponding age-related chronic diseases, epidemiological shift from infectious to chronic diseases, growing volume of surgical procedures and sports-related injuries, and increasing awareness about the medical complications occurred due to post-surgical adhesion formation. The key players in the global adhesion barrier market are Johnson & Johnson (J&J) (US), Sanofi (France), Baxter International (US), C.R. Bard (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll Holdings (Ireland), Betatech Medical (Turkey), SyntheMed (US), Aziyo Biologics (US), Biom’up (France), Terumo Corporation (Japan), and BMI Korea Co. (South Korea). |
May 2018 | $ 5650 |
|
Biological Safety Cabinet Market by Type (Class I, Class II (Type A, Type B), Class III), End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories, Academic & Research Institution) - Global Forecast to 2022The biological safety cabinets market is projected to reach USD 205.9 Million by 2022 from USD 144.3 Million in 2017, at a CAGR of 7.4% during the forecast period. Growth in the biological safety cabinets market is mainly driven by factors such as favorable regulations, increased risk of pandemics and communicable diseases, and pharmaceutical companies, and rapid growth in the number of biologics. The biological safety cabinets market is segmented on the basis of type, end user, and region. The major market players in the biological safety cabinets market include Thermo Fisher Scientific (US), Esco Micro (Singapore), Labconco (US), The Baker Company (US), Kewaunee Scientific (US), NuAire (US), Germfree Laboratories (US), EUROCLONE (Italy), Cruma (Spain), Air Science (US), Berner International (Germany), and BIOBASE (China). |
May 2018 | $ 5650 |
|
Point of Care Molecular Diagnostics Market by Product & Service (Assays, Kits, Analyzers, Software), Application (Respiratory Disease, Hospital Acquired Infection), Technology (RT-PCR, INAAT), End User (Physician Office, ICUS) - Global Forecast to 2023The global point of care (POC) molecular diagnostics market is projected to reach USD 1440.2 Million in 2023 from USD 725.5 Million in 2018, at CAGR of 14.7%. POC molecular diagnostics are point-of-care setting devices used by healthcare professionals to detect and diagnose various diseases in humans. Some of the key players in the global POC molecular diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Biomerieux SA (France), and Danaher (US). Product development was the major strategy adopted by these major players to maintain their leadership position in the global POC molecular diagnostics market. |
May 2018 | $ 5650 |
|
Cerebrospinal Fluid Management Market by Product (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) - Global Forecast to 2022The global cerebrospinal fluid management market is projected to reach USD 1.56 Billion by 2022 from an estimated USD 1.26 Billion in 2017, at a CAGR of 4.4% during the forecast period. The growth of this market is majorly driven by factors such as the growing geriatric population and the high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures. The key players in the global cerebrospinal fluid (CSF) management market are Medtronic (Ireland), Integra (US), B. Braun (Germany), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical Incorporated (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd. (Taiwan). |
May 2018 | $ 5650 |
|
Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices (Mad) & Tongue-Retaining Devices (TRD)), Type (Physician Prescribed/Customized Oral Appliances & Online OTC Oral Appliances) - Global Forecasts to 2023The sleep apnea oral appliances market is projected to reach USD 482.5 Million by 2023 from an estimated USD 233.2 Million in 2018. The major influencing factors driving the growth of this market are growing popularity of oral appliances in sleep apnea management, technological advancements in oral appliances, a large pool of undiagnosed sleep apnea patients, and growing awareness about sleep apnea. ResMed (US), SomnoMed (Australia), and Whole You (US) are the key players in the sleep apnea oral appliances market. Other players involved in this market are Oventus (Australia), Panthera Dental (Canada), Airway Management (US), Apnea Sciences (US), DynaFlex (US), OravanOSA (US), and Myerson (US). |
May 2018 | $ 5650 |
|
Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, Software), Technology (ELISA, Rapid Test), Platform (Radioimmunoassay), Specimen, Application (Infectious Diseases, Oncology, Cardiology), End User (Hospitals) – Global Forecast to 2023The global immunoassays market is expected to reach USD 27.15 Billion by 2023 from USD 20.19 Billion in 2018, at a CAGR of 6.1%. The market growth is primarily driven by the increasing incidence of chronic and infectious diseases and technological innovations in immunoassays instruments. Key players in the immunoassays market include Roche (Switzerland), Abbott Laboratories (US), Siemens (Germany), Danaher Corporation (US), Sysmex Corporation (Japan), bioMérieux (France), Ortho Clinical Diagnostics (US), DiaSorin (Italy), QIAGEN (Netherlands), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck (Germany), Bio-Rad Laboratories (US), Agilent Technologies (US), PerkinElmer (US), Quidel Corporation (US), Bio-Techne Corporation (US), and Mindray (China). |
May 2018 | $ 5650 |
|
Laparoscopic and Open Hernia Mesh Repair Surgery Market by Mesh Fixator (Glue And Tack Applicators), Country (US, Canada, Germany, France, UK, Italy, Spain, Japan, China, and India) - Forecast to 2022The laparoscopic and open hernia mesh repair surgery market is projected to reach USD 3.53 Billion by 2022 from USD 3.18 Billion in 2017, at a CAGR of 2.1% during the forecast period. The increasing adoption of mesh in hernia repair surgeries, rising geriatric population, new product developments, and efficient reimbursement system in developed countries are the major factors driving the growth of the hernia mesh repair surgery market during the forecast period. The major players in the hernia mesh repair surgery market profiled in this report are Medtronic (Ireland), Johnson & Johnson (US), B. Braun (Germany), C. R. Bard (US), and W.L. Gore (US). |
May 2018 | $ 5650 |
|
Plastic Surgery Instruments Market by Type (Handheld (Forceps, Needle Holder, Scissors, Retractor), Electrosurgery (Bipolar, Monopolar)), Procedure (Cosmetic (Breast Augmentation, Face, Head, Extremities), Reconstructive), End User - Global Forecast to 2023The global plastic surgery instruments market is expected to reach USD 1,479.0 Million by 2023 from USD 1,002.0 Million in 2018, at a CAGR of 8.1%. Increasing awareness and demand for cosmetic surgeries, growing number of age-related surgeries across the globe, and increasing incidence of cancer are the key drivers of the global plastic surgery instruments market. The plastic surgery instruments market is highly fragmented with the presence of several large as well as emerging players. Prominent players in the plastic surgery instruments market include Sklar Surgical Instruments (US), KLS Martin Group (Germany), Integra LifeSciences Corporation (US), Tekno-Medical Optik-Chirurgie GmbH (Germany), KARL STORZ GmbH & Co. KG (Germany), Zimmer Biomet (US), B. Braun Melsungen AG (Germany), BMT Medizintechnik GmbH (Germany), Anthony Products, Inc. (US), Bolton Surgical Ltd. (UK), Surgicon Pvt. Ltd. (Pakistan), and Blink Medical (UK). |
May 2018 | $ 5650 |
|
Heart Pump Device Market by Product (Ventricular Assist Device (LVAD, RVAD, BiVAD, and pVAD), Intra Aortic Balloon Pump, TAH), Type (Extracorporeal and Implantable Pump), Therapy (Bridge-to-transplant, Destination Therapy) - Global Forecast to 2022The global heart pump devices market is projected to reach USD 3.98 Billion by 2022 from an estimated USD 1.64 Billion in 2017, at a CAGR of 19.4% during the forecast period. The growth of this market is majorly driven by factors such as growing prevalence of cardiovascular diseases, increasing number of regulatory approvals, and an acute shortage of donor hearts. The key players in the global heart pump devices market are St. Jude Medical (a subsidiary of Abbott Laboratories) (US), Abiomed (US), Medtronic (Ireland), Getinge (Sweden), Teleflex (US), ReliantHeart (US), BerlinHeart (Germany), Terumo (Japan), SynCardia Systems (US), TandemLife (CardiacAssist) (US), Jarvik Heart (US), and Fresenius Medical Care (Germany). |
May 2018 | $ 5650 |
|
Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy (ddPCR, DHPLC)), Research Area (Proteomics, Lipidomics), Application (Biomarker Validation, Biomarker Discovery) - Global Forecast to 2022The global biomarker technologies market is expected to reach USD 74.51 Billion in 2022 from USD 42.88 Billion in 2016, at a CAGR of 9.7% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The key players in the biomarker technologies market are Thermo Fisher Scientific (US), Agilent Technologies (US), Roche (Switzerland), Danaher Corporation (US), Waters Corporation (US), Shimadzu Corporation (Japan), and Bio-Rad Laboratories (US). |
May 2018 | $ 5650 |
|
EMEA 3D CBCT/Cone Beam CT Systems Market by Application (Dental (Oral and Maxillofacial Surgery, Implantology, Orthodontic, Endodontic) and Non-Dental (Radiology, ENT)), End User (Hospitals and Clinics, Diagnostic Centres) - Forecast to 2023The EMEA 3D CBCT systems market is projected to reach USD 300.4 Million by 2023 from USD 194.3 Million in 2018, at a CAGR of 9.0%. The growing number of dentists is one of the major drivers for the growth of the dental CBCT market in this region. This increase, along with the subsequent establishment of new clinics and rising government spending on healthcare, has contributed to a growing demand for dental equipment like CBCT systems. The key players in the EMEA 3D CBCT systems market are Danaher Corporation (US), DENTSPLY SIRONA (US), Carestream Dental (US), Planmeca Group (Finland), VATECH (South Korea), CEFLA (Italy), J. MORITA CORPORATION (Japan), ACTEON GROUP (France), Asahi Roentgen (Japan), and Genoray (South Korea). |
May 2018 | $ 5650 |
|
Sternal Closure Systems Market by Product (Closure Devices (Wire, Plate, Screw, Cable,), Bone Cement), Procedure (Median Sternotomy, Hemisternotomy, Bilateral Thoracosternotomy), Material (Stainless Steel, Peek, Titanium) - Global Forecast to 2023The global sternal closure systems market is projected to reach USD 2.61 Billion by 2023 from USD 2.02 Billion in 2018, at a CAGR of 5.2% during the forecast period. Growing availability of medical reimbursements across major markets, technological advancements in sternotomy techniques, and increased target patient population with the subsequent increase in the number of surgical procedures are expected to drive the demand for sternal closure systems during the study period. As of 2017, the major players in the sternal closure systems market are DePuy Synthes (US), Zimmer Biomet Holdings (US), and A&E Medical (US). Other players in this market include KLS Martin Group (US), Orthofix International N.V. (US), ABYRX (US), Acute Innovations (US), Kinamed Incorporated (US), Praesidia Srl (Italy), and IDEAR S.R.L. (Argentina) among others. |
April 2018 | $ 5650 |
|
Veterinary Pain Management Market by Product (Drugs (NSAIDs, Opioids), Device (Laser, Electromagnetic)), Application (Osteoarthritis, Cancer), Animal Type (Dog, Cat, Horse, Cattle), Distribution Channel (Hospital, Pharmacy) - Global Forecast to 2023The veterinary pain management market is projected to reach USD 1.66 Billion by 2023 from USD 1.13 Billion in 2018, at a CAGR of 8.0% during the forecast period. Factors such as growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal disease causing pain and inflammation, and the rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of the market. However, increasing pet care costs may be a key restraining factor for the market in the next five years. The prominent players in the veterinary pain management market are Zoetis (US), Merck Animal Health (US), Elanco (US), Chanelle (Ireland), Boehringer Ingelheim (Germany), Vetoquinol (France), Bayer (Germany), Norbrook (Ireland), Ceva Santé Animale (France), K-Laser (US), Assisi (US), and Dechra Pharmaceuticals (UK). New product launches and acquisitions were the major strategies adopted by these payers to maintain their positions in the veterinary pain management market |
April 2018 | $ 5650 |
|
Angiographic Catheters Market by Application (Coronary, Endovascular, Neurology and Oncology), Geography (North America, Europe, Asia Pacific and Row), End-User Analysis (Reusage Scenario, Purchase Pattern) and Competitive Scenario - Global Forecast to 2022This report studies the angiographic catheters market based on application and region; end-user analysis; and competitive scenario. The market study covers the global angiographic catheters market from 2015 to 2022 and provides details of the factors influencing the market at both the macro- and micro-levels along with competitive developments and recent market trends. The report provides a detailed overview of the major drivers, restraints, opportunities, current market threats, and strategies impacting the growth of angiographic catheters market along with the estimates and forecasts of the revenue and market ranking analysis The global angiographic catheters market is expected to reach USD 1,402.8 Million by 2022 from USD 922.1 Million in 2016 and, at a CAGR of 7.4%. The base year for this study is 2016 and the forecast period is 2017–2022. Key players operating in the angiographic catheters market include Medtronic (US), Boston Scientific (US), Terumo Medical (Japan), Cardinal Health (US), and Merit Medical System (US). |
April 2018 | $ 5650 |
|
Magnetic Resonance Imaging (MRI) Systems Market by Architecture (Open MRI Systems and Closed MRI Systems (Standard Bore and Wide Bore)), Field Strength (Low-to-mid Field, High-field (1.5T and 3T), and Very-high Field) - Global Forecast to 2023The global MRI systems market is projected to reach USD 7.09 Billion by 2023 from USD 5.85 Billion in 2018, at a CAGR of 3.9%. Some key factors driving market growth include the increasing geriatric population, rising awareness about the benefits of early diagnosis, and the introduction of technologically advanced MRI systems with better image quality and high throughput. Factors such as novel application areas such as detection of metastasis in cancer, hybrid MRI systems and emerging markets are expected to offer lucrative growth opportunities for players in the MRI systems market. The major players in the global MRI systems market are Siemens Healthineers (Germany), GE Healthcare (US), Phillips (Netherlands), Hitachi (Japan), and Canon Medical Systems (Japan). |
April 2018 | $ 5650 |
|
Sleep Apnea Devices Market by Type, (Therapeutic (CPAP, APAP, Masks, ASV, Oral Appliances, Mandibular Advancement Device), Diagnostic (PSG, Oximeter)), End User (Sleep Laboratories & Hospitals, Home Care/Individuals) - Global Forecasts to 2023The sleep apnea devices market is projected to reach USD 6.49 Billion by 2023 from an estimated USD 4.44 Billion in 2018. The major influencing factors driving the growth of this market are increasing patient pool for sleep apnea on account of increasing obesity globally, improving patient compliance owing to stringent reimbursement regulations, increasing home sleep testing as well as initiatives to increase awareness globally. ResMed (US), Koninklijke Philips (Netherlands), and Fisher & Paykel Healthcare (New Zealand) are the key players in the sleep apnea devices market. Other players involved in this market are SomnoMed (Australia), Compumedics (Australia), Löwenstein Medical (Germany), Whole You (US), BMC Medical (China), Drive DeVilbiss Healthcare (US), and Braebon Medical (Canada). |
April 2018 | $ 5650 |
|
Occlusion Devices Market by Product (Occlusion Balloon, Stent Retriever, Suction Device, Coil Embolization, Liquid Embolics), Application (Cardiology, Neurology, Peripheral Vascular, Urology, Oncology, Gyno), End User - Global Forecast to 2023The global occlusion devices market is projected to reach USD 3.55 Billion by 2023 from USD 2.74 Billion in 2018, at a CAGR of 5.3%. The growth witnessed by occlusion devices is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for occlusion devices across developed countries, and rising adoption of minimally invasive surgical procedures across major countries. Major players operating in the market include Boston Scientific (US), Medtronic (Ireland), Terumo (Japan), Stryker Corporation (US), and Penumbra (US). Other prominent players present in this market are Abbott (US), Cardinal Health (US), B. Braun (Germany), Asahi Intecc (Japan), C.R. Bard (US), Cook Group (US), Angiodynamics (US), and Acrostak (US). |
April 2018 | $ 5650 |
|
Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User (Hospital, Research Institute) - Global Forecast to 2022The global infectious disease diagnostics market is projected to reach USD 19.35 Billion in 2022 from USD 14.73 Billion in 2017, at CAGR of 5.6%. Infectious disease diagnostics are various techniques used by healthcare professionals to detect and diagnose diseases causing pathogens in human samples such as serum, blood, urine, throat swab, and stool. Growth in this market is largely be driven by the increasing global prevalence of infectious diseases, the shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics. The key players in the global infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), bioMérieux (France), Bio-Rad (US), and Roche (Switzerland). |
April 2018 | $ 5650 |
|
Surgical Drapes and Gowns Market by Type (Drapes (Cardiovascular, General Surgery, C- Section, Lithotomy, Laparoscopy, Ophthalmic), Gown (Standard, Reinforced, High-Performance)), Utility (Reusable, Disposable), End User (Hospital) - Global Forecast to 2023The global surgical drapes and gowns market is expected to reach USD 3.14 Billion by 2023 from USD 2.47 Billion in 2018, at a CAGR of 4.9%. Major industry players launched innovative products to maintain and improve their position in the surgical drapes and gowns market. Cardinal Health (US), 3M (US), Mölnlycke Health Care (Sweden), Halyard Health (US), Thermo Fisher Scientific Inc. (US), Steris plc (US), and Paul Hartmann AG (Germany) have been identified as the key players in this market. |
April 2018 | $ 5650 |
|
Orthodontic Supplies Market by Product (Removable, Fixed Braces (Brackets (Self Ligating, Lingual), Archwire (Ni-Ti, Stainless Steel), Anchorage (Buccal Tube, Band), Ligature (Elastomeric, Wire)), Retainers), Patient, and Region - Global Forecast to 2023The global orthodontic supplies market is expected to reach USD 6.63 Billion by 2023 from USD 4.32 Billion in 2018, growing at a CAGR of 8.9%. The growing number of patients with malocclusions, jaw diseases, tooth decay/tooth loss, and jaw pain; increasing disposable incomes and expanding middle-class population in developing countries; increasing awareness about advanced orthodontic treatments; and ongoing research and technological advancements in orthodontic products are the key factors driving the growth of this market. The major players operating in the orthodontic supplies market include Align Technology, Inc. (US), 3M Company (US), Danaher Corporation (US), Henry Schien, Inc. (US), DENTSPLY SIRONA, Inc. (US), American Orthodontics (US), Rocky Mountain Orthodontics (US), G&H Orthodontics (US), DENTAURUM GmbH & Co. (Germany), TP Orthodontics, Inc. (US), ClearCorrect (a subsidiary of Straumann Holding AG, Switzerland), Ultradent Products, Inc. (US), Great Lakes Orthodontics, Ltd. (US), DB Orthodontics (UK), and Dental Morelli Ltda. (Brazil), among others. |
April 2018 | $ 5650 |
|
Neuroendoscopy Market by Product (Rigid (Videoscope, Fiberscope), Flexible endoscope), Usability (Reuse and Disposable), Application (Transnasal, Intraventricular, and Transcranial), Region (North America, Europe, Asia) - Global Forecast to 2022The global neuroendoscopy devices market is expected to reach USD 218.9 Million by 2022 from USD 170.5 Million in 2017, at a CAGR of 5.1% during the forecast period. Factors such favorable government initiatives, rising prevalence of neurological disorders, and benefits of neuroendoscopic surgery over conventional brain surgery are driving the growth of this market. The report segments the global neuroendoscopy devices market into product, application, usability, and region. The neuroendoscopy devices market includes various small and large players. Key players in this market are KARL STORZ (Germany), B.Braun Aesculap (Germany), Ackermann Instrumente (Germany), Adeor Medical (Germany), Hawk (China), Machida (Japan), Tonglu Wanhe Medical (China), Schindler (Germany), Clarus (US), LocaMed (UK), and Visionsense (US). |
April 2018 | $ 5650 |
|
Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Product (ECG, Cardiac Output Monitoring, ILR), CRM [ICDs, External Defibrillator, Pacemaker (Dual Chamber Pacemaker)], End User (Home and Ambulatory, Hospital) - Global Forecast to 2022The cardiac monitoring and cardiac rhythm management devices market is expected to reach USD 25.12 Billion by 2022 from USD 20.67 Billion in 2017, at a CAGR of 4.0% during the forecast period. The scope of the report includes cardiac monitoring and cardiac rhythm management devices used for the continuous monitoring, detection, and treatment of heart activities and abnormal heart rhythm (electric heart patterns). The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The cardiac monitoring and cardiac rhythm management devices market is dominated by players such as Medtronic (Ireland), Abbott (US), Boston Scientific (US), BIOTRONIK (Germany), GE Healthcare (US), and Philips Healthcare (Netherlands) |
April 2018 | $ 5650 |
|
Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023The sepsis diagnostics market is expected to reach USD 564.1 Million by 2021 from USD 370.0 Million in 2016, at a CAGR of 8.8% during the forecast period. Rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections, and increase in the number of product approvals are supporting the growth of this market. However, lack of standard protocols and awareness as well as shortage of skilled staff are the major challenges in this market. The major players of the sepsis diagnostics market are bioMérieux (France), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), Abbott (US), Roche (Switzerland), Danaher (US), Becton, Dickinson, and Company (US), EKF Diagnostics (UK), Immunexpress (Australia), Response Biomedical (Canada), Axis-Shield Diagnostics (UK), CytoSorbents (US), and Mitsubishi Chemical Europe (Germany). |
April 2018 | $ 5650 |
|
Infusion Pump Market by Product (Volumetric, Insulin, Enteral, Syringe, Ambulatory, Implantable, PCA, Accessories), Application (Oncology, Diabetes, Gastroenterology, Pediatrics, Hematology), End User (Hospital, Home Care, ACS) - Global Forecast to 2023The global infusion pumps market is projected to reach USD 15.89 Billion by 2023 from USD 11.90 Billion in 2018, growing at a CAGR of 6.0%. Factors such as the increasing prevalence of chronic diseases along with the rapid growth in the geriatric population, growing use of ambulatory infusion pumps in home care settings, and growing number of surgical procedures are driving the market growth. The prominent players in the infusion pumps market are Becton, Dickinson and Company (US), Baxter (US), ICU Medical (US), B. Braun (Germany), Fresenius Kabi (Germany), Medtronic (Ireland), Smiths Medical (US), Terumo Corporation (Japan), Moog (US), Roche Diagnostics (Switzerland), Halyard Health (US), Mindray Medical (China), Micrel Medical (Greece), and Insulet Corporation (US). |
April 2018 | $ 5650 |
|
Ophthalmic Equipment Market by Product (Optical Coherence Tomography (OCT), Fundus Camera, Ultrasound, Ophthalmoscope, Phoropter, Slit Lamp, Perimeter, Keratometer, Tonometer, IOL, Femtosecond Laser, Surgical Microscope, Contact Lenses) - Global Forecasts to 2023The ophthalmic equipment market is estimated to reach USD 58.44 Billion by 2023 from USD 49.30 Billion in 2018, at a CAGR of 3.5%. Rapid growth in the geriatric population and associated increase in the prevalence of eye diseases, technological advancements in ophthalmic devices, increasing government initiatives to control visual impairment, and rising adoption of contact lenses and spectacles are the major factors driving the growth of the market. However, the high-cost ophthalmic devices and reimbursement cuts for ophthalmic surgical procedures may hinder the growth of this market. Furthermore, the lack of awareness and low accessibility to eye care products in low-income economies is a major challenge for the growth of the ophthalmic equipment market. The prominent players in the ophthalmic equipment market are Essilor (France), Alcon (Switzerland), Johnson & Johnson Vision Care (US), Bausch + Lomb (US), Haag-Streit (Switzerland), TOPCON (Japan), Carl Zeiss Meditec (Germany), NIDEK (Japan), STAAR Surgical (US), HOYA (Japan), and Ziemer Ophthalmic Systems (Switzerland) |
March 2018 | $ 7150 |
|
Dental Implants and Prosthesis Market by Type (Dental Implants, Bridge, Crown, Abutment, Dentures, Veneers, Inlay & Onlays), Material (Titanium, Zirconium, Metal, Ceramic, Porcelain Fused to Metal), Type of Facility, and Region - Global Forecast to 2023The global dental implants and prosthesis market is projected to reach USD 13.01 Billion by 2023 from USD 9.50 Billion in 2018, at a CAGR of 6.5%. The growth of this market is driven by the growth in the geriatric population and corresponding age-related dental diseases, rising prevalence of tooth decay and periodontal diseases in the overall population across the globe, increasing willingness to adopt dental cosmetic surgery, and the growing number of implant placing dentists. However, the high cost of premium dental implants and limited reimbursement, and high risk of tooth loss associated with dental bridges may expect to hinder the growth of this market during the forecast period. The key players in the global dental implants and prosthesis market are Straumann (Switzerland), DENTSPLY Sirona (US), Zimmer Biomet (US), Danaher Corporation (US), AVINENT Implant System (Spain), Henry Schein (US), OSSTEM Implant Co. (South Korea), DIO Corporation (South Korea), Merz Dental (Germany), Bicon (US), Shofu Dental Corporation (Japan), Thommen Medical (Switzerland), and Southern Implant (South Africa). |
March 2018 | $ 5650 |
|
Microfluidics Market by Application (Genomics, Proteomics, Capillary Electrophoresis, IVD (POC, Clinical Diagnostics), Drug Delivery, Microreactor, Lab Tests), Component (Chips, Pump, Needle), Material (Polymer, Glass, Silicon) - Global Forecast to 2023The global microfluidics market is projected to reach USD 27.91 Billion by 2023 from USD 10.06 Billion in 2018, at a CAGR of 22.6%. Rising demand for point-of-care testing due to the rising incidence of chronic infectious diseases, fast returns on investment on the purchase of equipment integrated with microfluidic technology, faster testing and improved portability through microfluidic chip miniaturization, and entry of new players with innovative microfluidics technology & launch of new and advanced products embedded with microfluidics technology are some of the major factors attributed to the growth of the microfluidics market during the forecast period. However, there are certain challenges in incorporating the microfluidics technology into existing workflows. The key players in the global microfluidics market are Danaher (US), Thermo Fisher (US), PerkinElmer (US), Agilent (US), Bio-Rad (US), Becton, Dickinson and Company (US), Roche (Switzerland), Illumina (US), Fluidigm Microfluidics (US), and QIAGEN (Netherlands). Other key players include Dolomite Microfluidics (UK), GYROS PROTEIN TECHNOLOGIES AB (Sweden), Sphere Fluidics (UK), OPKO Health (US), Waters (US), thinXXS Microtechnology (Germany), Abaxis (US), BioMérieux (France), Abbott (US), Dolomite Microfluidics (UK), Microfluidic ChipShop (Germany), Elveflow (France), Cellix (Ireland), Micronit Microtechnologies (Netherlands), MicroLiquid (Spain), MiniFAB (Australia), uFluidix (Canada), Micralyne (US), and Fluigent (France). |
March 2018 | $ 5650 |
|
In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology) - Forecast to 2023The global in vitro diagnostics market is projected to reach USD 87.93 Billion by 2023 from USD 68.12 Billion in 2018, at a CAGR of 5.2%. The rising demand for early and accurate disease diagnosis, increasing prevalence of infectious diseases, increasing adoption of fully-automated instruments and automation in laboratories, increasing adoption of point-of-care testing, and growing awareness of personalized medicine are the key factors driving the growth of the market. The prominent players in the global in vitro diagnostics market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific (US), Johnson & Johnson (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMérieux (France), DiaSorin (Italy), Ortho Clinical Diagnostics (US), Agilent Technologies (US), and QIAGEN (Germany). |
March 2018 | $ 5650 |
|
Urgent Care Center Market by Service (Acute Illness Treatment, Trauma/Injury Treatment, Physical Examination, Immunization & Vaccination), Ownership (Corporate Owned, Physician Owned, Hospital Owned), and Region - Global Forecast to 2023The global urgent care center market is projected to reach USD 25.93 Billion by 2023 from USD 20.07 Billion in 2018, at a CAGR of 5.3% during the forecast period. The growth of this market is driven by factors such as growing investments in urgent care, increasing geriatric population, strategic developments between urgent care providers and hospitals, and affordable care and shorter waiting periods offered by urgent care centers. Concentra (US), MedExpress (US), American Family Care (US), NextCare Holdings (US), and FastMed Urgent Care (US) are the key players in the urgent care center market. Other players involved in this market are CityMD (US), CareNow Urgent Care (US), GoHealth Urgent Care (US), HCA Healthcare UK (UK), Columbia Asia Hospitals (India), International SOS (China), and St. Joseph's Health Care London (Canada). |
March 2018 | $ 5650 |
|
Medical Display Market by Technology (LED, OLED) Panel Size (≤22.9”, 27.0-41.9”, ≥42”) Resolution (≤2MP, 4.1-8MP, ≥8MP), Application (Radiology, Mammography, Digital Pathology, Multi-modality, Surgical), & Display color - Global Forecast to 2023The global medical display market is projected to reach USD 2.33 Billion by 2023 from USD 1.86 Billion in 2018, at a CAGR of 4.6%. Growing adoption of hybrid ORs, short replacement cycle of medical displays, increasing preference for minimally invasive treatments, and rising number of diagnostic imaging centers are the major factors driving the growth of the market. However, market saturation and the increased adoption of refurbished medical displays are expected to restrain the growth of this market to a certain extent. Prominent players in the healthcare medical display market include Barco (Belgium), EIZO (Japan), Sony (Japan), LG Display (South Korea), Novanta (US), FSN Medical (South Korea), Advantech (Taiwan), Quest International (US), STERIS (UK), Jusha Medical (China), Double Black Imaging (US), Dell (US), HP (US), Shenzhen Beacon Display (China), COJE Display (South Korea), and Axiomtek (Taiwan). |
March 2018 | $ 5650 |
|
Automated blood Tube Labeler & Specimen Transport Box Market – By End User (Hospitals, Diagnostic Center, Skilled Nursing Facility, Long Term Acute Care Facilities), Specimen Transport Box Type (Traditional Boxes, Smart Transportation Boxes) - Forecast to 2022The automated blood tube labeler market is expected to reach USD 142.0 Million by 2022 from USD 102.3 Million in 2017, at a CAGR of 6.8% during the forecast period. The scope of the report includes automated tube labeler used to label blood tubes. The specimen transportation box market is expected to reach USD 135.8 Million by 2022 from USD 94.7 Million in 2017, at a CAGR of 7.5% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The automated tube labeler market is dominated by players such as Techno Medica (Japan), Kobayashi Create (Japan), and Inpeco (Switzerland). The major players in specimen transport box market include Sonoco Product Company (US), Greiner Holding (Austria), and Alifax Holdings (Italy). |
March 2018 | $ 5650 |
|
Transradial Access Market by Product (Catheters, Guidewires, Sheath and Sheath Introducers), Application (Administration of Medicine and Administration of fluids), End User (Hospitals, Clinics & Ambulatory Centres) - Global Forecast 2022The transradial access devices market is projected to reach USD 2.18 Billion by 2022 from USD 1.52 Billion in 2017, at a CAGR of 7.5%. The prominent players include Becton, Dickinson and Company (US) and Terumo Corporation (Japan), Teleflex Incorporated (US), Smiths Group Plc (UK), Edward Lifesciences Corporation (US), Medtronic (Ireland), Merit Medical System, Inc. (US), Boston Scientific (US), NIPRO Medical Corporation (US), AngioDynamics (US), Ameco Medical Industries (Egypt), and OSCOR Inc. (US). |
March 2018 | $ 5650 |
|
Colposcopy Market by Instrument Type (Optical, Digital), Portability (Fixed, Portable, Handheld), Application (Cervical Cancer Diagnosis, Physical Examination), End User (Hospitals, Clinics, Diagnostic Centres), and Region - Global Forecast to 2023The global colposcopy market is expected to reach USD 740.1 Million by 2023 from USD 532.6 Million in 2018, at a CAGR of 6.8%. Market growth can largely be attributed to factors such as the heavy burden of cervical cancer, the rapidly growing geriatric population, and technological advancements in colposcopy. Increasing awareness about gynecological diseases and the emerging Asian markets are expected to present a wide array of growth opportunities for players in the market. Key players in the Colposcopy market include DySIS (US), CooperSurgical (US), Atmos (Germany), Olympus (Japan), Karl Kaps (Germany), McKesson (US), Danaher (US), and Carl Zeiss (Germany). |
March 2018 | $ 5650 |
|
Cranial Fixation & Stabilization Systems Market by Product (Screw, Mesh, Skullclamp, Horseshoe Headrest, Accessories, Adaptor, Arms, Base units), Material (Nonresorbable, Resorbable), End User (Hospitals, ASC), and Region - Global Forecast to 2022The global cranial fixation and stabilization systems market is expected to reach USD 1.74 Billion by 2022 from USD 1.14 Billion in 2017, at a CAGR of 8.7%. The growth of this market is mainly driven by the increasing prevalence of neurological diseases and high incidence of road accidents and fall related injuries. The cranial fixation and stabilization systems market is highly competitive with the presence of several large as well as emerging players. Prominent players in the cranial fixation and stabilization systems market include B. Braun (Germany), Changzhou Huida (China), DePuy Synthes (US), Evonos (Germany), Integra (US), Jeil Medical (South Korea), KLS Martin (Germany), Medicon (Germany), Medtronic (Ireland), Micromar (Brazil), NEOS Surgery (Spain), OsteoMed (US), Pro Med Instruments (Germany), Stryker (US), and Zimmer Biomet (US). |
March 2018 | $ 5650 |
|
Endoscopic Vessel Harvesting Market by Product (EVH systems, Endoscope, Accessories), Usability (Disposable, Reusable), Vessel (Saphenous Vein, Radial Artery), Application (Coronary Artery Disease, Peripheral Artery Disease) - Global Forecast to 2022The global endoscopic vessel harvesting market is projected to reach USD 504.8 Million by 2022 from an estimated USD 420.5 Million in 2017, at a CAGR of 3.7% during the forecast period. The growth of this market is majorly driven by factors such as the increasing prevalence of cardiovascular diseases, growing preference for minimally invasive harvesting owing to advantages it offers over conventional methods, and rising geriatric population. The key players in the global endoscopic vessel harvesting market are Getinge (Sweden), Terumo (Japan), LivaNova (UK), Saphena Medical (US), KARL STORZ (Germany), Cardio Medical (Germany), and Medical Instruments Spa (Italy). |
March 2018 | $ 5650 |
|
Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region - Global Forecast to 2022The global injection pen market is projected to reach USD 41.38 Billion by 2022 from USD 30.97 Billion in 2017 at a CAGR of 6.0% during the forecast period. The growth of this market is primarily driven by factors such as the growing prevalence of chronic diseases, increasing number of regulatory approvals, and favorable reimbursement in developed countries, and government support. The key players in the global injection pen market are Novo Nordisk (Denmark), Eli Lilly (US), Sanofi (France), Ypsomed (Switzerland), Merck (Germany), AstraZeneca (UK), F. Hoffman-la Roche (Switzerland), Becton, Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Pfizer (US), and Haselmeier (Switzerland). |
February 2018 | $ 5650 |
|
Arthroscopy Instruments Market by Type (Implants, Arthroscope, Visualization System, Surgical Shaver, RF Ablation, Fluid Management), Application (Knee, Hip, Shoulder), End User (Hospitals, Ambulatory Surgery Centers & Clinics) - Global Forecast to 2022The global arthroscopy instruments market is projected to reach USD 5.61 Billion by 2022 from USD 4.17 Billion in 2017, at a CAGR of 6.1% during the forecast period. The high incidence of sport-related injuries; technological advancements in arthroscopy products; and efficient reimbursement systems in developed countries are some of the factors driving the growth of the market. The major players of the arthroscopy instruments market are Arthrex (US), Smith & Nephew (UK), DePuy Synthes (US), Stryker (US), Zimmer Biomet (US), CONMED (US), Medtronic (Ireland), Karl Storz (Germany), B. Braun (Germany), Olympus (Japan), Richard Wolf (Germany), MEDICON (Germany), Sklar (US), Millennium (US), and GPC Medical (India). |
February 2018 | $ 5650 |
|
Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD) and External (Manual, AED, Wearable)), End User (Hospitals, Prehospital, Public Access, Home care) - Global Forecast to 2022The global defibrillators market is expected to reach USD 10.88 Billion by 2022 from USD 9.32 Billion in 2017, growing at a CAGR of 3.1% during the forecast period. Factors such as technological advancements in defibrillators, increasing burden of target diseases, growing focus on providing public-access defibrillators, and rising number of training & awareness programs on defibrillators are driving the growth of this market. The key players in the defibrillators market include Medtronic (Ireland), St. Jude Medical (US), Boston Scientific (US), Koninklijke Philips N.V. (Netherlands), ZOLL Medical (US), BIOTRONIK (Germany), Physio-Control (US), Cardiac Science (US), LivaNova (UK), Nihon Kohden (Japan), SCHILLER (Switzerland), Mindray Medical (China), Mediana (South Korea), METRAX (Germany), and METsis (Turkey). |
February 2018 | $ 5650 |
|
RSV Diagnostics Market by Product (Kits and Assays, Instruments), Method (Rapid Antigen Detection Test (Immunofluorescence Assay, ELISA), Molecular Diagnostic), End User (Hospitals & Clinics, Clinical Laboratories, Homecare) - Global Forecast to 2022The global RSV diagnostics market is expected to reach USD 929.2 Million by 2022 from USD 574.3 Million in 2017, at a CAGR of 10.1%. Market growth is primarily driven by the rising burden of RSV infections, growing demand for PoC molecular diagnostic tests for the diagnosis of RSV infections, and increasing approval of RSV diagnostic kits and assays. Key players in the RSV diagnostics market include bioMérieux (France), Becton Dickinson (US), Abbott (US), Roche (Switzerland), Danaher (US), Luminex (US), BioCartis (Belgium), Hologic (US), and Fast Track Diagnostics (Luxembourg). |
February 2018 | $ 5650 |
|
Point-of-Care/Rapid Diagnostics Market by Testing (Glucose, Lipids, HbA1c, HCV, HIV, Influenza, Urinalysis, Hematology, Cancer, Pregnancy, PT/INR), Platform (Lateral Flow, Immunoassay), Mode (Prescription, OTC), End-User - Global Forecast to 2022The global point-of-care diagnostics market is projected to reach USD 38.13 Billion by 2022 from USD 23.71 Billion in 2017, at a CAGR of 10.0% during the forecast period. Factors such as high prevalence of infectious diseases in developing countries, increasing incidence of target diseases, and rising preference for home healthcare across the globe are increasing the adoption of POC diagnostic products globally. The major players of the point-of-care diagnostics market are Abbott (US), Roche (Switzerland), Siemens (Germany), Danaher (US), Becton, Dickinson, and Company (US), Johnson & Johnson (US), Instrumentation Laboratory (US), PTS Diagnostics (US), Quidel (US), Chembio (US), Sekisui Diagnostics (US), Nova (US), EKF Diagnostics (UK), AccuBioTech (China), and Trinity Biotech (US). |
February 2018 | $ 5650 |
|
Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) - Global Forecast to 2023The global embolic protection devices market is projected to reach USD 604.9 Million by 2023 from USD 405.5 Million in 2018, at a CAGR of 8.3%. Factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, launch of technologically advanced embolic protection devices, and rising demand for minimally invasive procedures are expected to drive the growth of the market. On the other hand, product failures and recalls may hinder the overall market growth to a certain extent during the forecast period. The prominent players in the embolic protection devices market are Boston Scientific (US), Medtronic (Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical (Israel), Contego Medical (US), W.L. Gore & Associates (US), Silk Road Medical (US), Claret Medical (US), and AngioSlide (Israel). |
February 2018 | $ 5650 |
|
Microplate Systems Market by Product (Microplate Reader (Multi-mode {Hybrid}, Single-mode), Dispenser, Software), Application (Research, Clinical Diagnostics) & End User (Biotechnology, Pharmaceutical, Hospital, Diagnostic Labs) - Forecast to 2022The global microplate systems market is expected to reach USD 996.9 Million by 2022 from USD 820.3 Million in 2017 at a CAGR of 4.0%. The microplate systems market is highly competitive with the presence of several small and big players. Prominent players in this market include BioTek (US), Danaher (US), PerkinElmer (US), Tecan (Switzerland), Thermo Fisher (US), BMG LABTECH (Germany), BERTHOLD (Germany), Agilent (US), Bio-Rad (US), Promega (US), Biochrom (UK), Corning (US), Lonza (Switzerland), Rayto (China), and Mindray (China). |
February 2018 | $ 5650 |
|
Guidewires Market by Material (Nitinol, Stainless Steel, Hybrid), Product (Surgical, Diagnostic (Hydrophilic, Hydrophobic)), Application (Cardiology, Vascular, Neurology, GIT, ENT, Urology, Oncology), End User (Hospital, ASCs) - Global Forecast to 2022The global guidewires market is projected to reach USD 764.0 Million by 2022 from USD 605.2 Million in 2017, at a CAGR of 4.8%. The growth witnessed by guidewires is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for guidewires across developed countries, and rising adoption of minimally invasive surgical procedures across major countries. Major players operating in the market include Boston Scientific (US), Abbott (US), Medtronic (Ireland), Terumo (Japan), and Cook Group (US). Other prominent players present in this market include Cardinal Health (US), Olympus (Japan), Johnson & Johnson (US), B. Braun (Germany), C.R. Bard (US), Teleflex (US), and Angiodynamics (US). |
February 2018 | $ 5650 |
|
Intraocular Lens Market by Type (Traditional/Monofocal (Spheric, Aspheric), Premium (Multifocal, Accommodating, and Extended Depth of Focus), and Phakic), Material (PMMA, Foldable), End User (Hospital, Clinic), and Region - Global Forecast to 2022The global Intraocular Lens Market is projected to reach USD 4.56 Billion by 2022 from USD 3.50 Billion in 2017, at a CAGR of 5.4%. The growth of this market is majorly driven by the growth in the geriatric population and corresponding age-related eye disorders, rising prevalence of eye diseases & diabetes in the overall population across the globe, and increasing government initiatives to control and treat blindness caused by cataract. The key players in the global intraocular lenses market are Alcon, Inc. (US) (Novartis AG (Switzerland)), Bausch + Lomb (US) (Valeant Pharmaceuticals International (Canada)), Johnson & Johnson Vision Care, Inc. (US), Carl Zeiss Meditec (Germany), HOYA Corporation (Japan), STAAR Surgical Company (US), Rayner Intraocular Lenses Limited (UK), PhysIOL (Belgium), Ophtec BV (Netherlands), Swiss Advanced Vision (SAV IOL) (Switzerland), Oculentis GmbH (Germany), NIDEK CO., LTD. (Japan), Aurolab (India), Omni Lens Pvt Ltd. (India), Care Group (India), Hanita Lenses R.C.A Ltd. (Israel), and Fred Hollows Intraocular Laboratory (Eritrea). |
January 2018 | $ 5650 |
|
Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (RA, SLE, Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022The global autoimmune disease diagnosis market is expected to reach USD 4.73 Billion by 2022 from USD 3.09 Billion in 2017, at a CAGR of 8.9%. The growing incidence of autoimmune diseases along population, technological advancements in analyzing devices, increasing access to medical insurance in the US, and increasing healthcare expenditure are key factors driving the growth of this market. Key players in the autoimmune disease diagnosis market include Thermo Fisher Scientific.(US), Danaher (US), HYCOR Biomedical (US), Siemens (Germany), Bio-Rad Laboratories. (US), and Abbott (US). |
January 2018 | $ 5650 |
|
Medical Ceramics Market by Type of Material (Bioinert (Zirconia, Alumina), Bioactive (Hydroxyapatite, Glass Ceramics), Bioresorbable, Piezoceramics), Application (Dental, Orthopedic, Cardiovascular, Plastic Surgery), and Region - Global Forecast to 2022The global medical ceramics market is projected to reach USD 18.45 Billion by 2022 from USD 13.38 Billion in 2017, at a CAGR of 6.6%. The growth of this market is majorly driven by factors such as increasing research activities for the development of novel medical ceramics, growing demand for medical ceramics in plastic surgeries and wound healing applications, rising number of hip and knee replacement procedures, and increasing demand for implantable devices. Some of the key players in the medical ceramics market are CoorsTek (US), CeramTec (Germany), Kyocera (Japan), Morgan Advance Material (UK), NGK Spark Plug (Japan), DePuy Synthes (US), Zimmer Biomet (US), Rauschert (Germany), Straumann (Switzerland), H.C. Stark (Germany), 3M (US), and DSM (Netherlands). |
January 2018 | $ 5650 |
|
Bone Cement & Glue Market by Type (PMMA, Calcium Phosphate, Natural, Synthetic), Application (Arthroplasty (Total Knee, Hip, Shoulder), Kyphoplasty, Vertebroplasty), End User (Hospitals, Clinics, Ambulatory Surgery Centers) - Global Forecast to 2022The global bone cement and glue market is expected to reach USD 1,322.6 Million by 2022 from USD 993.0 Million in 2017, at a CAGR of 5.9%. The market growth is primarily driven by the growing incidence of sports injuries and increasing developments in regenerative medicine field. Key players in the bone cement and glue market include Stryker (US), Zimmer Biomet (US), DePuy Synthes (US), Smith & Nephew (UK), Arthrex (US), DJO Global (US), Exactech (US), TEKNIMED (France), Heraeus Medical (Germany), CryoLife (US), Cardinal Health (US), and Trimph (Australia). |
January 2018 | $ 5650 |
|
Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Neurology, Genetic Testing), Lab Type (Independent Labs, Hospital Laboratories), Technology (Mass Spectrometry, CLIA, ELISA, PCR) - Global Forecast to 2023The global esoteric testing market is projected to reach USD 35.24 Billion by 2023 from USD 20.38 Billion in 2018, at a CAGR of 11.6%. The rising demand for early and accurate disease diagnosis, increasing prevalence of infectious diseases, growing public-private investments as well as research funding & grants to develop innovative laboratory testing procedures, and advancements in clinical diagnostic techniques are the key factors driving the growth of the market. The prominent players in the global esoteric testing market include LabCorp (US), OPKO Health (US), ARUP Laboratories (US), Miraca Holdings (Japan), Myriad Genetics (US), Genomic Health (US), Quest Diagnostics (US), American Medical Laboratories (US), Foundation Medicine (US), Mayo Medical Laboratories (US), Primary Healthcare (Australia), Healthscope (Australia), Sonic Healthcare (Australia), Fulgent Genetics. (US), Invitae (US), Spectra Laboratories (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Enzo Biochem (US), Clinical Reference Laboratory (US), Sequenom (US), and American Pathology Partners (US). |
January 2018 | $ 5650 |
|
Vascular Graft Market by Indication (EVAR, Abdominal Aneurysm Repair, Thoracic Aneurysm, Peripheral Vascular Repair), Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic), End Users (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022The global vascular grafts market is expected to reach USD 3.80 Billion by 2022 from USD 2.67 Billion in 2017, at a CAGR of 7.3%. Growth in the vascular grafts market is mainly driven by the constant growth in the geriatric population and the corresponding prevalence of aneurysms, increasing incidence of end-stage renal disease, and the growing preference for minimally invasive surgeries. Key players operating in this market are B. Braun (Germany), C. R. Bard (US), Cardinal Health (US), Cook Medical (US), Endologix (US), LeMaitre Vascular (US), Medtronic (Ireland), Maquet (Germany), Terumo (Japan), and Gore Medical (US). |
January 2018 | $ 5650 |
|
Antimicrobial Susceptibility Testing Market by Product (Automated System, Disks, MIC Strips, Media), Method (Dilution, Diffusion), Type (Antibacterial, Antifungal), Application (Clinical, Drug Discovery), End User (Labs, Hospitals) - Global Forecast to 2022The global antimicrobial susceptibility testing market is expected to reach USD 3.47 Billion by 2022 from USD 2.71 Billion in 2017, at a CAGR of 5.1%. Factors such as increasing prevalence of infectious diseases across the globe, emergence of antimicrobial resistance caused due to drug overuse, increasing initiatives by government organizations towards improving the detection and control antimicrobial resistant species, and improving growth opportunities in emerging markets are boosting the demand for antimicrobial susceptibility testing products. As of 2016, some of the major players operating in this market include bioMérieux (France), BD (US), Danaher (US), Thermo Fisher (US), and Bio-Rad (US). |
January 2018 | $ 5650 |
|
Wearable Medical Devices Market by Device (Diagnostic (Heart, Pulse, BP, Sleep), Therapeutic (Pain, Insulin, Rehabilitation)), Application (Sport, Fitness, RPM), Type (Smartwatch, Patch), Distribution Channel (Pharmacy, Online) - Global Forecast to 2022The wearable medical devices market is expected to reach USD 14.41 Billion by 2022 from USD 6.22 Billion in 2017, at a CAGR of 18.3% during the forecast period. Factors such as technological advances in medical devices, increasing penetration of smartphones and growing number of smartphone-based healthcare apps compatible with wearable devices, growing preference for wireless connectivity among healthcare providers, and increasing awareness about physical fitness are driving the growth of this market. The wearable medical devices market is highly competitive with several big and small players. Prominent players in this market include Fitbit (US), Philips (Netherlands), LifeWatch (Switzerland), Garmin (Switzerland), and Omron (Japan). The other players operating in this market include Drägerwerk (Germany), Nokia Technologies (US), Jawbone (US), Polar (Finland), Wor(l)d Global Network (US), Activeinsights (UK), VitalConnect (US), Xiaomi (China), Misfit (US), and Monica Healthcare (UK). |
January 2018 | $ 5650 |
|
Ventilator Market by Mobility (Intensive Care, Portable), Type (Adult, Infant), Mode (Volume, Pressure, Combined), Interface (Invasive, Non-invasive), End User (Hospital, Home Care, Ambulatory Care Center, EMS) - Global Forecast to 2023The global ventilators market is projected to reach USD 1,261.9 Million by 2023 from USD 859.9 Million in 2018, at a CAGR of 8.0%. Rapid growth in the geriatric population, increasing incidence of preterm births, and rising number of ICU beds are the major factors driving the growth of the ventilators market. Moreover, the growing investments, favorable regulatory policies, and growth in the healthcare industry in emerging countries in the Asian region are expected to provide favorable growth opportunities for players operating in the ventilators market. The prominent players in the global ventilators market are Philips Healthcare (Netherlands), ResMed (US), Medtronic (Ireland), Becton, Dickinson and Company (US), Getinge (Sweden), Dräger (Germany), Smiths Group (UK), Hamilton Medical (Switzerland), GE Healthcare (US), Fisher & Paykel (New Zealand), Air Liquide (France), Zoll Medical (US), Allied Healthcare Products (US), Airon (US), Mindray (China), and Schiller (Switzerland). |
January 2018 | $ 5650 |
|
Neuroprosthetics Market by Type (Output (Cognitive, Motor Prosthetics), Input (Cochlear, Retinal Implant)), Techniques (Deep Brain, Vagus Nerve, Spinal Cord stimulation), Application (Epilepsy, Paralysis, Alzheimer’s Disease) - Global Forecast to 2022Neuroprostheses uses electrodes to interface with the central or peripheral nervous system to restore lost motor or sensory capabilities. These devices can receive neural signals from the external environment & brain, and convert the signals to restore functions such as loss of hearing and vision. They have applications in cognitive disorders, ophthalmic disorders, motor disorders, and auditory disorders. The global neuroprosthetics market is expected to reach USD 10.48 Billion by 2022 from USD 5.84 Billion in 2017, at a CAGR of 12.4%. Increasing number of neurological disorders, increasing incidence of hearing loss, increasing prevalence of diabetes, and increasing cases of amputation due to the rising number of accidents & injuries are the major driving factors for this market. Some of the major players operating in the neuroprosthetics market are Boston Scientific (US), LivaNova (UK), Medtronic (US), Abbott (US), Cochlear (Australia), and Second sight (US). |
January 2018 | $ 5650 |
|
Drug Screening Market by Product ((Immunoassay Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)), Drug Screening Services, Sample Type (Urine, Hair, Oral), End User (Workplace, Criminal Justice, Hospital) - Global Forecast to 2022The drug screening market was valued at USD 4.86 Billion in 2016 and is expected to reach USD 8.63 Billion by 2022, growing at a CAGR of 10.2% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The drug screening market is highly competitive with the presence of several small and big players. Some of the players offering products for drug screening market include Alere (US), Thermo Fisher (US), Siemens Healthineers (US), Alfa Scientific Designs (US), Roche (Switzerland), MPD, Inc. (US), Shimadzu (Japan), OraSure (US), Lifeloc (US), and Drägerwerk (Germany). On the other hand, LabCorp (US), Quest Diagnostics (US), Psychemedics (US), Omega Laboratories (US), CRL (US), SureHire (Canada), and CannAmm (Canada). |
January 2018 | $ 5650 |
|
Nerve Monitoring System Market by Product (Nerve Monitor, Electrode, Probe, Accessories), Technology (EEG, EMG, EP, ECOG), Application (Neurosurgery, ENT Surgery, Spine Surgery, Cardiovascular Surgery), End User (Hospital, ASC) - Global Forecasts to 2022The global nerve monitoring system market is projected to reach USD 1.45 Billion by 2022 from USD 1.14 Billion in 2017, at a CAGR of 4.9% during the forecast period. Increased target patient population, clinical benefits associated with nerve monitoring procedures, and the rising use of nerve monitoring in trauma cases are factors expected to drive the demand for nerve monitoring products during the study period. The major players of the nerve monitoring system market are Medtronic (Ireland), NuVasive (US), Nihon Kohden (Japan), Bovie Medical (US), and Natus Medical (US), Checkpoint Surgical (US), Magstim (UK), Inomed (Germany), Erbe Elektromedizin (Germany), Dr. Langer Medical (Germany), EMS Handels (Austria), Neurovision Medical (US), and Halyard Health (Georgia). |
January 2018 | $ 5650 |
|
Enteral Feeding Devices Market by Type (Feeding Pump, Feeding Tube, Giving Set, Enteral Syringes), Age Group (Adult, Pediatric), Application (Oncology, Gastroenterology, Diabetes), End User (Hospital, Home Care) - Global Forecast to 2022The enteral feeding devices market is expected to reach USD 3.19 Billion by 2022 from USD 2.26 Billion in 2016, at a CAGR of 6.0% during the forecast period. The increasing prevalence of chronic diseases, rising geriatric population, rising incidence of preterm births, growing demand for enteral feeding devices in the home care sector, and the shift from parenteral to enteral nutrition are the major factors driving the growth of the enteral feeding devices market. The prominent players in the enteral feeding devices market are Fresenius Kabi (Germany), Halyard Health (US), Medtronic (Ireland), B. Braun (Germany), Abbott (US), C.R. Bard (US), Boston Scientific (US), Cook Medical (US), CONMED (US), Nestlé (Switzerland), Danone (France), Moog (US), Vygon (France), and Applied Medical Technology (US). |
January 2018 | $ 5650 |
|
Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters (Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection), IVC Filters, Guidewires) - Global Forecast to 2022The global peripheral vascular devices market is expected to reach USD 12.63 Billion by 2022 from USD 9.09 Billion in 2017, at a CAGR of 6.8%. Market growth is primarily driven by the growing incidence of peripheral vascular diseases, growing geriatric population, and increasing preference for minimally invasive surgeries. Key players in the peripheral vascular devices market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B.Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and Biotronik (Germany). |
January 2018 | $ 5650 |
|
Cancer/Tumor Profiling Market by Application (Clinical, Research), Technology (Immunoassay, Hybridization (PCR, In Situ Hybridization, DNA/RNA Microarray), NGS, Mass Spectrometry), Cancer Type (Breast, Lung, Prostate, Colorectal) - Global Forecast to 2022Global cancer/tumor profiling market is projected to reach USD 8.74 Billion in 2022 from USD 5.26 Billion in 2017 at CAGR of 10.7%. Major players operating in the cancer/tumor profiling market include Illumina (US), QIAGEN (Netherlands), NeoGenomics Laboratories (US), HTG Molecular Diagnostic (US), and Genomic Health (US). These players focus on inorganic strategies such as acquisitions, agreements, and collaborations as well as organic strategies such as product launches and expansions to sustain their growth in the cancer/tumor profiling market. |
January 2018 | $ 5650 |
|
Clinical Laboratory Services Market by Specialty (Biochemistry, Endocrinology, Microbiology, Hematology, Cytology, Histopathology, Genetic Testing), Providers (Independent Laboratory, Reference Laboratory, Hospital Laboratory) - Global Forecasts to 2022The global clinical laboratory services market is projected to reach USD 146.41 Billion by 2022 from USD 113.44 Billion in 2017, at a CAGR of 5.2%. The major players in the market are Mayo Medical Laboratories (US), Laboratory Corporation of America Holdings (US), Quest Diagnostics Incorporated (US), Spectra Laboratories Inc. (US), DaVita Healthcare Partners (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Bio-Reference Laboratories (US), Sonic Healthcare (UK), Cerba HealthCare (France), and among others |
December 2017 | $ 5650 |
|
Amniocentesis Needle Market by Type (Smaller Than 100 mm, 100 - 150 mm, Larger Than 150 mm), Procedure (Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion), End User (Hospitals, Diagnostic Centers, Clinics) - Global Forecast to 2022The global amniocentesis needles market is expected to reach USD 172.8 Million by 2022 from USD 150.6 Million in 2017, at a CAGR of 2.8%. Major industry players acquired companies and business units from other companies to maintain and improve their position in the amniocentesis needles market. Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), and Cook Medical (US) have been identified as the key players in this market. |
December 2017 | $ 5650 |
|
Infection Control Market by Disinfection Products (Disinfectant, Wipes, Sprays, AER, Wraps), Sterilization Products (Steam, Hydrogen Peroxide, Radiation, Indicators, Services), End User (Hospitals, Life Science, Pharmaceuticals) - Global Forecast to 2022The global infection control market is projected to reach USD 21.06 Billion by 2022 from USD 14.40 Billion in 2016, at a CAGR of 6.5% from 2017 to 2022. The growth of the market can be attributed to the factors such as the increasing demand of sterilization and disinfection products among pharmaceutical companies, hospitals, and medical device manufacturers; increasing prevalence of hospital-acquired infections; growing number of surgical procedures, rising focus on food sterilization and disinfection, and the increasing cost burden due to rising geriatric population and incidence of chronic diseases. The key players in the infection control market are STERIS (UK), Getinge (Sweden), Cantel Medical (US), Ecolab (US), 3M (US), Sotera Health (US), Advanced Sterilization Products (US), MMM Group (Germany), Matachana (Spain), Belimed AG (Switzerland), Halyard Health (US), Metrex Research (US), Reckitt Benckiser (UK), and Pal Internation (UK). |
December 2017 | $ 5650 |
|
Kidney/Renal Function Test Market by Product (Dipsticks, Reagents, Disposables), Type (Urine Test (Urine Protein, Microalbumin, Creatinine Clearance), Blood Test (Serum Creatinine, BUN)), End User -Global Forecast to 2022The global kidney/renal function test market was valued at USD 558.3 Million in 2016 and expected to reach USD 790.1 Million by 2022, growing at a CAGR of 6.1% during the forecast period. Growth in the kidney function test market can primarily be attributed to factors such as the rising prevalence of kidney disease, growing prevalence of diabetes and hypertension, rapid growth in the geriatric population, and the rise in alcohol consumption are driving the growth of the market. The prominent players in the global kidney function/renal function test market are Abbott (US), Siemens (Germany), Sysmex (Japan), Beckman Coulter (US), Roche (Switzerland), ACON Laboratories, Inc. (US), URIT Medical (China), Nova Biomedical (US), ARKRAY (Japan), OPTI Medical (US), 77 Elektronika (Hungary), and Randox Laboratories (UK). |
December 2017 | $ 5650 |
|
Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) - Global Forecast to 2022The global blood glucose monitoring system market was valued at USD 8.10 Billion in 2016 and is projected to reach USD 10.58 Billion by 2022, at a CAGR of 4.8% during the forecast period. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022. Rising prevalence of diabetic population, and increasing innovative product launches are factors driving the growth in the blood glucose monitoring system market. The key players in the global blood glucose monitoring system market are Roche (Switzerland), Abbott (US), LifeScan (US), Ascensia (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), and Nova Biomedical (US). |
December 2017 | $ 5650 |
|
Optometry/Eye Exam Equipment Market by Type (OCT, Fundus Cameras, Perimeters, Ophthalmoscope, Ultrasound, Autorefractor, Slit Lamp, Corneal Topography, Lensmeter, Chart Projectors, Wavefront Analyzer), End User (Hospital, Clinic) - Global Forecast to 2022The global eye exam equipment market is projected to reach USD 3.05 Billion by 2022 from USD 2.29 Billion in 2017, at a CAGR of 6.0% during the forecast period. Growth in this market can primarily be attributed to the rising prevalence of eye diseases, technological advancements in ophthalmic devices, increasing government initiatives to control visual impairment, and increasing healthcare expenditure and rising disposable incomes. The prominent players in the global eye exam equipment market are Carl Ziess (Germany), Haag-Streit (Switzerland), Topcon (Japan), NIDEK (Japan), Heidelberg Engineering (Germany), Escalon (US), Novartis (Switzerland), Valent (Canada), Canon (Japan), Essilor (France), Heine Optotechnik (Germany), and Luneau Technology (France). |
December 2017 | $ 5650 |
|
EMS Products Market by Type (Laryngoscope, ET Tube, ECG, Pulse Oximeter, EEG, ICP, TCD, Temperature and Pre-Natal Monitors, Disinfectant, Dressing, Suture, Staple, Wheelchair, Beds), Application (Cardiac, Trauma), End User - Global Forecast to 2022The global emergency medical service (EMS) products market is expected to reach USD 25.56 Billion by 2022 from USD 19.01 Billion in 2017, at a CAGR of 6.1%. The market growth is primarily driven by the high demand for emergency care; increasing incidence of trauma injuries; and growing investments by government bodies on healthcare infrastructure development. Key players in the EMS products market include Stryker (US), Medtronic (Ireland), Asahi Kasei (Japan), Cardinal Health (US), Philips (Netherlands), GE Healthcare (US), Smith & Nephew (UK), 3M (US), Smiths Medical (UK), Becton, Dickinson (US), Johnson & Johnson (US), B. Braun (US), and C. R. Bard (US). |
December 2017 | $ 5650 |
|
Stoma/Ostomy Care Market by Product (Bags (Surgery Type (Ileostomy, Colostomy, Urostomy), System (One, Two-Piece), Usability (Drainable, Closed), Shape (Flat, Convex)), and Accessories (Powder, Paste)), End User (Home, Hospital) - Global Forecast to 2022The global ostomy care market is projected to reach USD 2.99 Billion by 2022 from USD 2.40 Billion in 2017, at a CAGR of 4.5% during the forecast period. The high incidence of bladder/colorectal cancer/inflammatory bowel disease; rising geriatric population; growing number of awareness programs to educate patients regarding the use of ostomy products; technological advancements in ostomy products; and efficient reimbursement system in developed countries are some of the factors driving the growth of the ostomy market. The major players in the ostomy care market are ConvaTec (UK), Coloplast (Denmark), Hollister Incorporated (US), B. Braun (Germany), Alcare (Japan), Nu-Hope (US), Marlen (US), Welland Medical (UK), BAO-Health (China), Flexicare Medical (UK), Cymed (US), Schena Ostomy (US), Perma-Type (US), 3M (US), and Smith & Nephew (UK). |
December 2017 | $ 6780 |
|
Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022A gastrointestinal stent is a cylindrical medical device primarily used as a safe and effective alternative to surgery or repetitive endoscopic procedures to widen a narrow or stenosed lumen in order maintain the patency of the lumen. The gastrointestinal stents market is expected to reach USD 452.6 Million by 2022 from USD 337.5 Million in 2016, at a CAGR of 5.1% during the forecast period. The increasing preference for minimally invasive surgeries and rising prevalence of GI cancers and other digestive diseases are the major factors driving the growth of the gastrointestinal stents market. The prominent players in the global gastrointestinal stents market are Boston Scientific (US), Cook Group (US), C.R. Bard (US), ELLA-CS (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED (US), Cantel Medical (US), Olympus (Japan), Taewoong Medical (South Korea), Micro-Tech (Nanjing) (China), Endo-Flex (Germany), and M.I. Tech (South Korea). |
December 2017 | $ 5650 |
|
Interventional Cardiology Devices Market by type (Angioplasty, Catheters, Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath)) - Global Forecast to 2022The global interventional cardiology devices market is expected to reach USD 20.85 Billion by 2022 from USD 14.52 Billion in 2017, at a CAGR of 7.5%. Market growth is primarily driven by the growing incidence of CVD and technological advancements in interventional cardiology devices. Key players in the interventional cardiology devices market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B.Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and Biotronik (Germany). |
December 2017 | $ 5650 |
|
Endoscopy Equipment Market by Product (Endoscope (Flexible, Rigid, Capsule) Visualization Systems, Endoscopic Ultrasound, Insufflator)), Application (GI Endoscopy, Laparoscopy, Cystoscopy, Bronchoscopy, Colonoscopy, Arthroscopy) - Global Forecast to 2022The global endoscopy equipment market was valued at USD 24.32 Billion in 2016 and is projected to reach USD 34.82 Billion by 2022, at a CAGR of 6.4% during the forecast period. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022. The key players in the global endoscopy equipment market are Olympus (Japan), KARL STORZ (Germany), Stryker (US), Boston Scientific (US), Ethicon (US), Fujifilm (Japan), Medtronic (Ireland), Hoya (Japan), CONMED (US), Richard Wolf GmbH (Germany), Smith & Nephew (UK), Cook Medical (US), Cogentix Medical (US), and B. Braun (Germany). |
December 2017 | $ 7150 |
|
OTC Braces & Support Market by Product (Knee, Back, Spine, Hip, Ankle, Foot, Shoulder, Elbow, Hand), Application (Osteoarthritis, Preventive Care, Ligament Injury), Sales Channel (Pharmacies, Retailers, E-Commerce, Hospitals) - Global Forecasts to 2022The global OTC braces and supports market is projected to reach USD 1.42 Billion by 2022 from USD 1.10 Billion in 2017, at a CAGR of 5.2%. Factors such as growing prevalence of musculoskeletal disorders and diseases, rapid growth in the geriatric population, rising number of sports-related injuries, and growing adoption of e-commerce platforms for OTC orthopedic braces are driving the growth of the market. As of 2016, key players in this market are DJO Finance LLC (US), Breg, Inc. (US), Ossur Hf (Iceland), DeRoyal Industries, Inc. (US), and Bauerfeind AG (Germany). Other important players in this market include Otto Bock HealthCare (Germany), BSN Medical (Germany), medi GmbH & Co. KG (Germany), 3M Company (US), and THUASNE Group (France), among others. |
December 2017 | $ 5650 |
|
Ophthalmic Surgical Instruments Market by Product (Cataracts (IOL, OVD), Refractive (Femtosecond, Excimer Laser) Glaucoma, Vitreoretinal (Vitrectomy Machine & Packs) Surgical Microscope] End User (Hospital, Specialty Clinic) - Global Forecast to 2022The global ophthalmic surgical instruments market is expected to reach USD 11.18 Billion by 2022 from USD 7.87 Billion in 2016, at a CAGR of 6.0%. Growth in the global ophthalmic surgical instruments market is mainly driven by factors such as the increasing number of ophthalmic surgeries owing to the growth in geriatric population & related eye diseases, technological advancement in ophthalmic surgical devices, and government initiatives to increase the awareness about visual blindness across the globe. The prominent players in the ophthalmic surgical instruments market are Alcon (Switzerland), Carl Zeiss Meditec (Germany), Johnson & Johnson Vision Care (US), Hoya Corporation (Japan), Bausch + Lomb (US), NIDEK (Japan), Topcon Corporation (Japan), Ellex Medical Lasers (Australia), IRIDEX Corporation (US), Lumenis (Israel), STAAR Surgical Company (US), and Ziemer Ophthalmic Systems (Switzerland). |
November 2017 | $ 5650 |
|
Blood Warmer Devices/Sample Warmer Market by Sample (Blood, Embryo, Ovum, Semen), End User (Hospital, Blood Bank, Transfusion Center, Tissue Bank), Region (North America, Europe, Asia Pacific) - Global Forecast to 2022The blood warmer devices market is expected to reach USD 225.6 Million by 2022 from USD 138.7 Million in 2016 at a CAGR of 8.4%. The base year for this study is 2016 and the forecast period is 2017–2022. Key players in the tissue diagnostics market include 3M (US), BD (US), The 37Company (Netherlands), Geratherm Medical (Germany), Stryker (US), Sarstedt (Germany), Barkey (Germany), Stihler Electronic (Germany), Belmont instrument (US), Biegler (Austria), and EMIT (US). |
November 2017 | $ 5650 |
|
Airway Stent / Lung Stent Market by Type (Tracheal, Laryngeal), Product (Self expandable, Balloon expandable), Material (Metal (Nitinol, Stainless Steel) Silicone, Hybrid), Procedure (Bronchoscopy (Rigid, Flexible), Laryngoscopy) - Global Forecast to 2022The lung stents market is expected to reach USD 105.6 Million by 2022 from an estimated USD 76.3 Million in 2017, at a CAGR of 6.7%. The rapidly increasing geriatric population, rising preference for minimally invasive procedures, high prevalence of tobacco smoking, and rising prevalence of lung cancer and other respiratory diseases are the major factors driving the growth of the lung stents market. The prominent players in the global lung stents market are Boston Scientific (US), C.R. Bard (US), Teleflex (US), Cook Group (US), Merit Medical Systems (US), Novatech (France), Fuji Systems (Japan), Taewoong Medical (South Korea), ENDO-FLEX (Germany), M.I.Tech (South Korea), Micro-Tech (Nanjing) (China), EFER ENDOSCOPY (France), Hood Laboratories (US), S&G BIOTECH (South Korea), Changzhou Health Microport Medical Device (China), and Kapitex Healthcare (UK). |
November 2017 | $ 5650 |
|
Contrast Media/Contrast Agents Market by Type (Iodinated, Gadolinium, Barium, Microbubble) Modality (X-ray, CT, MRI, Ultrasound) Application (Radiology, Interventional Radiology, Interventional Cardiology) & by Indication - Global Forecast to 2022The global contrast media/contrast agents market is projected to reach USD 5.53 Billion by 2022 from an estimated USD 4.57 Billion in 2017, growing at a CAGR of 3.9% during the forecast period. This growth can be attributed to factors such as increasing approvals for contrast agents and growing number of public and private diagnostic centers. The prominent players in the global contrast media market include GE Healthcare (US), Bracco Imaging (Italy), Bayer (Germany), and Guerbet (France) are the major players operating in the market. Other prominent players in the market are Lantheus (US), Daiichi Sankyo (Japan), Unijules (India), J.B. Chemicals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), and Magnus Health (India). |
November 2017 | $ 5650 |
|
Thawing System Market by Type (Manual, Automated), Sample (Blood, Plasma, RBC, Platelets, Whole Blood, Embryo, Semen), End User (Blood Bank, Transfusion Center, Hospital, Tissue Bank, Biotechnology & Pharmaceutical) - Global Forecast to 2022The thawing system market is expected to reach USD 252.7 Million by 2022 from USD 139.6 Million in 2017, at a CAGR of 12.6%. Factors driving the growth of this market include technological advanced applications of thawing devices, expanding storage capacities of biorepositories, and increasing use of thawed cells in the treatment of cancers and diabetes. Key players in the thawing system market include Helmer Scientific (US), Boekel Scientific (US), Sarstedt (Germany), Barkey (Germany), BioCision (US), Cardinal Health (US), Sartorius (Germany), GE Healthcare (US), Thermo Fisher Scientific (US), and CytoTherm (US). |
November 2017 | $ 5650 |
|
Urology Devices Market by Product ((Endoscopes, Robotic, Lasers & Lithotripsy, Dialysis, Urodynamic Systems), (Guidewires, Catheters, Biopsy Devices)), Disease (Kidney Disease, Urologic Cancer, Pelvic Organ Prolapse), End User - Global Forecast to 2022The global urology devices market is expected to reach USD 44.37 Billion by 2022 from USD 31.44 Billion in 2017, at a CAGR of 7.1%. The growing incidence of urological cancer along with a rapidly aging population, technological advancements in urology devices, and increasing healthcare expenditure are key factors driving the growth of this market. Key players in the urology devices market include Fresenius Medical Care (Germany), Baxter (US), Boston Scientific (US), Olympus (Japan), Richard Wolf (US), KARL STORZ (Germany), Cook Medical (US), Medtronic (US), C. R. Bard (US), Dornier MedTech (Germany), Prometheus Group (US), Medi-Globe (US), Intuitive Surgical (US), Merit Medical Systems (US), Siemens Healthcare (Germany), Stryker (US), ROCAMED (France), Medica (Italy), NOVAmedtek (Turkey), SRS Medical Systems (US), ProSurg (US), Albyn Medical (UK), EMD Medical Technologies (Canada), and Biolitec (Germany). |
November 2017 | $ 5650 |
|
Blood Collection Market by Product (Serum Tube, Plasma Tube, EDTA, Heparin, Coagulation, Glucose, Needle, Lancet, ESR, Syringe, Blood Bag), Method (Manual, Automated), End User (Hospital, Blood Bank Center, Academics, Home Care) - Global Forecast to 2022Blood collection is the process of acquiring blood samples from the donor for performing laboratory diagnostic tests and treating patients. This is an integral part of the blood management procedure in hospitals and blood banks centers. The global blood collection market is expected to reach USD 10.59 Billion by 2022 from USD 8.10 Billion in 2017, at a CAGR of 5.5% during forecast period. The increasing prevalence of various diseases, rising number of surgeries, and growing number of accidental and trauma cases are fueling the demand for blood collection products. The key players in the global blood collection market are BD (US), Medtronic (US), and Terumo (Japan). Some of the other players operating in this market are Haemonetics (US), Fresenius (Germany) Nipro Medical (US), Kawasumi Laboratories (Japan), F.L. Medical (Italy), Greiner Holding (Austria), and Grifols (Spain). |
November 2017 | $ 5650 |
|
Surgical Imaging Market by Technology (Image Intensifier C-arms, Flat Panel Detector C-arms (FPD C-arms)), Application (Orthopaedic & Trauma Surgeries, Neurosurgeries, Cardiovascular Surgeries), and Region - Global Forecasts to 2022The global surgical imaging market is projected to reach USD 1.63 Billion by 2022 from USD 1.25 Billion in 2017, at a CAGR of 5.5% during the forecast period. The growth of this market is majorly driven by factors such as technological advancements in C-arms, increasing demand for minimally invasive procedures, rising geriatric population, and growing chronic disease prevalence. GE Healthcare (US), Koninklijke Philips (Netherlands), Siemens (Germany), and Ziehm Imaging (Germany) are the key players in the surgical imaging market. Other players involved in this market are Hologic (US), Shimadzu Corporation (Japan), OrthoScan (US), Medtronic (US), Toshiba Medical Systems Corporation (Japan), GENORAY (South Korea), Eurocolumbus (Italy), and Allengers Medical Systems (India). |
November 2017 | $ 5650 |
|
Home Healthcare Market by Product (BP & Heart Rate Monitor, Ovulation Kit, HIV Test, ECG, Nebulizer, Hearing Aids, Pedometer, Cane, Crutches, Wheelchair), Software, Services (Rehabilitation, Pregnancy, Palliative), & Telehealth - Global Forecast to 2022The global home healthcare market is expected to reach USD 364.69 Billion by 2022 from USD 239.30 Billion in 2017, at a CAGR of 8.8%. The growth of this market is mainly driven by the growing geriatric population; increasing incidence of chronic diseases; and rising demand for affordable healthcare delivery systems due to increasing healthcare cost, technological advancements, and government initiatives to promote home healthcare. The home healthcare market is highly competitive with the presence of several small and big players. Prominent players in the home healthcare market include Philips Healthcare (Netherlands), Kindred Healthcare (US), Linde Group (Germany), Almost Family Inc. (US), Abbott Laboratories (US), LHC Group (US), A&D (Japan), Amedisys (US), Fresenius (Germany), Omron (Japan), McKesson (US), BAYADA Home Health Care (US), Kinnser Software, Inc. (US), and Roche (Switzerland). |
November 2017 | $ 5650 |
|
Nerve Repair and Regeneration Market, by Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), - Global Forecast to 2022The nerve repair and regeneration market is expected to reach USD 10.59 Billion from USD 5.13 Billion in 2016, at a CAGR of 12.9%. Factors such as increasing number of neurological disorders, rising geriatric population, and technological advancements are contributing to the growth of this market. Some of the major players operating in the nerve repair and regeneration market are AxoGen (US), Baxter (US), Boston Scientific (US), LivaNova (UK), Integra LifeSciences (US), Medtronic (US), Abbott Laboratories (US), Stryker (US), Nevro (US), Polyganics (Netherlands), and Nuvectra (US). |
November 2017 | $ 5650 |
|
Tissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology & Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End User (Hospital, CRO) - Global Forecast to 2022The global tissue diagnostics market is expected to reach USD 5.14 Billion by 2022 from USD 3.68 Billion in 2017, at a CAGR of 6.9%. The growing incidence of cancer along with a rapidly aging population, technological advancements in tissue diagnostics techniques, and increasing healthcare expenditure are key factors driving the growth of this market. Key players in the tissue diagnostics market include Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), Merck (Germany), Sakura Finetek Japan (Japan), Abcam (UK), BD (US), QIAGEN (Netherlands), Sienna Cancer Diagnostics (Australia), Royal Philips (Netherlands), A. Menarini Diagnostics (Italy), Cell Signaling Technology (US), Enzo Life Sciences (US), Master Diagnóstica (Spain), TissueGnostics (Austria), Bio SB (US), MedImmune (US), Cernostics (US), Zenalux Biomedical (US), 3DHISTECH (Hungary), Lunaphore Technologies (Switzerland), BioGenex (US), and Biocare Medical (US). |
November 2017 | $ 5650 |
|
Atherectomy Devices Market by Product (Directional, Rotational, Laser, Orbital), Application (Peripheral, Cardiovascular, Neurovascular), End User (Hospitals, Surgical Centers, Ascs, Research Laboratories, Academic Institutes) - Global Forecasts To 2022The report studies the global atherectomy devices market over the forecast period of 2017 to 2022. The market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%. Factors such as favorable reimbursement scenario for atherectomy procedures, increasing number of research activities in the field of atherectomy, and increasing healthcare expenditure are driving the growth of the market. Major players operating in the market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), and Cardiovascular Systems (US). Other prominent players present in this market include Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US). |
November 2017 | $ 5650 |
|
US Anticoagulation Therapy Market by Product ((Anticoagulants Drugs (NOACs, Warfarin)), PT/INR Devices (In-Office, Home Testing)), Service Type (Testing & Consulting), Type of Clinic (Hospital Associated, Independent & Pharmacy-based) - Forecast to 2022The US anticoagulation therapy market is projected to reach USD 27.83 Billion by 2022 from USD 17.25 Billion in 2016, at a CAGR of 8.5%. The US anticoagulation therapy market is segmented into products (anticoagulation drugs and PT/INR testing devices) and anticoagulation clinics. C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), and Portola Pharmaceuticals (US) are the major market players in the US anticoagulation therapy market for drugs while Roche (Switzerland), Abbott (US), Siemens (Germany), Alere (US), and CoaguSense (US) are the major market players in the US anticoagulation therapy market for PT/INR home testing devices. |
November 2017 | $ 5650 |
|
Intravascular Temperature Management Market by Type (Warming, Cooling), Application (Perioperative, Post-operative, Acute Care), Medical Condition (Stroke, Cardiac Arrest, Traumatic Brain Injury (TBI), Myocardial Infarction) - Global Forecasts to 2022The global intravascular temperature management market is projected to reach USD 272.3 Million by 2022 from USD 219.8 Million in 2016, growing at a CAGR of 3.6%. The base year considered for the study is 2016 and the forecast for the market size is provided for the period between 2017 and 2022. Key players in the intravascular temperature management market include 3M (US), Smiths (UK), ZOLL Medical (US), The 37Company (Netherlands), Belmont Instrument (US), Biegler (Austria), Stihler Electronic (Germany), and BD company (US). |
November 2017 | $ 18000 |
|
Hearing Aids Market by Product (Receiver In The Ear, Behind The Ear, In The Ear, In The Canal Hearing Aids, Cochlear Implant, BAHA implant), Types of Hearing Loss (Sensorineural, Conductive Hearing loss) & Patient (Adult, Pediatric) - Forecast to 2022The global hearing aids market is projected to reach USD 9.78 Billion by 2022 from USD 6.97 Billion in 2017, at a CAGR of 7.0%. Factors such as high prevalence of hearing loss, rising geriatric population, and technological advancements in hearing aids are driving the global hearing aids market. The hearing aids market is dominated by big players such as Sonova (Switzerland), William Demant (Denmark), and GN Store Nord (Denmark) with the presence of several small players as well. Some of the players operating in this market include Cochlear (Australia), Starkey (US), Widex (Denmark), MED-EL (Austria), SeboTek Hearing Systems (US), Audina Hearing Instruments (US), RION (Japan), Horentek (Italy), Microson (Spain), and Arphi Electronics (India). |
November 2017 | $ 5650 |
|
Advanced Wound Care Market by Product (Dressings (Foams, Hydrocolloids, Alginates), Therapy Devices, NPWT, Autograft, Allograft, Xenograft), Wound (Surgical, Trauma, Diabetic Foot, Ulcers, Burns), End User (Hospital, Home Care) - Global Forecast to 2022The global advanced wound care market is expected to reach USD 13.07 Billion by 2022 from USD 10.43 Billion in 2017, at a CAGR of 4.6%. The market growth is primarily driven by the rising incidence and prevalence of diabetes, growth in geriatric population, increasing prevalence of wound ulcers, technological advancements in advanced wound care products, increasing funding for wound care research, and growing awareness programs about wound management. The key players in the advanced wound care market are Smith & Nephew (UK), Mölnlycke Health Care (Sweden), B. Braun (Germany), ConvaTec Group (US), Coloplast (Denmark), Integra LifeSciences(US), 3M Company (US), Cardinal Health (US), Acelity L.P. (US), Medtronic (US), MPM Medical (US), PAUL HARTMANN (Germany), Medline Industries (US), Lohmann & Rauscher (Germany), Advanced Medical Solutions Group (UK), BSN medical GmbH (Germany), Wound Care Technologies (US), Vivostat A/S (Denmark), Organogenesis (US), Hematris Wound Care (Germany), Alliqua BioMedical (UK), MiMedX Group (US), Triage Meditech (India), DeRoyal Industries (US), and Laboratoires URGO (UK). |
November 2017 | $ 5650 |
|
Weight Loss and Weight Management Market by Equipment (Surgical Equipment (Biliopancreatic Diversion, Gastric Bypass), Fitness (Treadmill, Elliptical, Stair Stepper)), Diet (Meal, Beverage, Supplement) and Weight Loss Services - Global Forecast to 2022The weight loss and weight management market is projected to reach USD 245.51 Billion by 2022 from USD 175.94 Billion in 2017, at a CAGR of 6.9%. Factors such as growing obesity rates, increasing number of bariatric surgeries, and increasing prevalence of lifestyle diseases are driving the global weight loss and weight management market. The weight loss and weight management market is highly competitive, with the presence of several small and large players. Some of the players operating in this market include Atkins Nutritionals (US), Herbalife (US), Nutrisystem (US), Ethicon (US), Covidien (US), Apollo Endosurgery (US), Brunswick (US), Amer Sports (Finland), Johnson Health Technology (Taiwan), Technogym (Italy), Weight Watchers (US), Jenny Craig (US), eDiets.com (US), VLCC Healthcare (India), Slimming World (UK), The Gold’s Gym (US), Duke Diet & Fitness Center (US), Equinox (US), Life Time Fitness (US), Fitness First Group (US), and Town Sports (US). |
October 2017 | $ 5650 |
|
Sterilization Services Market by Method (Steam, Ethylene Oxide, Gamma, E-beam), Type (Contract Sterilization Services, Validation Services), End User (Hospitals and Clinics, Food and Beverage, Pharmaceuticals), and Region - Global Forecast to 2022The global sterilization services market is expected to reach USD 3.31 Billion by 2022 from USD 2.39 Billion in 2017, at a CAGR of 6.7%. Factors driving market growth include the increasing incidence of HAIs, rising number of surgical procedures owing to the rapidly growing geriatric population, and increasing incidence of chronic disorders across the globe. The key players in the sterilization services market are STERIS (UK), Cantel Medical (US), Cretex Companies (US), E-BEAM Services (US), Medistri (Switzerland), Beta-Gamma-Service (Germany), Sterigenics International (US), COSMED Group (US), Life Science Outsourcing (US), Noxilizer (US), Centurion Medical Products (US), Johnson & Johnson (US), and Stryker (US). |
October 2017 | $ 5650 |
|
Surgical Drains/Wound Drainage Market by Product (Accessories, System (Open, Closed)), Type (Active, Passive), Application (Orthopedic, CVD, Thoracic, Obstetrics & Gynecology, Plastic surgery), End user (Hospitals, Clinics, ASC) - Global Forecast to 2022The surgical drains market is expected to reach USD 2.18 Billion by 2022 from USD 1.78 Billion in 2016, growing at a CAGR of 3.7% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The surgical drains market is highly competitive with the presence of several small and big players. Some of the players in the surgical drains market include B. Braun (Germany), Cardinal Health (US), ConvaTec (UK), C.R. Bard (US), Redax (Italy), Ethicon (US), Stryker (US), Romsons (India), Medtronic (Ireland), Medline Industries (US), Cook Medical (US), Poly Medicure (India), Zimmer Biomet (Indiana), Global Medikit (India), and Degania Silicone (Israel). |
October 2017 | $ 5650 |
|
Endoscope Reprocessing Market by Product (High-level Disinfectants & Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors, Endoscope Tracking Systems, Brushes), End User (Hospitals, Ambulatory Surgery Centers) - Global Forecast to 2022The global endoscope reprocessing market has been valued at USD 1.34 Billion in 2016 and is expected to grow at a CAGR of 8.6% to reach to USD 2.15 Billion by 2022. Base year considered for the report is 2016 and the forecast period is 2017 to 2022. The various players in the endoscope reprocessing market include Advanced Sterilization Products (ASP) (US), Cantel Medical (US), Laboratories Anios (France), Olympus (Japan), Wassenburg Medical (The Netherlands), Custom Ultrasonics (US), STERIS (US), Steelco (Italy), Getinge (Sweden), ENDO-TECHNIK (Germany), BES Decon (UK), ARC Healthcare Solutions (Canada), and Metrex Research (US) among others. |
October 2017 | $ 5650 |
|
Hysteroscopy Instruments Market by Product (Forceps, Scissors, Hysteroscope (Rigid, Flexible), Resectoscope (Unipolar, Bipolar), Usability, Application (Diagnosis, Myomectomy, Polypectomy, EA), End User (Hospital, Clinic, ASC) - Global Forecast to 2022The hysteroscopy instruments market is expected to reach USD 1.89 Billion by 2022 from USD 1.30 Billion in 2017, at a CAGR of 7.8%. The growth of the market is attributed to the growth in female geriatric population and the rising incidence of gynecological diseases; increasing adoption of minimally invasive treatments; implementation of favorable government initiatives and the increasing adoption of office hysteroscopy. The hysteroscopy instruments market is highly competitive with the presence of several small and big players. Some of the players in the hysteroscopy instruments market include KARL STORZ (Germany), Olympus (Japan), Richard Wolf (Germany), Stryker (US), Hologic (US), Medtronic (Ireland), Ethicon (Scotland), B. Braun (Germany), Boston Scientific (US), MedGyn Products (US), CooperSurgical (US) , Cook Medical (US), Medicon (Germany), Maxer Medizintechnik (Germany), and Hospiline Equipments (India). |
October 2017 | $ 5650 |
|
Cancer Biomarkers Market by Type (Protein Biomarker, Genetic Biomarker), Cancer Type (Breast, Melanoma, Leukemia, Lung), Profiling Technology (Omics, Imaging, Immunoassay, Bioinformatics), Application (Diagnosis, Prognostics, R&D) - Global Forecast to 2022Cancer biomarkers are substances or processes that are indicative of the presence of cancers in the human body. Biomarkers may be produced by the cancer tissue itself or by other cells in the body in response to cancer. They can be found in the blood, stool, urine, tumor tissue, or other tissues or bodily fluids. They enhance cancer detection and facilitate high-speed noninvasive diagnosis using genomics and proteomics. The global cancer biomarkers market is accounted for USD 10.31 Billion in 2016 and is expected to grow at a CAGR of 12.2% to USD 20.48 Billion by 2022 during the forecast period. The major players in the cancer biomarkers profiling technology market are Abbott (US), Affymetrix (US), Roche (Switzerland), Illumina (US), QIAGEN (Netherlands), Agilent (US), Thermo Fisher (US), Merck (US), Becton Dickinson (US), and Hologic (US). |
October 2017 | $ 7150 |
|
Sports Medicine Market by Application (Knee, Shoulder, Elbow), Product (Implants, Arthroscopy, Prosthetic, Orthobiologics, Braces, Compression Clothing, Physiotherapy (Thermal, Ultrasound), Bandages & Tapes) - Global Forecast to 2022Sports medicine pertains to the treatment and prevention of injuries resulting from sports and athletic activities. Sports injuries involve both bone and soft tissue injuries. The sports medicine market includes devices that are used for the prevention of sports injuries as well as for the cure, recovery, and rehabilitation of such injuries. The global sports medicine market is projected to reach USD 8.24 Billion by 2022 from USD 5.41 Billion in 2016, at a CAGR of 7.4% during the forecast period. Base year considered for the report is 2016. Forecast period considered for the report is 2017–2022. The key players in the global sports medicine market are Arthrex (US), Smith & Nephew (UK), DePuy Synthes (US), Stryker (US), CONMED (US), Zimmer Biomet. (US), Breg (US), DJO Global (US), Mueller Sports, (US), Wright Medical Group (US), Medtronic (Ireland), RTI Surgical (US), and Performance Health International (US). |
October 2017 | $ 5650 |
|
In Vitro Fertilization Market by Product (Imaging System, Incubator, Cabinets, Sperm Separation System, Cryopreservation media, Embryo Culture media), Type of Cycles & End Users (Fertility Clinics and Surgical Centres, Cryobanks) - Global Forecast to 2022The global in vitro fertilization market is projected to be valued at USD 465.2 Million in 2016 and is expected to grow at a CAGR of 10.9% from 2017 to reach to USD 847.8 Million by 2022. The key factors propelling the growth of this market include growth in the median age of first-time motherhood, declining fertility rates, rising male infertility, rise in consumption of alcohol and cigarettes, and growing public awareness about infertility and the available treatment options. CooperSurgical (US), Vitrolife (Sweden), Cook Medical (US), Irvine Scientific (US), and Thermo Fisher Scientific (US) are the major players in the in vitro fertilization market. Other players include Esco Micro (Singapore), IVFtech (Denmark), EMD Sereno (US), Genea Limited (Australia), Rocket Medical (UK), and Nidacon International (Sweden). |
October 2017 | $ 5650 |
|
Industrial Centrifuges Market by Type (Sediment, Decanter, Disc, Filter, Basket, Screen, Peeler, Pusher), Operation (Batch, Continuous), Design (Horizontal, Vertical), End User, and Region - Global Forecast to 2022The global industrial centrifuges market is projected to reach USD 11.06 Billion by 2022 from USD 8.69 Billion in 2017, at a CAGR of 4.9%. The increasing demand for centrifuges in process industries, rising need for wastewater management solutions, and technological advancements in centrifuge systems are the major factors driving the growth of this market. The market is highly fragmented with several big and small players. Prominent players in the market include Andritz, Alfa Laval, GEA Group, Mitsubishi Kakoki Kaisha, Thomas Broadbent, FLSmidth, Schlumberger, Hiller, Ferrum, TEMA, HEINKEL, Gruppo Pieralisi, SPX Flow, and HAUS Centrifuge Technologies. |
September 2017 | $ 5650 |
|
Endodontics Market by Instruments (Scalers, Apex Locator, Motors, Handpiece, Laser), Consumables (Access Cavity Preparation, Endodontic Files, Burs, Drill, Lubricant, Obturation), End User (Clinic, Hospital) - Global Forecast to 2022The global endodontics market is projected to reach USD 1.61 Billion by 2022 from USD 1.26 Billion in 2017, at a CAGR of 5.1% during the forecast period. Growth in this market is attributed to the rapid growth in the geriatric population, increasing number of dentists and dental practices, rising dental tourism, increasing dental expenditure, and an increase in disposable incomes. The prominent players in the endodontics market are DENTSPLY SIRONA (US), Danaher Corporation (US), Ivoclar Vivadent (Liechtenstein), Ultradent Products (US), Septodont Holding (France), FKG Dentaire (Switzerland), Brasseler USA (US), MICRO-MEGA (France), DiaDent Group International (Canada), MANI (Japan), COLTENE Holding (Switzerland), and VOCO (Germany). |
September 2017 | $ 5650 |
|
Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia) - Global Forecast to 2022The global orthobiologics market is projected to reach USD 6.06 Billion by 2022 from USD 4.66 Billion in 2017, at a CAGR of 5.4% during the forecast period. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures are driving the orthobiologics market. The major players in the market are DePuy Synthes, Medtronic, Stryker, Zimmer Biomet, Harvest Technologies, Globus Medical, Orthofix International, RTI Surgical, K2M Group, Kuros Biosciences, Bioventus, NuVasive, SeaSpine, Arthrex, and Xtant Medical. |
September 2017 | $ 5650 |
|
Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA, Cell-Free DNA), Product (Instruments, Assay Kits), End User (Reference Laboratory) - Global Forecast to 2022The global liquid biopsy market is projected to be valued at USD 580.0 Million in 2016 and is expected to grow at a CAGR of 23.4% to reach to USD 2,047.9 Million by 2022. Base year considered for the report is 2016 and forecast period includes 2017–2022. Some of the key factors driving the growth of this market include increasing prevalence of cancer, increasing preference for noninvasive procedures, and availability of funding for liquid biopsy R&D. The key players in the global liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDx Health SA (US). |
September 2017 | $ 5650 |
|
Restorative Dentistry Market by Product (Restorative Material (Composite, Amalgam, Ceramic, Adhesive, Biomaterial), Prosthetic, Equipment (CAD/CAM, Handpiece, Articulator, Furnace) End User (Hospital, Dental Clinic, Laboratory) - Global Forecast to 2022The global restorative dentistry market is projected to reach USD 21.27 Billion by 2022 from USD 14.64 Billion in 2016, at a CAGR of 6.4% from 2017 to 2022. The major players in the restorative dentistry market are DENTSPLY SIRONA Inc. (US), Danaher Corporation (US), Institut Straumann (Switzerland), 3M Company (US), Zimmer Biomet Holdings, Inc. (US), Ultradent Products, Inc. (US), GC Corporation (Japan), Mitsui Chemicals, Inc. (Japan), Septodont Holding (France), Ivoclar Vivadent AG (Liechtenstein), COLTENE Holding (Switzerland), and VOCO (Germany). |
September 2017 | $ 5650 |
|
Orthopedic Braces and Supports Market by Product (Lower Extremity (Knee, Foot, Ankle, Back), Upper Extremity (Shoulder, Elbow, Wrist)), Application (Ligament Injury, Preventive Care, Osteoarthritis), End User (Hospitals, OTC) - Global Forecast to 2022The global orthopedic braces and supports market is projected to reach USD 4.93 Billion by 2022 from USD 3.76 Billion in 2017, at a CAGR of 5.6%. The major players in the market include DJO Finance LLC (US), Breg, Inc. (US), Ossur Hf (Iceland), DeRoyal Industries, Inc. (US), and Bauerfeind AG (Germany). Other key players in this market include Otto Bock HealthCare (Germany), BSN Medical (Germany), medi GmbH & Co. KG (Germany), 3M Company (US), and THUASNE Group (France). |
September 2017 | $ 5650 |
|
Dental Lab Market by Material (Metal Ceramic, Ceramic (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, Scanner, Furnace, Articulators), Prosthetics (Bridge, Crown (Porcelain Fused to Metal, CAD CAM Ceramics), Dentures) - Global Forecast to 2022The global dental laboratories market is projected to reach USD 43.08 Billion by 2022 from USD 32.56 Billion in 2017, at a CAGR of 5.8% from 2017 to 2022. The major players in the dental laboratories market are DENTSPLY SIRONA Inc. (US), Danaher Corporation (US), 3M Company (US), Ivoclar Vivadent AG (Liechtenstein), GC Corporation (Japan), Planmeca Oy (Finland), VITA Zahnfabrik H. Rauter GmbH & Co. KG (Germany), Zimmer Biomet Holdings, Inc. (US), Mitsui Chemicals, Inc. (Japan), Septodont Holding (France), and Shofu Inc. (Japan). |
September 2017 | $ 5650 |
|
Fluoroscopy Equipment Market by Product (Fixed Fluoroscopy Equipment (Remote Controlled, Conventional), C-arms), Application (Diagnostic (Cardiology, Gastroenterology), Surgical (Orthopedic, Cardiovascular)) and Region - Global Forecast to 2022The global fluoroscopy equipment market is projected to reach USD 2.79 Billion by 2022 from USD 2.21 Billion in 2017, at a CAGR of 4.8% during the forecast period. The key players in the global fluoroscopy equipment market are Siemens AG (Germany), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Shimadzu Corporation (Japan), Ziehm Imaging GmbH (Germany), Toshiba Medical Systems Corporation (Japan), Hitachi Ltd. (Japan), Carestream Health, Inc. (US), Hologic, Inc. (US), Lepu Medical Technology Co., Ltd. (China), Agfa-Gevaert Group (Belgium), and Adani Systems Inc. (Belarus). |
September 2017 | $ 5650 |
|
Medical Electrodes Market by Usability (Disposable, Reuse), Technology (Dry Electrodes, Wet, Needle), Diagnostic Procedures (ECG, EEG, EMG, EOG, ERG), Application (Cardio, Neurophysiology, Sleep Disorders, Intraoperative) - Global Forecast to 2022The diagnostic medical electrodes market was valued at USD 560.8 Million in 2016 and is projected to reach USD 732.4 Million by 2022, at a CAGR of 4.7%. The medical electrodes market is highly competitive with the presence of several small and big players. Some of the major players in the market include 3M (US), Medtronic plc (Ireland), Ambu (US), Natus Medical Incorporated (US), Rhythmlink International, LLC (US), Koninklijke Philips N.V. (Netherlands), Cognionics, Inc. (US), CONMED Corporation (US), Leonhard Lang GmbH (acquired by DCC plc), and Nihon Kohden Corporation (Japan). The other players in this market include Compumedics Limited (Australia), General Electric Company (US), g.Tec Medical Engineering GmbH (Austria), Vermed (US), Vectracor (US), Neuro Therapeutics (US), Emotiv (US), BIONEN sas (Italy), Nikomed (US), NeuroWave Systems Inc. (US), Wearable Sensing (US), Orbital Research Inc. (US), NeuroSky (US), ANT Neuro (Netherlands), and SOMNOmedics GmbH (Germany). |
September 2017 | $ 7000 |
|
Urinary Catheters Market by Product (Intermittent, Foley, Condom), Type (Coated, Uncoated), Indication (Urinary Incontinence, Benign Prostate Hyperplasia, Bladder Dysfunction, Spinal Cord Injury), Gender, End User - Global Forecast to 2022The urinary catheters market is projected to reach USD 2.19 Billion by 2022 from USD 1.33 Billion in 2016, at a CAGR of 8.5% during the forecast period. The urinary catheters market is highly competitive with the presence of major players. B. Braun Melsungen AG (Germany), Coloplast A/S (Denmark), C.R. Bard, Inc. (US), Hollister Incorporated (US), Medtronic plc (Ireland), Cook Medical (US), Teleflex Incorporation (US), and ConvaTec Group plc (UK) are the major companies operating in the urinary catheters market. |
September 2017 | $ 5650 |
|
Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) - Global Forecast to 2022The global allergy diagnostics market is expected to reach USD 5.74 Billion by 2022 from USD 3.49 Billion in 2017, at a CAGR of 10.5%. Key players in the allergy diagnostics market include Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US), Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd. (Japan), bioMérieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd. (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc. (US), EUROIMMUN AG (Germany), INDOOR Biotechnologies, Inc. (US), DR. FOOKE - Achterrath Laboratorien GmbH (Germany), R-Biopharm AG (Germany), GA Generic Assays GmbH (Germany), Tecan Trading AG (Switzerland), DST Diagnostische Systeme & Technologien GmbH (Germany), ROXALL Medical GmbH (Germany), ALK-Abelló A/S (Denmark), Astra Biotech GmbH (Germany), HAL Allergy Group (Netherlands), Theradiag (France), and Demeditec Diagnostics GmbH (Germany). |
August 2017 | $ 5650 |
|
Wound Care Market by Product (Advanced (Foam, Alginate, Hydrogel, NPWT, Active), Surgical, Traditional), Type (Chronic (Diabetic Foot, Pressure Ulcer), Acute (Burn, Trauma)), End User (Hospital, Long-term Care, Home Healthcare) - Global Forecast to 2022The global wound care market is expected to reach USD 22.01 Billion by 2022 from USD 18.35 Billion in 2017, at a CAGR of 3.7%. Key players in the wound care market include Acelity L.P. Inc. (US), Smith & Nephew plc (UK), Mölnlycke Health Care AB (Sweden), ConvaTec Group Plc (UK), Baxter International Inc. (US), Coloplast A/S (Denmark), BSN medical GmbH (Germany), Organogenesis Inc. (US), DeRoyal Industries, Inc.(US), IonMed (Israel), Ethicon, Inc. (US), Medtronic plc (Ireland), 3M Company (US), Hill-Rom Holdings, Inc. (US), Paul Hartmann AG (Germany), NovaBay Pharmaceuticals, Inc. (US), Derma Sciences, Inc. (US), Vivostat A/S (Denmark), Wound Care Technologies, Inc. (US), Leap Therapeutics Inc. (US), Hematris Wound Care GmbH (Germany), Alliqua BioMedical, Inc. (US), LayerBio Inc. (US) Triage Meditech Pvt. Ltd (India), and Fidia Pharma USA Inc. (US). |
August 2017 | $ 7150 |
|
Patient Lateral Transfer Market by Product (Air Assisted Transfer Device (Type (Regular Mattress, Split Legs Mattress, Half Mattress), Material (Single Patient Use, Reusable)), Slide Sheets, Transfer Accessories) - Global Forecast to 2022Lateral transfer devices is a device or repositioning aid, which reduces the friction. This includes air-assisted lateral transfer devices and sliding sheets. The global patient lateral transfer market is poised to reach USD 305.4 Million by 2022 from USD 196.4 Million in 2017, at a CAGR of 9.2% from 2017 to 2022. The patient lateral transfer market is dominated by established players such as Getinge AB (Sweden), HoverTech International (U.S.), AirPal (U.S.), Patient Positioning Systems (U.S.), Medline Industries (U.S.), EZ Way (U.S.), and McAuley Medical (U.S.). |
August 2017 | $ 5650 |
|
3D Printing Medical Devices Market by Component (3D Printers, 3D Bioprinters, Material (Plastic, Metal, Ceramic), Software & Services), Technology (EBM, LBM, Photopolymerization, 3DP, and DD), Product Type (Prosthetics, Implant) - Global Forecast to 2022The global 3D printing medical devices market is projected to reach USD 1.88 Billion by 2022 from USD 0.84 Billion in 2017, at a CAGR of 17.5% during the forecast period. Technological advancements, increasing public-private funding, easy development of customized medical products, and growing applications in the healthcare industry are the major factors driving the growth of the 3D printing medical devices market. The key players in the global 3D printing medical devices market are Stratasys, Ltd. (Israel & U.S.), 3D Systems Corporation (U.S.), EnvisionTEC GmbH (Germany), Materialise NV (Belgium), EOS GmbH (Germany), Arcam AB (Sweden), Concept Laser GmbH (Germany), Renishaw plc (U.K.), Prodways Group (France), and 3T RPD Ltd. (U.K.). |
August 2017 | $ 5650 |
|
Compression Therapy Market by Technique (Static, Dynamic), Product (Compression Garment (Stockings, bandages, Wraps), Compression Braces, Compression Pump), Application (Varicose Vein, Deep Vein Thrombosis, Lymphedema, Leg Ulcer) - Global Forecast to 2022The global compression therapy market is projected to reach USD 3.40 Billion by 2022 from USD 2.70 Billion in 2017, at a CAGR of 4.7%. Factors such as rising aging population; significant patient population suffering from DVT, varicose veins, and lymphedema; and availability of clinical evidence favoring the adoption of compression therapy in the treatment of different diseases are driving the growth of the market. Some of the major players in the market include BSN medical (Germany), DJO Global Inc. (U.S.), medi GmbH & Co KG (Germany), Tactile Medical (U.S.), PAUL HARTMANN AG (Germany), SIGVARIS (Switzerland), Sanyleg S.r.l. (Italy), 3M Company (U.S.), ConvaTec Inc. (U.K.), ArjoHuntleigh (Getinge Group) (Sweden), and Julius Zorn GmbH (Juzo) (Germany). |
August 2017 | $ 5650 |
|
Bioabsorbable Stent/Bioresorbable Scaffold Market by Material (Polymer/Metal), Absorption Rate (Slow, Fast), Application (Coronary Artery Disease/CAD, Peripheral/PAD) & End User (Hospital, Cardiovascular Center) - Global Forecasts to 2022The global bioresorbable stents market is expected to reach USD 417.2 Million by 2022 from USD 223.6 Million in 2016, at a CAGR of 11.5% during the forecast period 2017-2022. Market growth of bioresorbable stents is attributed to the growing aging population susceptible to coronary and peripheral artery diseases, rising PCI procedures, increasing focus of companies on clinical trials of bioresorbable stents, increasing adoption of these stents by physicians and patients, and patients’ preference for minimally invasive therapies. However, factors such as the increasing product withdrawals due to severe complications of these stents may hamper market growth. The bioresorbable stents screening market is a niche market with the presence of several emerging players and few big players. Prominent players in the market include Abbott (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), and Kyoto Medical Planning Co., Ltd. (Japan). |
August 2017 | $ 5650 |
|
Veterinary CT Scanner Market by Type (Multi Slice CT Scanner, Portable CT Scanner), Animal (Small Animals, Equine, Livestock), Application (Neurology, Oncology, Orthopedic, Traumatology), End User (Animal Hospital, Clinic) - Global Forecast to 2022The veterinary CT scanner market is expected to reach USD 173.7 Million by 2022 from an estimated USD 122.3 Million in 2017, at a CAGR of 7.3%. The key players in the global veterinary CT scanner market are GE Healthcare (US), Canon, Inc. (Toshiba Medical Systems Corporation) (Japan), Siemens AG (Siemens Healthineers) (Germany), Samsung Electronics Co. Ltd. (NeuroLogica Corporation) (South Korea), Epica Medical Innovation (US), Hitachi, Ltd. (Japan), Koninklijke Philips N.V. (Netherlands), Animage, LLC (US), GIN ApS (Denmark), QR s.r.l. (Italy), and 4DDI (US). |
August 2017 | $ 5650 |
|
Surface Disinfectant Market by Type (Quaternary Ammonium Compounds, Chlorhexidine Gluconate, Phenol, Alcohol, Aldehyde), Formulation (Liquid, Spray, Wipe), Application (In-house, Instrument), End User (Hospitals, Laboratories) - Global Forecast to 2022Surface disinfectants are chemical formulations that eliminate microorganisms from surfaces or significantly decrease the possibility of their transfer through hand contact between surfaces. These include bedside tables, chairs, walls, floors, and medical equipment (clinical contact surfaces). The global surface disinfectants market is expected to reach USD 789.1 Million by 2022 from USD 529.6 Million in 2017, at a CAGR of 8.3%. Some of the major players operating in the surface disinfectants market are 3M Company (U.S.), Cantel Medical Corporation (U.S.), Johnson & Johnson (U.S.), Procter & Gamble (U.S.), Reckitt Benckiser Group plc. (U.K.), The Clorox Company (U.S.), Sealed Air Corporation (U.S.). Steris Corporation (U.S.), and Ecolab (U.S.). |
August 2017 | $ 5650 |
|
Biopsy Devices Market by Product (Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy) Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy) Guidance (Stereotactic, Ultrasound) & by End User (Hospital) - Global Forecast to 2022The global biopsy devices market is projected to reach USD 2.42 Billion by 2022 from USD 1.74 Billion in 2017, growing at a CAGR of 6.8% during the forecast period. The major players in the biopsy devices market are C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (U.S.), and Medtronic plc (Ireland). |
August 2017 | $ 5650 |
|
Lateral Flow Assay Market by Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Multiplex, Sandwich), End User - Global Forecast to 2022The global lateral flow assay market is projected to reach USD 8.24 Billion by 2022 from USD 5.55 Billion in 2017, at a CAGR of 8.2%. The growth of this market is majorly driven by the high prevalence of infectious diseases worldwide, rapidly growing geriatric population, growing demand for point-of-care testing, and rising use of home-based lateral flow assay devices. The prominent players in the global lateral flow assay market are Alere, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Siemens AG (Germany), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Johnson & Johnson (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Netherlands), and PerkinElmer, Inc. (U.S.). |
August 2017 | $ 5650 |
|
Hybrid Operating Room Market by Component (Surgical Booms, Surgical Lights, Operation Tables, MRI, CT, Angiography, AV Tools), Application (Cardiovascular, Neurovascular, Thoracic, Orthopedic), End User, and Region - Global Forecast to 2022The global hybrid operating room market is expected to reach USD 1,174.9 Million by 2022 from USD 652.0 Million in 2017; growing at a CAGR of 12.5% during the forecast period. As of 2016, the major product manufacturers operating in the global hybrid operating room market included Philips Healthcare (The Netherlands), Siemens Healthineers (Germany), Stryker Corporation (U.S.), Toshiba Corporation (Japan), GE Healthcare (U.S.), IMRIS Inc. (U.S.), Eschmann Equipment (U.K.), MAQUET GmbH (Germany), Trumpf Medical (Germany), and Skytron LLC (U.S.), among others. |
August 2017 | $ 5650 |
|
Medical Power Supply Market by Current Type (AC-DC Power Supply), Application (Monitoring Equipment (MRI, ECG, EEG, PET, Multiparameter Monitor, Ultrasound, X-ray, MEG)), Construction (Enclosed, External), Power Ranges (200w) - Global Forecast to 2022The medical power supply market is estimated to grow at a CAGR of 6.6% from 2017 to 2022 to reach USD 1,218.6 Million by 2022 from USD 830.5 Million in 2016. The base year considered for the study is 2016 and the forecast for the market size is provided for the period between 2017 and 2022. XP Power (Singapore), Spellman High Voltage Electronics Corporation (U.S.), Powerbox International AB (Sweden), Delta Electronics (Taiwan), and Astrodyne TDI Power Supplies and EMI Filters (U.S.) are the key players in the medical power supply market between 2017 and 2022. Other major players operating in this market are Meanwell Enterprises (Taiwan), Handy and Harman (U.S.), Globtek (U.S.), FRIWO Gerätebau (Germany), Inventus Power (U.S.), Wall Industries (U.S.), SynQor (U.S.), Protek Power N.A., (U.S.) |
August 2017 | $ 5650 |
|
X-ray Detector Market by Type (FPD, CSI, GADOX, CCD, Line Scan), Panel (Small, Large), Portability (Fix, Portable), Digital System (New, Retrofit), Application (Medical, Orthopedic, Mammogram, Dental, Security, Industrial, NDT) - Global Forecast to 2022The x-ray detectors market is expected to reach USD 3.31 Billion by 2022 from USD 2.53 Billion in 2017, at a CAGR of 5.6%. While the X-ray detectors market presents significant growth opportunities, market growth may be limited to a certain extent due to the high cost of digital X-ray systems. The x-ray detectors market is highly competitive with several big and small players. Prominent players in the x-ray detectors market include Varian Medical Systems (U.S.), PerkinElmer, Inc. (U.S.), Thales Group (France), Canon, Inc. (Japan), Konica Minolta, Inc. (Japan), Teledyne DALSA Inc. (U.S.), Fujifilm Holdings Corporation (Japan), Agfa-Gevaert Group (Belgium), Carestream Health (U.S.), Vieworks Co., Ltd (South Korea), Analogic Corporation (U.S.), Rayence (South Korea), YXLON International GmbH (Germany), Hamamatsu Photonics K.K. (Japan), and DRTECH (Korea). |
August 2017 | $ 5650 |
|
Companion Diagnostics Market by Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), Technology (PCR, IHC, NGS, ISH), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) - Global Forecast to 2022The global companion diagnostics market is projected to reach USD 6.51 Billion by 2022 from USD 2.61 Billion in 2017, at a CAGR of 20.1%. The growth of this market is majorly driven by the factors such as improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence across the globe, and increasing collaborations and partnerships for companion diagnostics test development. However, uncertain reimbursement scenarios in different countries such as the U.S., U.K., Japan, and Australia are expected to limit market growth. In 2016, F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (U.S.), and QIAGEN N.V. (Netherland) dominated the global companion diagnostics market. |
August 2017 | $ 5650 |
|
Adherence Packaging Market by System (Unit-dose, Multi-dose) Type (Blister Card, Pouch) Material (Plastic, Paper & Paperboard, Aluminum) End User (Retail, Long-term care facility, Hospital, Mail-order Pharmacies) - Global Forecast to 2022The global adherence packaging market is projected to reach USD 917.7 Million by 2022 from a base USD 646.0 Million in 2016, at a CAGR of 6.2%. The key players in the adherence packaging market are Omnicell, Inc. (U.S.), McKesson Corporation (U.S.) , Becton, Dickinson and Company (U.S.), Parata Systems LLC (U.S), KUKA AG (Germany), TCGRx (U.S.), RxSafe, LLC (U.S.), ARxIUM Inc. (U.S.), and Talyst Systems LLC. (U.S.). |
July 2017 | $ 5650 |
|
Medical Tapes and Bandages Market by Product (Tapes (Fabric, Paper, Plastic), Bandage (Gauze, Adhesive, Cohesive & Elastic)), Application (Surgery, Trauma & Laceration, Ulcer, Sport, Burns), End User (Hospitals, ASCS, Clinics, Homecare) - Forecast to 2022This report studies the global medical tapes and medical bandages market over the forecast period of 2017 to 2022. This market is projected to reach USD 7.39 billion by 2022 from USD 6.13 billion in 2017, at a CAGR of 3.8%. The major players in the market include 3M Company (U.S.), Medtronic plc (Ireland), Johnson & Johnson Consumer Inc. (U.S.), Medline Industries, Inc. (U.S.), BSN Medical (Germany), Cardinal Health, Inc. (U.S.), Beiersdorf (Germany), Nitto Denko Corporation (Japan) Nichiban Co., Ltd. (Japan), Lohmann & Rauscher (Germany), Derma Sciences Inc. (U.S.), Smith & Nephew (U.K.), B Braun Melsungen AG (Germany), PAUL HARTMANN AG (Germany), Mölnlycke Health Care (Sweden), Andover Healthcare Inc. (U.S.), Dukal Corporation (U.S.), Dynarex Corporation (U.S.), AVCOR Health Care Products, Inc (U.S.), Tetra Medical Supply Corporation (U. S.), Kerma Medical Products Inc. (U.S.), and DermaRite Industries, LLC. (U.S.). |
July 2017 | $ 5650 |
|
Vascular Access Device Market by Type (Peripheral (Midline, Short), Central (PICC, Tunneled, Non-Tunneled, Implanted Ports), Accessories), Application (Drug Administration, Fluid & Nutrition Administration) & End Users - Global Forecasts to 2022The global vascular access devices market is expected to reach USD 5.45 Billion by 2022 from USD 3.87 Billion in 2017, at a CAGR of 7.1%. The major players in this market include Major players include Becton Dickinson and Company (U.S.), Smiths Medical, Inc. (U.K.), and C.R.Bard, Inc. (U.S.). Other players include Teleflex Incorporated (U.S.) B.Braun Melsungen Ag (Germany), Angiodynamics (U.S.), Terumo Corporation (Japan), Nipro Medical Corporation, Edwards Lifesciences Corporation (U.S.), Ameco Medical (Egypt), Romsons Scientific & Surgical Pvt. Ltd (India), and Prodi med (France). |
July 2017 | $ 5650 |
|
Continuous Renal Replacement Therapy (CRRT) Market by Product (Systems, Disposables (Hemofilters & Bloodlines), & Dialysate), Modality (SCUF, CVVH, CVVHD, CVVHDF), Adoption & Procedures, and Region (Europe, North America, Asia-Pacific) - Forecast to 2022The global CRRT market is projected to reach USD 1.53 Billion by 2022 from USD 1.09 Billion in 2017, at a CAGR of 7.0%. The major players in the market are Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Bellco S.r.l. (Italy), NxStage Medical, Inc. (U.S.), Asahi Kasei Corporation (Japan), Infomed SA (Switzerland), Medica S.p.A. (Italy), and Toray Medical Co., Ltd. (Japan). |
July 2017 | $ 5650 |
|
Temperature Management Market by Product (Surface & Intravascular Systems - Warming & Cooling), Application (Acute & Perioperative Care), End User (Surgeon & Anesthesiologist), Medical Specialties (Pediatric, Orthopedic, Neurology) - Forecast to 2022The global temperature management market is projected to reach USD 2.72 Billion by 2022 from USD 2.40 Billion in 2017, at a CAGR of 2.5%. In 2016, 3M Company (U.S.), Smiths Medical (U.K.), and Medtronic plc (Ireland) dominated the global temperature management market. Some of the other players competing in this market are C.R. Bard Inc. (U.S.), Cincinnati Sub-Zero Products, Inc. (U.S.), Geratherm Medical AG (Germany), Inspiration Healthcare Group plc (U.K.), Stryker Corporation (U.S.), The 37Company (Netherlands), ZOLL Medical Corporation (U.S.), GE Healthcare (U.S.), Becton, Dickinson and Company (U.S.), DRÄGERWERK AG & CO. KGAA (Germany), and Ecolab (U.S.). |
July 2017 | $ 5650 |
|
In Vitro Diagnostics (IVD) Quality Control Market by Application (Immunoassay, Molecular Diagnostics, Microbiology, Hemostasis, Hematology), Source (Serum, Whole Blood, Urine), Type (Instrument Specific, Third Party Control) - Global Forecast to 2022The global in vitro diagnostics (IVD) quality controls market is estimated to reach USD 1.04 Billion by 2022, growing at a CAGR of 3.5% during the forecast period of 2017 to 2022. Major players in this market are continuously focusing on securing higher market shares through product launches, expansions, agreements, partnerships, and acquisitions. The major players in the global IVD quality controls market are Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Randox Laboratories (U.K.), Roche Diagnostics Limited (Switzerland), Abbott Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Siemens Healthcare (Germany), and Sysmex Corporation (Japan). |
July 2017 | $ 5650 |
|
CT Scanner Market by Type (Stationary, Portable), Architecture (C-arm, O-arm), Technology (High, Mid, Low Slice, CBCT), Application (Human, Veterinary, Research), End User (Hospital, Diagnostic Center, Research, Veterinary Clinic) - Global Forecast to 2022The global CT scanner market is projected to reach USD 6.20 Billion by 2022 from USD 4.76 Billion in 2017, at a CAGR of 5.4% during the forecast period. The major players in the market are Koninklijke Philips N.V. (Netherlands), GE Healthcare (U.S.), Toshiba Corporation (Japan), Siemens AG (Germany), Hitachi Ltd. (Japan), Shimadzu Corporation (Japan), Samsung Electronics Co., Ltd. (South Korea), Neusoft Medical Systems Co., Ltd. (China), Medtronic plc (Ireland), Shenzhen Anke High-tech Co., Ltd. (Hong Kong), Accuray Incorporated (U.S.), PlanMED (Finland), Koning Corporation (U.S.), Carestream Health Inc. (U.S.), and PointNix Co. Ltd (South Korea). |
July 2017 | $ 5650 |
|
Trauma Products Market by Type (Internal (Screw, Nails, Staples), External Fixator (Circular, Unilateral, Hybrid)), Surgical Site (Hand, Shoulder, Arm, Elbow, Hip, Pelvis, Knee, Leg, Thigh, Feet, Ankle), End User (Hospital, ASC) - Global Forecast to 2022The trauma products market is expected to reach USD 8.43 Billion by 2022 from USD 5.98 Billion in 2017, at a CAGR of 7.1% during the forecast period. The trauma products market is highly competitive with several big and small players. Prominent players in the trauma product market include DePuy Synthes (U.S.), Stryker (U.S.), Zimmer Biomet Holding Inc. (U.S.), and Smith & Nephew (U.K.); whereas, Accumed LLC (U.S.), Arthrex Inc. (U.S.), B. Braun Melsungen AG (Germany), Cardinal Health (U.S.), Citieffe S.R.L. (Italy), Conmed Corporation (U.S.), Double Medical Inc. (China), Integra LifeSciences Corporation (U.S.), Medtronic plc (Ireland), Orthofix Holdings Inc. (U.S.), and Wright Medical Group N.V. (U.S.) are some other players operating in the market. |
June 2017 | $ 5650 |
|
Needles Market by Type (Conventional (Bevel, Vented) & Safety), Product (Suture, Blood Collection, Insufflation), Material (Stainless Steel, Plastic), Delivery Mode (IV, IM, Hypodermic), End-User (Hospitals, Diagnostic Centers) - Global Forecast to 2022The global needles market is projected to reach USD 8.47 Billion by 2022 from USD 5.82 Billion in 2017, at a CAGR of 7.8% during the forecast period. The key players in the global needles market are Hamilton Company (U.S.), Medtronic plc (Ireland), Becton, Dickinson and Company (U.S.), Stryker Corporation (U.S.), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (U.S.), Terumo Corporation (Japan), Novo Nordisk A/s (Denmark), Smiths Medical (U.K.), and Thermo Fisher Scientific (U.S.). |
June 2017 | $ 5650 |
|
Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT), Internal (LDR, HDR) & Systemic), Product (Proton Beam, Cyberknife, LINAC, Seed, Samarium), Application (Prostate, Breast, Cervical), End User, and Region - Global Forecasts to 2022The global radiotherapy market is expected to reach USD 9.47 Billion by 2022 from USD 6.81 Billion in 2017, at a CAGR of 6.8%. The growth of this market is majorly driven by rapidly increasing geriatric population, growing incidence of cancer cases across the globe, increasing symposiums driving investments in radiotherapy, and rising demand for radiotherapy devices. In 2016, Varian Medical Systems, Inc. (U.S.) and Elekta AB (Sweden) dominated the global radiotherapy market. Other prominent players include Accuray Incorporated (U.S.), Ion Beam Applications (IBA) (Belgium), Nordion, Inc. (Canada), C. R. Bard, Inc. (U.S.), Isoray Medical, Inc. (U.S.), RaySearch Laboratories (Sweden), Mevion Medical Systems, Inc. (U.S.), and Mitsubishi Electric Corporation (Japan). |
June 2017 | $ 5650 |
|
Surgical Staplers Market by Product (Manual, Powered), Type (Disposable, Reuse), Application (Abdominal, Pelvis, General Surgery, Cardiac, Thoracic, Orthopedic, Hemorrhoids, Cosmetic, Pediatric), and End User (Hospital, ASC, Clinic) - Global Forecast to 2022The global surgical staplers market is expected to reach USD 4.78 Billion by 2022 from USD 3.38 Billion in 2017, at a CAGR of 7.2%. The surgical stapler market is duopolistic in nature with two major players Ethicon Inc. (U.S.) and Medtronic plc (Ireland). CONMED Corporation (U.S.), Smith & Nephew (U.K.), Purple Surgical Inc. (U.K.), Intuitive Surgical Inc. (U.S.), Welfare Medical Ltd. (U.K.), Reach surgical Inc. (China), Meril Life Science Pvt. Ltd. (India), Grena Ltd. (U.K.), B. Braun Melsungen AG (Germany), Dextera Surgical Inc. (U.S.), Frankenman International (China), and Becton, Dickinson and Company (U.S.) are some of the other players operating in the global surgical staplers market. |
June 2017 | $ 5650 |
|
Oral Care/Oral Hygiene Market by Product (Toothbrush (Manual, Electric, Battery-Powered), Toothpaste, Mouthwash, Dental Floss, Teeth Whitening, Breath Freshener, Fixative), Distribution Channel (Consumer Store, Drug Store, Online) - Global Forecast to 2022The global oral care/oral hygiene market is projected to reach USD 53.97 Billion by 2022 from USD 43.31 Billion in 2017, at a CAGR of 4.5%. The major players in the global oral care market are Colgate-Palmolive Company (U.S.), The Procter & Gamble Company (U.S.), Unilever plc (U.K.), Glaxosmithkline plc (U.K.), GC Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Johnson & Johnson (U.S.), Lion Corporation (Japan), 3M Company (U.S.), Dr. Fresh LLC. (U.S.), Ivoclar Vivadent AG (Germany), Henkel KgaA (Germany), Jordan AS (Denmark), Panasonic Corporation (Japan), Sunstar Suisse S.A. (Switzerland), Church & Dwight Co., Inc. (U.S.), Dentaid (U.S.), Kao Corporation (Japan), LG Household & Health Care Ltd. (Japan), Dabur India Ltd. (India), Himalaya (India), Patanjali Ayurved Ltd. (India), Supersmile (U.S.) Ranir, LLC. (U.S.), Young Innovations, Inc. (U.S.), and Ultradent Products, Inc. (U.S.). |
June 2017 | $ 5650 |
|
Medical Device Reprocessing Market by Product (Reprocessed Device (Catheter, Endoscope, Laparoscopic Instruments, Biopsy, Pulse Oximeter), Service), Application (Cardiology, Gastroenterology, Arthroscopy, Orthopedic, Anesthesia) - Global Forecast to 2022The global medical device reprocessing market is projected to reach USD 1,754.0 Million by 2022 from USD 823.5 Million in 2017, at a CAGR of 16.3%. In 2016, Stryker Corporation (U.S.) and Johnson & Johnson (U.S.) dominated the global medical device reprocessing market. Some of the other players competing in this market are Vanguard AG (Germany), Medline ReNewal (U.S.), Medtronic plc (Ireland), SteriPro Canada, Inc. (Canada), Pioneer Medical Devices AG (Germany), Vascular Solutions, Inc. (U.S.), HYGIA Health Services, Inc. (U.S.), ReNu Medical, Inc. (U.S.), SureTek Medical (U.S.), and Centurion Medical Products Corporation (U.S.). |
June 2017 | $ 5650 |
|
Medical Equipment Maintenance Market by Device (Imaging (MRI, CT, PET, SPECT, X-ray, Ultrasound, C Arm), Endoscopy, ECG, EMG, Defibrillator, Dental, Ventilator), Service Provider (OEM, ISO, In house), End User (Public, Private) - Global Forecast to 2022The medical equipment maintenance market is expected to reach USD 32.94 Billion by 2022 from USD 20.31 Billion in 2017, at a CAGR of 10.2% during the forecast period. The medical equipment maintenance market is highly competitive with the presence of both OEMs and ISOs. GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Toshiba Medical Systems Europe (Germany), FUJIFILM Holdings Corporation (Japan), Carestream Health, Inc. (U.S.), Agfa-Gevaert Group (Belgium), and Drägerwerk AG & Co. KGaA (Germany) are some of the leading OEMs; whereas, Aramark Services, Inc. (U.S.), TBS Group S.p.A. (Italy), BC Technical, Inc. (U.S.), Alliance Medical Group (U.K.), Pantheon Group (Italy), Avensys UK Ltd. (U.K.), and Grupo Empresarial Electromédico (Spain) are some of the leading ISOs operating in the medical equipment maintenance market. |
June 2017 | $ 5650 |
|
European Medical Equipment Maintenance Market by Device (Imaging (MR, CT, PET-CT, C-Arms, general X-ray), Endoscopy, Surgical instruments, Electromedical), Service Provider (OEM, ISO, In-house) & End User (Public-sector, Private-sector)-Forecasts to 2022The European medical equipment maintenance market is expected to reach USD 8.93 Billion by 2022 from USD 6.64 Billion in 2017, at a CAGR of 6.1% during the forecast period. The European medical equipment maintenance market is highly competitive with the presence of both OEMs and ISOs. GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Toshiba Medical Systems Europe (Germany), and Drägerwerk AG & Co. KGaA (Germany) are some of the leading OEMs; whereas, TBS Group S.p.A. (Italy), Pantheon Group (Italy), Technologie Sanitarie S.p.A. (Italy), Avensys UK Ltd. (U.K.). |
June 2017 | $ 15000 |
|
Patient Positioning System Market by Product (Tables (Surgical Tables, Radiolucent Imaging Tables), Accessories), Application (Surgery, Cancer Therapy, Disease Diagnosis), and End User (Hospitals, Ambulatory Surgery Center) - Global Forecast to 2022The patient positioning systems market is expected to reach USD 1,233.8 Million by 2022 from USD 990 Million in 2017, at a CAGR of 4.5% from 2017 to 2022. Some of the major players operating in the patient positioning systems market are Getinge AB (Sweden), Hill-Rom, Inc. (U.S.), Stryker Corporation (U.S.), Steris Plc. (U.S.), Span-America Medical Systems, Inc. (U.S.), Skytron, LLC. (U.S.), Elekta AB (Sweden), C-RAD (Sweden), LEONI AG (Germany), and Mizuho OSI (U.S.) |
June 2017 | $ 5650 |
|
Medical Device Cleaning Market by Process (Presoak, Manual Cleaning, Automatic Cleaning, Disinfection) Type (Enzymatic & Non-enzymatic Detergent) Application (Surgical Instruments, Endoscope, Ultrasound Probe) - Global Forecast to 2022The global medical device cleaning market is projected to reach USD 1.71 Billion by 2022 from USD 1.31 Billion in 2017, at a CAGR of 5.6%. The major players in the global medical device cleaning market are STERIS plc (U.S.), 3M Company (U.S.), Getinge Group (Sweden), Advanced Sterilization Products (U.S.), Ecolab Inc. (U.S.), Metrex Research, LLC (U.S.), Ruhof Corporation (U.S.), Cantel Medical Corporation (U.S.), BODE Chemie Gmbh (Germany), Integra LifeSciences Holdings Corporation (U.S.), Sklr Surgical Instruments (U.S.), Biotrol (U.S.), and Oro Clean Chemie AG (Switzerland). |
June 2017 | $ 5650 |
|
Prosthetic Heart Valve/ Artificial Heart Valve Market by Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), and Region (North America, Europe, Asia-Pacific, and RoW) - Global Forecast to 2022The prosthetic heart valves market is projected to reach USD 8.86 Billion by 2022 from USD 4.84 Billion in 2017, at a CAGR of 12.9%. Market growth can be attributed to the rising geriatric population and the subsequent increase in the prevalence of HVD, regulatory approvals for new and advanced prosthetic heart valves, increasing government funding for heart valve research, rising awareness about HVD, and favorable reimbursement scenario for prosthetic heart valves. Medtronic plc (Ireland), Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomédica (Brazil) are the prominent players in the global prosthetic heart valves market. |
June 2017 | $ 5650 |
|
Vascular Imaging Market by Technology (CT, MRI, X-Ray, Ultrasound, Nuclear Imaging), Procedure (Coronary Angiography, Peripheral, Cerebral Angiography), Application (Diagnostic, Therapeutic), End User (Hospital, Diagnostic Center) - Global Forecast to 2022The vascular imaging market is expected to reach USD 5.95 Billion by 2022 from USD 4.35 Billion in 2017, at a CAGR of 6.5%. Key players in the market include Siemens Healthineers (Germany), GE Healthcare (U.K.), Toshiba Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan), Samsung Medison (South Korea), Shimadzu Corp. (Japan), St. Jude Medical, Inc. (U.S.), TERUMO Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Fujifilm SonoSite (Japan), Hologic, Inc. (U.S.), Esaote SpA (Italy), Carestream Health, Inc. (U.S.), Konica Minolta (Japan), Alpinion Medical Systems (South Korea), Pie Medical Imaging (Netherlands), CorVascular Diagnostics LLC (U.S.), Evena Medical, Inc. (U.S.), LumedX Healthcare Technologies (U.S.), Xograph Healthcare (U.K.), Mindray Medical International Ltd. (China), Novadaq Technologies Inc. (Canada), Omega Medical Imaging LLC. (U.S.), BK Ultrasound (U.S.), and Piur imaging GmbH (Austria). |
June 2017 | $ 5650 |
|
Veterinary Chemistry Analyzer Market by Product (Chemistry Analyzer, Glucometer, Consumables (Panel, Test Strip, Reagent)) Application (Blood Chemistry Analysis, Urinalysis, Glucose Monitoring) & Animal (Companion & Livestock) - Global Forecast to 2022The global veterinary chemistry analyzers market is estimated to grow at a CAGR of 8.7% between 2017 and 2022, to reach USD 1,205.2 Million by 2022 from 795.8 Million in 2017. Factors such as increase in animal population, growing pet adoption, rising demand for animal-derived food products, increasing incidence of zoonotic diseases, growing demand for pet insurance, rising animal health expenditure, and growth in the number of veterinary practitioners and their income levels in developed economies are driving the growth of the global veterinary chemistry analyzers market. |
May 2017 | $ 5650 |
|
IV Equipment Market by Product (Infusion Pump, Catheter, Solution and Blood Administration Set, Securement Device, Cannula, Stopcock, Needleless Connector), End User (Hospitals & Clinics, Homecare, Ambulatory Care Center) - Global Forecast to 2022The global IV equipment market is expected to reach USD 13.63 Billion by 2022 from USD 10.07 Billion in 2017, at a CAGR of 6.2% from 2017 to 2022. The major factors driving the growth of this market include increasing incidence of chronic diseases, rapid growth in the aging population, and growing number of surgical procedures. The high growth in developing countries across Asia-Pacific and Latin America are expected to provide significant growth opportunities for players operating in the IV equipment market in the coming years. |
May 2017 | $ 5650 |
|
Oxygen Therapy Equipment Market by Product (Oxygen Source (Concentrator, Cylinder), Delivery Devices), Portability (Stationary, Portable), Application (COPD, Asthma, Cystic Fibrosis, Pneumonia), End User (Hospital, Home Care) - Global Forecast to 2022The oxygen therapy equipment market is expected to reach USD 4.01 Billion by 2022 from USD 2.65 Billion in 2017, at a CAGR of 8.7% from 2017 to 2022. Factors driving the growth of this market are the increasing prevalence of respiratory disorders, rapid growth in the geriatric population, prevalence of tobacco smoking, preference towards home-based oxygen therapy, and technological advancements to develop novel products delivering oxygen therapy. |
May 2017 | $ 5650 |
|
Medical Bed Market by Usage (Acute Care, Long Term Care, Psychiatric Care, Maternity), Application (Intensive Care, Non Intensive), Type (Electric Beds, Semi Electric Bed, Manual Bed), End User (Hospital, Home Care, Elderly Care) - Global Forecast to 2022The global medical beds market is projected to USD 3.41 Billion by 2022 from USD 2.59 Billion in 2017, growing at a CAGR of 5.6% during the forecast period (2017–2022). Factors such as increasing investments in healthcare infrastructural development, technological innovations in ICU beds, increasing number of beds in private hospitals, and increasing volume of chronic care patients are expected to drive the growth of the medical beds market in the coming years. On the other hand, the declining number of beds in public hospitals may limit market growth to a certain extent. |
May 2017 | $ 5650 |
|
Cardiac Surgery Instruments Market by Product (Clamps, Forceps, Scalpel, Scissors, Needle Holder), Application (Coronary Artery Bypass Graft, Heart Valve Surgery, Pediatric Surgery, Heart Transplant), & End User (Hospital, ASC) - Global Forecast to 2022The cardiac surgery instruments market is expected to reach USD 1.63 Billion by 2022 from USD 1.16 Billion in 2017, at a CAGR of 7.1%. The market is mainly driven by factors such as high incidence of cardiac diseases, growing prevalence of cardiac conditions and the subsequent increase in the number of surgical procedures, rising geriatric population, and growing investments, funds, and grants by government bodies worldwide. |
May 2017 | $ 5650 |
|
Contrast Injector Market by Product (Injector Systems (CT Injector, MRI Injector), Consumables (Injector Head, Tubing), Accessories), & Application (Radiology, Interventional Cardiology, Interventional Radiology) - Global Forecast to 2021The contrast injector market is projected to reach USD 636.1 Million by 2021 from USD 445.5 Million in 2016, growing at a CAGR of 7.4% during the forecast period. The contrast injector market growth can primarily be attributed to factors such as the large number of approvals for contrast agents in different geographies and increasing number of public and private diagnostic centers. |
May 2017 | $ 5650 |
|
Vascular Closure Devices Market by Type (Passive Approximators (Collagen Plugs Sealent/Gel Based), Active Approximators (Clip, Suture Devices)), Access (Femoral,Radial) & Procedure (Interventional Cardiology, Radiology) - Global Forecasts to 2022The global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%. The major drivers for the market include a large number of approvals for vascular closure devices, increasing focus of market players on large-bore vascular closure devices, the high prevalence of cardiovascular diseases, and high prevalence of obesity. On the other hand, the high cost of vascular closure devices, product recalls and failures, and increasing preference for interventional procedures using radial artery access are limiting the growth of the global vascular closure devices market to a certain extent. |
May 2017 | $ 5650 |
|
Poultry Diagnostics Market by Test (ELISA, PCR) Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Pasteurellosis, Encephalomyelitis, Infectious Bronchitis), Service (Virology, Bacteriology, Parasitology) - Global Forecast to 2022The global poultry diagnostics market is projected to reach USD 495.3 Million by 2022 from USD 300.6 Million in 2017, growing at a CAGR of 10.5%. Significant increase in the avian diseases outbreak and rising incidence of zoonotic diseases, rising consumer focus on food safety along with the increasing animal health awareness, and increasing trade in terms of export within the poultry industry are the major drivers for the growth of the poultry diagnostics market. |
May 2017 | $ 5650 |
|
IVD Market in BRIC by Product & Service (Instruments, Reagents, Software), Technology (Immunoassay, Hematology, Microbiology), Application (Diabetes, Cardiology, Infectious Diseases), Country (Brazil, Russia, India, China) - Forecast to 2022The BRIC IVD Market and other emerging countries is expected to reach USD 15.71 Billion by 2022 from USD 10.60 Billion in 2017, at a CAGR of 8.2%. The key factors driving the growth of the market are growing patient awareness of personalized medicine, increasing prevalence of lifestyle and chronic diseases, growth in the number of private diagnostic centers, and improving healthcare system in emerging countries. However, market growth is restrained by the lack of reimbursement and the slow growth of the economy in some emerging countries. |
May 2017 | $ 5650 |
|
Medical Connectors Market by Product (Flat Silicone, Hybrid, Embedded, Radio Frequency, Push-Pull), Application (Patient Monitoring, Electrosurgery, Endoscopy, Diagnostic Imaging, Respiratory, Dental Device) & by End User - Global Forecast to 2021The medical connectors market is projected to reach USD 2.69 Billion by 2021 from USD 1.63 Billion in 2016, at a CAGR of 10.5%. The high incidence and prevalence of chronic disorders, rise in healthcare expenditure, and growth in the home healthcare market are the major factors fueling the growth of this market. |
May 2017 | $ 5650 |
|
Infertility Treatment Market by Procedure (ART, Artificial Insemination, IVF, Surrogacy, Fertility Surgery), Product (Instruments, Media, Accessories), Patient Type (Male), End User (Fertility Clinics, Hospitals, Cryobanks) - Global Forecasts to 2022The global infertility treatment devices market is expected to reach USD 2.05 Billion by 2022 from USD 1.24 Billion in 2017, at a CAGR of 10.6% from 2017 to 2022. The rising public awareness about various treatment options is an important growth driver for this market. However, the high procedural costs and unsupportive government regulations are the major factors restraining the growth of this market. Furthermore, legal & ethical issues and the limited efficacy of these treatments on geriatric patients present a challenge to market growth. |
May 2017 | $ 5650 |
|
Bone Growth Stimulator Market by Product (Device, Bone Morphogenetic Protein, PRP), Application (Spinal Fusion, Delay Union & Non-union Bone Fracture, Oral-maxillofacial), End User (Hospitals, Home Care, Academia, CROs) - Global Forecasts to 2022The global bone growth stimulators market is estimated to reach USD 1.41 Billion by 2022, growing at a CAGR of 5.4% during the forecast period. The growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population, and procedural benefits offered by bone stimulation devices in bone fracture treatments are some key factors propelling the growth of this market. |
May 2017 | $ 5650 |
|
Vascular Stent Market by Type (BMS, BVS, Drug Eluting), Product (Coronary, Peripheral, Carotid, Femoral, Aortic Aneurysm), Material [Metal (Stainless Steel, PtCr, Nitinol), Polymer], End User (Hospital, Cardiology Center, ASC)- Global Forecast to 2021The vascular stent market is projected to reach USD 17.68 Billion by 2021 from USD 12.21 Billion in 2016, at a CAGR of 7.7% from 2016 to 2021. Technological advancements in stents, increasing number of angioplasty procedures, rising burden of vascular diseases, increasing demand for minimally invasive procedures, and the rising geriatric population are the major factors driving the growth of the vascular stent market. Moreover, the development of bioresorbable vascular scaffolds and expansion in emerging markets are expected to offer potential growth opportunities to market players in the coming years. However, the presence of alternative treatment methods for cardiac diseases, stringent regulations for product approval, and numerous cases of product failure and recalls are expected to restrain the growth of the market during the forecast period. |
May 2017 | $ 5650 |
|
Hospital Lighting Market by Product (Troffers, Surface-mounted lights, Surgical lamps), Technology ( Fluorescent, LED, Renewable Energy) Application (Patient Wards & ICUs, Examination Rooms, Surgical Suites - Global Forecast to 2021The hospital lighting market is projected to reach USD 7.03 Billion by 2021 from USD 5.19 Billion in 2016, at a CAGR of 6.2% from 2016 to 2021. The increasing adoption of LED based lighting products and increasing number of hospital in emerging economies are the key factor driving the market growth. Moreover, increasing government support to energy efficiency program for hospitals is contributing to the growth of hospital lighting market. |
April 2017 | $ 5650 |
|
Blood Group Typing Market by Product (Consumable (Anti-sera), Instrument, Service), Test Type (ABO, Antigen, Antibody Screening, Cross Matching, HLA), Technique (Assay, PCR, Microarray, Massively Parallel Sequencing), End User - Global Forecast to 2021The blood group typing market is projected to reach USD 3.12 Billion by 2021 from USD 1.95 Billion in 2016, at a CAGR of 9.8%. The increasing demand for blood and blood products, growing number of road accidents and trauma cases that necessitate blood transfusion, need for blood grouping during prenatal testing, and increasing usage of blood group typing in forensic sciences are the major factors fueling the growth of this market. |
April 2017 | $ 5650 |
|
Thrombectomy Devices Market by Type (Hydrodynamic, Ultrasound, Aspiration, Mechanical Thrombectomy), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs) - Global Forecasts to 2022The global thrombectomy devices market is expected to reach a value of USD 1.45 Billion by 2022; growing at a CAGR of 6.7% during the forecast period. A number of factors such as growing target patient population, ongoing technological advancements, favorable medical reimbursements, rising demand for minimally invasive thrombectomy procedures, and increasing healthcare expenditure across emerging markets are driving the growth of the market. |
April 2017 | $ 5650 |
|
Medical Camera Market by Camera Type (Endoscopy, Surgery, Dermatology, Ophthalmology, Dental), Resolution (HD, SD), Sensor (CMOS, CCD), End-Users (Hospitals, Diagnostic Centers, Speciality Clinics & Ambulatory Surgery Centers) - Global Forecast to 2021The global medical cameras market is expected to reach USD 3.69 Billion by 2021 from USD 2.43 Billion in 2016, at a CAGR of 8.7% during the forecast period. Technological advancements and increasing number of surgical procedures requiring medical cameras are the key drivers of this market. |
April 2017 | $ 5650 |
|
Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (External/Tethered, Patch), Pen Needles (Standard, Safety), Insulin Syringes) and End User (Patients/Homecare, Hospitals & Clinics) - Global Forecast to 2021The insulin delivery devices market is projected to reach USD 17.85 Billion by 2021 from USD 11.54 Billion in 2016, growing at a CAGR of 9.1% during the forecast period. The growth of the overall insulin delivery devices market can be attributed to the favorable reimbursement scenario and strong government support in selected countries, technological advancements in insulin delivery devices, growing diabetic population, and rising awareness about insulin delivery devices. |
April 2017 | $ 5650 |
|
Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Heart-lung Machines, Oxygenators), Ex Vivo Organ Perfusion, Technique (Hypothermic, Normothermic), Cell Perfusion, by Type (Bioreactor, Microfluidic)) - Global Forecast to 2021The global perfusion systems market is expected to reach USD 1,198.8 Million by 2021 from USD 989.4 Million in 2016, at a CAGR of 3.9%. The growth of the market can be attributed to the increasing prevalence of cardiovascular & respiratory diseases, initiatives by governments & NGOs to encourage organ donation, increasing investment in cell-based research, and developments in biologics manufacturing. The high cost of organ transplantation and organ supply-demand gap, however, are expected to hinder the growth of the market. |
April 2017 | $ 5650 |
|
Pharmacy Automation Market by Product (Medication Dispensing System (Robot, Carousel), Packaging & Labeling System (Unit Dose, Multi Dose), Tabletop Counter, Storage System), End User (Inpatient, Outpatient, Retail Pharmacy) - Global Forecast to 2022The pharmacy automation market is estimated to grow at a CAGR of 8.2% from 2017 to 2022 to reach USD 5.38 Billion by 2022. Market growth can be attributed to the growing need to minimize medication errors, rapid decentralization of pharmacies, rising geriatric population and rising labor cost. On the other hand, reluctance among the healthcare organizations to adopt pharmacy automation systems is expected to restrain the overall market growth to a certain extent during the forecast period. |
April 2017 | $ 5650 |
|
Veterinary Imaging Market by Product (Ultrasound, Radiography, MRI, Video Endoscopy), Therapeutic Area (Oncology, Cardiology, Neurology, Orthopedic), Animal (Small Companion Animals, Large Animals), End User (Hospital, Clinic) - Global Forecast to 2022The global veterinary imaging market is projected to reach USD 1.94 Billion by 2022 from USD 1.40 Billion in 2017, at a CAGR of 6.8%. Significant growth in the population of small companion as well as large animals, rising demand for pet insurance along with increasing animal healthcare expenditure, and increasing number of veterinary practitioners are the major drivers for the growth of the veterinary imaging market. Other factors such as the launch of innovative products that offer rapid and accurate results such as portable imaging modalities and rising demand for animal-derived food products are also contributing to the growth of the veterinary imaging market. |
April 2017 | $ 5650 |
|
Surgical Sutures Market by Product (Automated Suturing Device (Disposable, Reuse), Suture Thread (Natural, Nylon, Stainless Steel, Silk)), Application (Cardiac, Gynec, Opthalmic, Orthopedic), End User (Hospital, Clinic, ASC) - Global Forecast to 2021The global surgical sutures market is projected to reach USD 4.40 Billion by 2021 from USD 3.46 Billion in 2016, at a CAGR of 5% during the forecast period. The growing number of surgical procedures, favorable reimbursement scenario for a number of surgical procedures, and the launch of advanced sutures are driving the market growth for surgical sutures. Key players in this market include Ethicon Inc. (U.S.), B. Braun Melsungen AG (Germany), and Medtronic plc (Ireland). Other players include DemeTECH Corporation (U.S.), Internacional Farmaceutica, S.A. de C.V. (Mexico), Sutures India Pvt. Ltd. (India), Péters Surgical (France), Smith & Nephew plc (U.K.), EndoEvolution, LLC (U.S.), Boston Scientific Corporation (U.S.)., CP Medical (U.S.), Lotus Surgicals Pvt. Ltd. (India), and Teleflex Medical OEM (U.S.). |
April 2017 | $ 5650 |
|
Pharmaceutical Robots Market by Type (Traditional Robots (Articulated Robots, SCARA Robots, Delta Robots, Cartesian Robots), Collaborative Robots), Application (Picking and Packaging, Laboratory Applications) - Global Forecast to 2021This report studies the global pharmaceutical robots market for the forecast period of 2016 to 2021. This market is expected to reach USD 119.5 Million by 2021 from USD 64.4 Million in 2016, at a CAGR of 13.2% during the forecast period. The key factor driving the growth of the market is the benefits offered by robotic systems in pharmaceutical manufacturing. |
April 2017 | $ 5650 |
|
Active Implantable Medical Devices Market by Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices) - Global Forecast to 2022The active implantable medical devices market is expected to witness significant growth in the coming years. The growing aging population, increasing prevalence of cardiovascular and neurological diseases, investments and funds to develop technologically advanced products, expanded applications of neurostimulators, and favorable reimbursement scenario for ENT procedures in developed countries are some of the factors driving the growth of this market. The implantable and life-sustaining devices market is projected to reach USD 26.75 Billion by 2022 from 18.42 Billion in 2017, at a CAGR of 7.8% from 2017 to 2022. |
April 2017 | $ 5650 |
|
Intraoperative Imaging Market by Product (Mobile C-arms, CT, Intraoperative MRI, Intraoperative Ultrasound), Application (Neurosurgery, Orthopedic, Trauma, Spine Surgery, Cardiovascular, ENT, Gastro, Maxillofacial Surgery) & End User (Hospitals, ASC, Clinic) - Global Forecast to 2021The global Intraoperative Imaging market is projected to reach USD 2.06 Billion by 2021 from USD 1.61 Billion in 2016, at a CAGR of 5.2% during the forecast period of 2016 to 2021. A number of factors, such as the growth in the aging population, rising burden of chronic diseases with changing lifestyles, increasing preference and demand for minimally invasive surgeries (MIS), and expanding applications of neurosurgery and orthopedic surgery are expected to fuel the growth of the intraoperative imaging market. |
March 2017 | $ 5650 |
|
Dental Syringes Market by Product (Non-disposable Syringes, Disposable Syringes and Safety Syringes), Type (Aspirating & Non-aspirating), Material (Plastic and Metallic), Region (North America, Europe , Asia-Pacific, and RoW) - Forecast to 2021The global dental syringes market is projected to reach USD 126.9 Million by 2021 from USD 98.5 Million in 2016; growing at a CAGR of 5.2% during 2016-2021. The rising demand for dental syringes can be attributed to the growing technological advancements and growth in geriatric population. |
March 2017 | $ 5650 |
|
Rehabilitation Equipment Market by Type (Mobility (Wheelchair, Assist Device), Body Support (Lift, Sling), Exercise (Upper, Lower Body), Living Aids (Reading, Writing)), Application (Physiotherapy, OT), End User (Hospital, Clinic, Home Care) - Forecasts to 2021The global rehabilitation equipment market is projected to reach USD 14.91 Billion by 2021 from USD 9.86 Billion in 2016, at a CAGR of 8.6% during the forecast period. The market is mainly driven by factors such increasing incidence of disabilities, favorable healthcare reforms, and rapid growth in the geriatric population. |
March 2017 | $ 5650 |
|
Medical Supplies Market by Type (Diagnostic, Dialysis, Wound Care, Inhalation, Infection Control, Infusion, Intubation, PPE), Application (Anesthesia, Radiology, Sterilization) & End User (Hospital, Clinic, Nursing Home) - Global Forecast to 2021The medical supplies market is projected to reach USD 136.63 Billion by 2021 from USD 98.33 Billion in 2016, at a CAGR of 6.8% during the forecast period. Medical supplies include single-use or disposable products used in all healthcare facilities such as hospitals, clinics, and nursing homes. They are categorized based on their applications and usage in healthcare facilities. |
March 2017 | $ 5650 |
|
Medical Radiation Detection, Monitoring & Safety Market by Detection Type (Gas-Filled Detectors, Geiger Muller, Survey Meter, Solid-State), Products (Personal Dosimeters, OSL, Badges), Safety (Apron, Shields, Face Mask, Gloves), End User - Forecast to 2021The global medical radiation detection, monitoring, and safety market is expected to reach USD 1,215.4 Million by 2021 from USD 887.0 Million in 2016, at a CAGR of 6.5% from 2016 to 2021. This market is segmented based on detectors, detection and monitoring products, safety products, end users, and regions. Growth in the medical radiation detection and monitoring market is mainly driven by factors such as increasing usage of nuclear medicine and radiation therapy for diagnosis and treatment, growing worldwide prevalence of cancer, increasing safety awareness among people working in radiation-prone environments, and the growing number of people covered by insurance. |
March 2017 | $ 5650 |
|
Topical Drug Delivery Market by Product Type (Formulation (Solid, Cream, Lotion, Paste, Liquid), Transdermal (Patch, Gel)), Route of Administration (Skin, Ophthalmic, Rectal, Vaginal, Nasal), & Facility of Use (Hospital, Clinic, Home care, Research) - Global Forecast to 2021The topical drug delivery market is expected to reach USD 125.88 Billion by 2021 from USD 92.40 Billion in 2016 at a CAGR of 6.4% during the forecast period. Major factors driving the growth of this market are the high incidence of burn injuries, rising geriatric population, and increasing incidence of diabetes. However, the negative impact of product recalls may restrain the growth of this market in the coming years. |
March 2017 | $ 5650 |
|
Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtome), Consumables (Reagent & Antibodies), Histopathology, Cytopathology), Application (Disease Diagnosis, Drug Discovery & Development) - Forecasts to 2021The anatomic pathology market was valued at USD 16.2 Billion in 2016 and poised to grow at a CAGR of 6.1% between 2016 and 2021, to reach USD 21.9 Billion in 2021. Key players operating in the anatomic pathology market include F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.). |
March 2017 | $ 5650 |
|
Geomembranes Market by Raw Material (HDPE, LDPE & LLDPE, PVC, EPDM, PP), Manufacturing Process (Blown Film, Calendering), Application (Waste Management, Mining, Water Management, Tunnel Lining), Region - Global Forecast to 2021The global geomembranes market is projected to reach USD 3.41 Billion by 2021 at a CAGR of 9.2% from 2016 to 2021. The geomembranes market has witnessed high growth in the recent years. Geomembranes, due to their functionalities, such as excellent chemical resistance, ability to withstand an elevated temperature range, low permeability, weatherability, UV resistance, and high tear and puncture resistance, are used in a wide range of applications, including waste management, mining, and others. |
March 2017 | $ 5650 |
|
Blood Flow Measurement Devices Market by Product (Ultrasound (Transit Time Flow Meter), Laser Doppler), Application (Invasive (CABG, Microvascular Surgery), Non-invasive (Cardiovascular, Gastroenterology & Tumor Monitoring)) - Global Forecast to 2021The blood flow measurement devices market is projected to reach USD 533.0 Million by 2021 from USD 343.6 Million in 2016, growing at a CAGR of 9.2% in the next five years (2016 to 2021). The growth of the overall blood flow measurement devices market can be contributed to the growing prevalence of cardiovascular diseases and diabetes coupled with rising geriatric population, technological advancements, and the influx of VC funding. |
March 2017 | $ 5650 |
|
Venipuncture Procedure Analysis By Success Rate (Total Venipuncture, Successful Venipuncture), Vein Type (Cephalic Vein, Median Cubital Vein, Basilic Vein), End Users (Hospitals (Private), Diagnostic Labs, Physicians Offices) - Global Forecast to 2021Venipuncture needle and syringes market is projected to reach USD 1,044.6 Million by 2021 from USD 790.8 Million in 2016, at a CAGR of 5.7% during the forecast period. The U.S. total venipuncture procedure volume contributed the largest share in 2016 and poised to grow at a CAGR of 1.8%. Factors such as aging population, cardiovascular disease death rate, pediatric population, chronic diseases conditions will make venipuncture difficult. |
March 2017 | $ 7150 |
|
Coronary Stent Market by Type (BMS, BVS, Drug Eluting), Mode of Delivery (Self, Balloon Expandable), Material (Metal (Stainless Steel, CoCr, PtCr, Nitinol), Polymer, Copolymer), & End User (Hospital, Cardiology Center, ASC) - Global Forecasts to 2021The coronary stent market is expected to reach USD 10.31 Billion by 2021 from USD 7.16 Billion in 2016, at a CAGR of 7.6% from 2016 to 2021. Major factors driving the growth of this market include technological advancements, increasing number of percutaneous coronary intervention (PCI) procedures, rising burden of CAD, increasing demand for minimally invasive procedures, and rising geriatric population. |
March 2017 | $ 5650 |
|
HIV Diagnosis Market by Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification, Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Hospitals) - Global Forecast to 2021The HIV diagnosis market is projected to reach USD 3.88 Billion by 2021 from USD 2.35 Billion in 2016, at a CAGR of 10.5% from 2016 to 2021. Factors such as the growing worldwide prevalence of HIV/AIDS, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments and kits, and increasing government initiatives are expected to drive the growth of the HIV diagnosis market worldwide. |
March 2017 | $ 5650 |
|
Brain Monitoring Market by Product (MRI, CT, PET, EEG, EMG, MEG, TCD, ICP, Electrodes, Sensors, Gels, Cables), Procedure (Invasive, Non-Invasive), Disease (TBI, Stroke, Dementia, Epilepsy) & End User (Hospital, Clinic, ASC, Ambulance) - Forecasts to 2021The global brain monitoring market is expected to reach USD 12.22 Billion by 2021 from USD 8.80 Billion in 2016, growing at a CAGR of 6.8% from 2016 to 2021. The increasing incidence of neurological disorders, rising awareness about neurodegenerative diseases, growth in the number of traumatic brain injuries, and technological advancements are major factors driving the demand for brain monitoring devices. On the other hand, the shortage of trained professionals to effectively operate brain monitoring devices and unfavorable reimbursement policies are restraining the growth of this market. |
March 2017 | $ 5650 |
|
Interventional Radiology Market by Product (MRI System, Ultrasound Imaging System, CT Scanner, Angiography System), Procedures (Angiography, Angioplasty, Biopsy) & Application (Cardiology, Oncology, Urology & Nephrology) - Global Forecast to 2021The market is expected to reach USD 23.50 Billion by 2021 from USD 16.99 Billion in 2016, at a CAGR of 6.7%. This market is segmented based on product, procedure, and application. A number of factors, such as rising incidence and prevalence of chronic diseases, increasing demand for minimally invasive procedures, technological advancements are expected to drive the growth of this market. |
March 2017 | $ 5650 |
|
Surgical Sealants and Adhesives Market by Product (Natural & Synthetic, Fibrin, Collagen, Gelatin, Cyanoacrylate, Albumin, Human blood), Indication (Hemostasis, Tissue Sealing), Application (CNS, Cardiovascular, Cosmetic Surgery) - Global Forecast to 2021The global surgical sealants and adhesives market is estimated to grow at a CAGR of 9.6% from 2016 to 2021 to reach USD 2.96 Billion by 2021. The majority of the demand for surgical sealants and adhesives is driven by the growing prevalence and incidence of various disorders such as obesity and CVDs, increasing incidence of trauma, growth in the number of accidents, rising need to manage blood loss in patients, growth in the number of surgeries, and rising geriatric population. In addition, the greater uptake of technologically advanced products and growing adoption of surgical sealants and adhesives in the U.S. and Europe (owing to FDA and CE Mark approvals) are responsible for driving the overall growth of this market. |
February 2017 | $ 5650 |
|
Ultrasound Market by Technology (Diagnostic, Therapeutic, 2D, 3D/4D, HIFU), Display (B/W, Color), Portability (Cart, Compact, PoC), Application (Radiology, OB/GYN, Cardiac), End User (Hospitals, Academia, Ambulatory, Diagnostic Center) - Forecast to 2021The global ultrasound market is estimated to reach USD 6.86 Billion by 2021 at a CAGR of 5.2% during the forecast period. The growth in this market can largely be attributed to factors such as rising patient population base for chronic and lifestyle-related disorders (coupled with a growing geriatric population that is at greater risk of target diseases as compared to adults); technological advancements; and growing market demand for minimally invasive diagnostic and therapeutic techniques (including ultrasound). |
February 2017 | $ 7150 |
|
Neurovascular Devices/Interventional Neurology Market by Product (Embolic Coils, Stents, Neurothrombectomy Devices, Microcatheters, Balloon Occlusion Devices, Flow Diversion Devices, Clot Retrievers), Pathology (Aneurysm, AVM) - Global Forecasts to 2021The global neurovascular devices/interventional neurology market is estimated to reach USD 2.62 Billion by 2021, at a CAGR of 8.6% during the forecast period. The large patient population base with target diseases, ongoing product development & commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across emerging markets, and growing market demand for effective neurovascular devices are some key factors driving the growth of the market. |
February 2017 | $ 5650 |
|
Extracorporeal Membrane Oxygenation Machine Market by Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)), and Region - Analysis & Forecasts to 2021The global extracorporeal membrane oxygenation (ECMO) machine market is expected to reach USD 305.3 Million by 2021 from USD 247.2 Million in 2016, at a CAGR of 4.3%. The global market is segmented on the basis of modality, application, and region. By modality, the market is segmented into venoarterial (VA), venovenous (VV), and arteriovenous (AV). The venovenous (VV) segment is accounted for the largest share of the market in 2016. The large share of this segment is mainly attributed to the high incidence of respiratory failure, rising lung transplants, increasing incidence of COPD, and technological advancements. The arteriovenous (AV) segment is projected to grow at the highest CAGR in the forecast period. |
February 2017 | $ 5650 |
|
Hemodialysis and Peritoneal Dialysis Market by Products (Machines, Dialyzer, AV Fistula, AV Graft, Bloodlines, Catheters, Transfer Sets, CAPD, APD) & Services, Modality (Conventional, Nocturnal), End User (In-center, Hospital, Home) - Global Forecast to 2021The global hemodialysis and peritoneal dialysis market is estimated to reach 83.89 Billion by 2021, at a CAGR of 6.0% from 2016 to 2021. The growth in this market is driven by the increasing number of ESRD patients, growing prevalence of diabetes & hypertension (major causes of kidney failure), rapid growth in the aging population, preference for dialysis treatments over kidney transplants due to lack of donors, and initiatives taken by leading players to introduce advanced products & services. However, product recalls and the risks & complications associated with dialysis are restricting the growth of this market to a certain extent. Moreover, high competition among market players, high procedural cost, and low cost of kidney transplantation are the foremost challenges faced by industry players. |
February 2017 | $ 5650 |
|
Ablation Technology Market by Product (Radiofrequency, Ultrasound (ESWL, HIFU), Laser, Electrical (Argon Plasma, IRE), Cryotherapy, Microwave, Hydrothermal) & Application (Cardiovascular, Cancer, Pain Management, Orthopedics) - Global Forecasts to 2021The global ablation technology market is estimated to be valued at USD 2.82 Billion in 2016, growing at a CAGR of 10.9% between 2016 and 2021 and reach USD 4.73 Billion. On the basis of type, the market is categorized into laser/light, radiofrequency, ultrasound, electrical, cryoablation, microwave, and hydrothermal ablation technology. The radiofrequency ablation segment is estimated to command the largest share of the global market in 2016 due to lower cost of radiofrequency ablation procedures as compared to other ablation techniques coupled with its high safety, efficacy, and short procedural duration for the treatment of cancer, atrial fibrillation, and pain management. |
February 2017 | $ 5650 |
|
Diagnostic Imaging Market by Product (X-ray Imaging (Digital, Analog), MRI (Closed, Open), Ultrasound, CT, Nuclear Imaging (SPECT, Hybrid PET)), Application (OB/GYN, MSK, Cardiology, Oncology), End User (Hospitals, Imaging Centers) - Global Forecast to 2021The global diagnostic imaging market is expected to reach ~USD 36.43 Billion by 2021 from USD 26.53 Billion in 2016, at a CAGR of 6.6%. Factors such as increasing incidence and prevalence of chronic diseases across the globe, technological advancements in the imaging systems, growing government investments for modernization of imaging facilities, and the rising number of diagnostic imaging centers are driving the growth of this market. However, the high cost of diagnostic imaging systems, technological limitations associated with standalone systems, unfavorable healthcare reforms in the U.S., and shortage of helium are the key factors limiting the growth of the market. |
February 2017 | $ 5650 |
|
Gynecology Surgical Instruments Market by Product (Scissors, Forceps, Trocar, SIMS, CUSCO), Application (Laparoscopy, Colposcopy, Hysteroscopy, D&C, Ablation, Biopsy), & End User (Hospital, Clinic, Ambulatory Surgery Center) - Global Forecast to 2021The gynecology surgical instruments market is expected to reach USD 2.44 Billion by 2021 from USD 1.73 Billion in 2016, at a CAGR of 7.1% from 2016 to 2021. The market is mainly driven by factors such as high incidence of gynecological diseases, increasing awareness programs, and rising government investments for providing advanced healthcare facilities & services, increasing disposable income in developing countries, and rising incidence of lifestyle disorders. |
February 2017 | $ 5650 |
|
Apheresis Market by Product (Plasma & Component Separator, Hemoperfusion, Disposable), Procedure (Therapeutic, Photopheresis, Donor), Application (Plasmapheresis, Plateletpheresis), Technology (Centrifuge, Membrane Separation) - Global Forecast to 2021The global apheresis market is estimated to reach USD 2.06 Billion by 2021, at a CAGR of 7.7% during the forecast period. The increasing demand for blood components and growing concerns regarding blood safety across the globe, rising prevalence of various blood disorders, increasing number of surgical procedures and emergency care cases in hospitals around the world are driving market growth. Extending reach of apheresis in the untapped pediatric segment and growth in emerging markets due to increasing investments presents significant growth opportunities for players in this market. However, high costs of apheresis machines & procedures and scarcity of qualified donors are the major restraining factors for this market. |
February 2017 | $ 5650 |
|
Pulmonary/ Respiratory Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications (COPD) - Forecasts to 2021The global pulmonary drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is mainly driven by increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development of smart/digital inhalers and increasing incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis. Emerging markets such as India, China, & Japan and growth in online marketing channels are expected to offer lucrative growth opportunities for market players in the coming years. On the other hand, factors such as regulatory issues and pricing pressures are the major factors restraining market growth. |
February 2017 | $ 5650 |
|
Professional Dental Care Market by Type (Toothbrush (Electric, Battery-powered), Toothpaste, Mouthwash, Denture Products, Dental Accessories (Whitening Products, Breath Freshener, Dental Floss, Dental Water Jet)) - Global Forecast to 2021The professional dental care market is expected to witness significant growth in the coming years. Factors such as the growing number of small/private dental clinics, rising incidences of dental caries, increasing disposable income in emerging countries, rising awareness about dental hygiene, an economic gain for dental practitioners are the major factors driving the growth of the global professional dental care market. The global professional dental care market is projected to USD 961.0 Million by 2021 from USD 769.3 Million in 2016, at a CAGR of 4.5% from 2016 to 2021. However, the rising trend of group/large dental practices and reluctance by dental practitioners towards the dental dispensing practices are expected to restrain the growth of this market to certain extent. |
February 2017 | $ 5650 |
|
Cold Plasma Market by Industry (Polymer, Textile, Electronics & Semiconductor, Food & Agriculture, Medical), Application (Coating, Adhesion, Finishing, Wound Healing, Decontamination), Regime (Atmospheric, Low-Pressure) - Global Forecast to 2021The cold plasma market witnessed healthy growth rate during the last decade and is expected to grow at a CAGR of 16.2% between 2016 and 2021 to reach USD 2.91 Billion by 2021. The growth in this market is mainly attributed to the benefits of cold plasma, such as its environment-friendliness; innovations in textile production; growing food safety concerns; innovations in cold plasma technology; and the increasing use of cold plasma in meat and poultry packaging decontamination |
February 2017 | $ 5650 |
|
Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End User (Hospital, Home Care), Indication - Global Forecast to 2021The global respiratory care devices market is projected to reach USD 24.07 Billion by 2021, at a CAGR of 9.7% from 2016 to 2021. The market growth can be attributed to a number of factors such as high prevalence of respiratory diseases, rapid growth in the aging population, the high prevalence of smoking, rising urbanization and pollution levels, increasing incidence of preterm births, and lifestyle changes. The rising demand for enhanced portable devices, growing demand for multimodal ventilators and focus of market players on expanding their geographic presence are the key trends of this market. However, the lack of awareness of respiratory conditions leading to a large underdiagnosed and undertreated population and the harmful effects of certain respiratory care devices on neonates are the major challenges in this market. |
February 2017 | $ 5650 |
|
Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel (Hospital), Patient Care Setting (Hospital, Home Care) - Forecast to 2021The global injectable drug delivery market, in terms of value, is projected to reach USD 624.50 Billion by 2021 from USD 362.38 Billion in 2016, at a CAGR of 11.5% during the forecast period. The injectable drug delivery market is segmented based on type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, facility of use, and regions. |
February 2017 | $ 5650 |
|
Surgical Lasers Market by product type (Carbon Dioxide, Argon, Nd:YAG & Diode Lasers), Procedure (Open, Laparoscopic & Percutaneous), & Application (Ophthalmology, Urology, Gynaecology, Dermatology, Dental, Cardiology, & Oncology) - Global forecast to 2021The global surgical lasers market is projected to reach USD 2.37 Billion by 2021 from USD 1.85 Billion in 2016; growing at a CAGR of 5.1% during 2016-2021. The rising demand for surgical lasers can be attributed to the growing prevalence of chronic diseases, technological advancements, increasing incidence and prevalence of targeted diseases, and high prevalence of ophthalmic disorders. In addition, growing preference for minimally invasive surgeries among patients and healthcare professionals is supporting the growth of the surgical lasers market. |
February 2017 | $ 5650 |
|
Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps, Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument) - Global Forecast to 2021The lung cancer surgery market is projected to reach USD 29.99 Billion by 2021 from USD 21.58 Billion in 2016, at a CAGR of 6.8% from 2016 to 2021. The major players in the lung cancer surgery market are Ethicon US LLC (U.S.), Intuitive Surgical Inc. (U.S.), Olympus Corporation (Japan), Accuray Inc. (U.S.), AngioDynamics Inc. (U.S.), Teleflex Inc. (U.S.), KARL STORZ GmbH (Germany), Ackermann Instrumente GmbH (Germany), Scanlan International Inc. (U.S.), and Trokamed GmbH (Germany). |
January 2017 | $ 5650 |
|
Surgical/Operating Microscopes Market by Application (Neuro and Spine Surgery, Plastic and Reconstructive Surgery, Ear, Nose, and Throat Surgery, Oncology, Urology, Documentations), End User (Hospitals, Outpatient Facility) - Global Forecast to 2021The global surgical/operating microscope market is projected to reach USD 915.6 Million by 2021 from USD 508.1 Million in 2016, growing at a CAGR of 12.5% during the forecast period. The increasing use of fluorescence image-guided surgery (FIGS), increase in the number of surgeries and growing demand for MIS, advancements in healthcare facilities, technological advancements, and customized microscopy solutions are the key factors driving the growth of the global surgical/operating microscopes market. |
January 2017 | $ 5650 |
|
U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin, Valerian Root)) - Forecasts to 2021The U.S. insomnia market is categorised into pharmacological treatments and non-pharmacological treatments. The U.S. insomnia pharmacological treatment market is projected to reach USD 4.24 Billion by 2021 from USD 3.38 Billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021. The duration of insomnia can be from a day to years. Based on duration, insomnia is divided into three major categories, namely, transient insomnia (less than a month), short term insomnia (between 1 month and 6 months), and chronic insomnia (more than 6 months). |
January 2017 | $ 5650 |
|
U.S. Veterinary Infusion Pumps Market by Type (Large Volume Infusion Pumps, Syringe Infusion Pumps), End User (Private Hospitals, Private Clinics, Teaching Hospitals) - Forecast to 2021The U.S. veterinary infusion pumps market is expected to witness growth in the coming years as a result of the growing demand for pet insurance and increasing animal healthcare expenditure, rising demand for animal-derived food products, and growth in the number of veterinary practitioners and their income levels. This market is projected to reach USD 35.4 Million by 2021 from USD 26.6 Million in 2016, at a CAGR of 5.8% from 2016 to 2021. Growing adoption of companion animals and increasing prevalence of animal diseases requiring surgeries are the major factors that are expected to offer potential growth opportunities to market players. However, increasing pet care costs may hinder the growth of this market to a certain extent. |
January 2017 | $ 5650 |
|
CBCT/Cone Beam Imaging Market by Application (Dental (Oral and Maxillofacial Surgery, Implantology, Orthodontics, Endodontics), Patient Position (Standing/Sitting, Seated, Supine), End User (Hospital, Private Practice) - Global Forecast to 2021The global CBCT/Cone beam imaging market is expected to reach USD 801.2 Million by 2021 from USD 494.4 Million in 2016, at a CAGR of 10.1% during the forecast period (2016-2021). Factors such as increasing prevalence of dental disorders, growth in geriatric population, growing demand for cosmetic dentistry, and expanding applications of CBCT systems are expected to fuel growth in the CBCT systems market in the coming few years. |
January 2017 | $ 5650 |
|
Drug Delivery Technology Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal (Oral)), Patient Care Setting (Hospital, ASC) - Global Forecast to 2021The global drug delivery technology market is projected to reach USD 1,669.40 Billion by 2021 from USD 1,179.20 Billion in 2016, at a CAGR of 7.2% during the forecast period. This market is segmented based on route of administration, facility of use, and region. |
January 2017 | $ 5650 |
|
Interventional Radiology Products Market by type (Stents, Catheters, IVC Filter, Accessories), Procedure Type (Angioplasty, Angiography, Biopsy, Thrombolysis, Embolization), Applications (Oncology, Cardiology, Urology & Nephrology) - Forecast to 2021The global interventional radiology products market is expected to reach USD 8.02 Billion by 2021 from USD 6.35 Billion in 2016, at a CAGR of 4.8%. The major factors driving the growth of this market are rising incidence of chronic diseases, rising geriatric population, and increasing demand for minimally invasive surgeries. |
January 2017 | $ 5650 |
|
Nasal Drug Delivery Technology Market by Dosage Form (Nasal Drops, Sprays, Powder, Gel), System (Multidose, Unit Dose, BI-Dose), Therapeutic Applications (Rhinitis, Congestion, Vaccinations), End User (Hospitals, Homecare) - Global Forecast to 2021The global nasal drug delivery technology market is projected to reach USD 64.20 Billion by 2021 from USD 44.00 Billion in 2016, at a CAGR of 6.5% during the forecast period. This market is segmented based on dosage form, therapeutic application, end user, system, container, and region. |
January 2017 | $ 5650 |
|
Diagnostic Catheter Market by Type (Angiography, OCT, Ultrasound, Electrophysiology, Pressure and Hemodynamic Monitoring), Application Area (Cardiology, Urology, Neurology, Gastroenterology), End User (Hospitals, Imaging Centers) - Global Forecast to 2021The global diagnostic catheters market is projected to reach USD 4.30 Billion by 2021 from USD 3.02 Billion in 2016, at a CAGR of around 7.3% from 2016 to 2021. This market is mainly driven by the rising geriatric population, increasing prevalence of cardiovascular disorders, growing number of minimally invasive surgeries, growth in the number of diagnostic imaging centers, and technological advancements in imaging catheters. |
January 2017 | $ 5650 |
|
Electrosurgery Market by Product (Generators, Instruments-Bipolar (Vessel Sealing, Forceps) & Monopolar (Pencils, Electrodes), Accessories, Argon & Smoke Management Systems), Type of Surgery (Orthopedic, Cosmetic, Gynecology) - Global Forecast to 2021The global electrosurgery market is projected to reach USD 5.17 Billion by 2021, at a CAGR of 3.9% in the forecast period (2016–2021). Factors such as technological advancements in electrosurgery devices, growing number of medical, aesthetic and plastic surgeries, rising demand for minimally invasive surgeries, and growing number of ambulatory surgery centers are driving the growth of this market. On the other hand, healthcare reforms in the U.S., frequent product recalls, and risks associated with electrosurgical procedures are some of the key factors limiting the growth of the global electrosurgery market. |
January 2017 | $ 5650 |
|
Nuclear Imaging Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), Hybrid PET, Planar Scintigraphy), Application (Oncology, Cardiology & Neurology), End user (Hospitals, Imaging Centers) - Global Forecasts to 2021The nuclear imaging equipment market is projected to reach USD 2.85 Billion by 2021 from USD 2.25 Billion in 2016, growing at a CAGR of 4.8% during the forecast period, The major players in the global nuclear imaging equipment market are Siemens Healthineers (Germany), Philips Healthcare (Netherlands), and GE Healthcare (U.S.). The other players in the market include Toshiba Medical Systems Corporation (Japan), Neusoft Medical Systems Co., Ltd. (China), Mediso Medical Imaging Systems Ltd. (Hungary), Digirad Corporation (U.S.), CMR Naviscan Corporation (U.S.), SurgicEye GmbH (Germany), and DDD Diagnostics (Denmark). |
January 2017 | $ 5650 |
|
Blood Screening Market by Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecasts to 2021The global blood screening market consists of various technologies and products & services which are used in blood banks and hospitals for the screening of various TTIs. The blood screening market is expected to reach USD 2.80 Billion by 2021 from USD 1.76 Billion in 2016, at a CAGR of 9.7%. The major factors driving the growth of this market are increasing number of blood donations and blood donors and rising awareness regarding the safety of donated blood. In addition, increasing affordability and adoption of nucleic acid test (NAT) for blood screening, rising demand for donated blood, and increasing prevalence of infectious diseases are also driving the growth of this market. |
January 2017 | $ 5650 |
|
Cardiovascular Ultrasound System Market by Test Type (Transesophageal, Stress, Transthoracic, Fetal), Technology (2D, 3D & 4D, Doppler Imaging), Device Display (Black & White, Color), End User (Hospitals, Home Care, Ambulatory) - Forecast to 2021The global cardiovascular ultrasound market is projected to reach USD 1.66 Billion by 2021 from USD 1.27 Billion in 2016, at a CAGR of 5.4% from 2016 to 2021. In this report, the global cardiovascular ultrasound system market is segmented on the basis of test type, technology, device display, end user, and region. Based on test type, the cardiovascular ultrasound system market is categorized into transthoracic echocardiogram, transesophageal echocardiogram, stress echocardiogram, and other echocardiograms. The other echocardiograms include fetal & intracardiac echocardiograms. |
December 2016 | $ 5650 |
|
Clinical Trial Imaging Market by Product & Services (Software), Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-Ray), End User (Pharmaceutical Companies, Biotechnology Companies, CROs, Medical Device Manufacturers) - Global Forecast to 2021The global clinical trial imaging market is projected to reach USD 1069.7 Million by 2021 from USD 773.4 Million in 2016, at a CAGR of 6.7% from 2016 to 2021.In this report, the global clinical trial imaging market is broadly segmented by product and service, modality, end user, and region. Major factors fueling market growth are the increase in R&D spending and growth in the pharmaceutical and biotechnology industries and the increasing number of contract research organizations are the key drivers for the growth of the clinical trial imaging market. On the other hand, the high implementation cost of imaging systems is restraining the growth of this market. |
December 2016 | $ 5650 |
|
Fluid Management Systems Market by Product (Dialyzers, Insufflators, Fluid Warming systems, Pressure Transducers, Suction Canister), Disposables and Accessories, & Application (Urology, Laparoscopy, Gastroenterology, Gynecology) - Forecast to 2021The fluid management systems and accessories market is projected to reach USD 12.47 Billion by 2021 from USD 9.39 Billion in 2016, at a CAGR of 5.8% during the forecast period. Factors such as increasing number of minimally invasive surgeries, technological advancements in fluid management systems, and increase in government funds and grants worldwide for endosurgical procedures are driving the fluid management systems and accessories market. Moreover, the untapped potential in emerging markets and rising use of single-use disposable devices and accessories are expected to offer growth opportunities for players operating in the fluid management systems and accessories market. |
December 2016 | $ 5650 |
|
ECG Cable and ECG Lead wires Market by Material (Thermoplastic Elastomer, TPU), Usability (Reusable, Disposable), ECG Leadwires by Machine Type (3 lead, 5 lead), Patient Care Setting (Long term care facilities, Home care) - Forecast to 2021The ECG cable and ECG leadwires market is expected to witness significant growth in the coming years owing mainly to factors such as the rapidly increasing geriatric population, rising incidences of cardiovascular diseases and technological advancements. The global ECG cable and ECG leadwires market is projected to reach USD 1.75 Billion by 2021 from USD 1.32 Billion in 2016, at a CAGR of 5.7% from 2016 to 2021. However, factors such as high cost of the disposable cables and leadwires is limiting the growth of this market. |
November 2016 | $ 5650 |
|
Needle Free Injection Systems Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period. Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. |
November 2016 | $ 5650 |
|
Spinal Implants and Surgical Devices Market by Technology (Fusion, Fixation, VCF, Decompression, Motion Preservation), Product (Thoracic, Lumbar, Cervical, Interbody, Kyphoplasty, Artificial Discs, MIS, Biologics, Stimulators) - Global Forecast to 2021The global spinal implants and surgical devices market is estimated to reach 17.27 Billion by 2021, at a CAGR of 5.3% in during the forecast period. Technological advancements in spine surgery devices, and increasing aging and obese population with increasing number of spine deformities, and rising demand for minimally invasive spine surgery procedures are the key factors fueling the growth of the spinal implants and spinal devices market. Moreover, the emerging Asian and Latin American countries, growth in the number of hospitals and surgical centers, and commercial applications in high growth areas such as MIS, nucleus arthroplasty, artificial disc replacement, and stem cell technologies are expected to offer growth opportunities for players operating in the global spinal implants and surgical devices market. |
November 2016 | $ 5650 |
|
Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period. This market is mainly driven by the increased adoption of point-of-care & rapid diagnostic tests, growth in the number of private diagnostic centers, high prevalence of infectious diseases in women, rising incidence of chronic & lifestyle-related disorders in women and increasing awareness about fertility testing in women & initiatives taken by government and health organizations. |
November 2016 | $ 5650 |
|
Medical Aesthetics Market by Product (Liposuction, Cellulite & Fat Reduction, Skin Tightening, Breast Implants, Botox, Dermal Fillers, Tattoo Removal, Thread Lift, Laser Hair Removal), End-User (Clinics & Medical Spas, Beauty Center) - Forecast to 2021The global Medical aesthetic market is estimated to grow at a CAGR of 10.8% from 2016 to 2021 to reach USD 13.29 Billion by 2021. Key factors such as the growing adoption of non-invasive procedures, growth in aging population, increasing awareness among customers, technological advancements in energy-based medical aesthetic devices, and increasing demand for aesthetic treatments among the male population are driving the growth of the aesthetic devices market. |
November 2016 | $ 5650 |
|
Surgical Navigation Systems Market by Application (ENT, Orthopedic (Type (Imageless, Fluoroscopy, CT), Procedure (Knee, Hip)), Neuro, Spinal, Dental), Technology (EM, Hybrid, Optical), Patient Care Setting (Hospital, Clinic, Ambulatory) - Forecasts to 2021The global surgical navigation systems market is expected to reach USD 906.8 Million by 2021 from USD 662.5 Million in 2016, at a CAGR of 6.5% during the forecast period (2016–2021). Growth of this market is primarily driven by factors such as the rising adoption of minimally invasive surgical procedures; growing number of regulatory approvals, and partnerships, agreements, and collaborations among market players; increasing incidence of orthopedic and neurological disorders; and high prevalence of ENT disorders. However, the high cost of surgical navigation systems and product recalls are likely to create a negative impact on the growth of this market. |
November 2016 | $ 5650 |
|
Coagulation/Hemostasis Analyzer Market by Product (Clinical Laboratory & PoCT Analyzers), Consumables, Test (PT, Fibrinogen, APTT, ACT, D Dimer, Platelet Function), Technology (Mechanical, Optical, Electrochemical), End User (PoCT) - Forecast to 2021The coagulation analyzer market is projected to reach USD 4.84 Billion by 2021 from USD 2.98 Billion in 2016, at a CAGR of 10.2% from 2016 to 2021. On the basis of product, the coagulation analyzer market is segmented into clinical laboratory analyzers & PoC testing analyzers. The clinical laboratory analyzers segment is expected to account for the largest share of the global coagulation analyzers market in 2016, owing to increasing incidence of cardiovascular and blood related diseases. |
November 2016 | $ 5650 |
|
Prefilled Syringes Market by Material (Glass, Plastic), Type (Conventional, Safety), Design (Dual & Single-Chamber, Customized ), Region (North America (U.S.), Europe (Germany, UK, France), Asia-Pacific (Japan, India, China)) - Forecast to 2021The prefilled syringes market is expected to reach USD 6.36 Billion by 2021 from USD 3.93 Billion in 2016, at a CAGR of 10.1% during the forecast period. Increasing prevalence of chronic diseases, technological advancements in prefilled syringes, large patient population base, and benefits associated with prefilled syringes are the major factors driving the growth of this market. In addition, growing initiatives undertaken by leading market players to establish production facilities in both mature and developing markets are further adding to the growth prospects of this market. |
November 2016 | $ 5650 |
|
Respiratory Diagnostics Market by Product & Service (Instruments/Devices, Kits/Reagents), Test Type (Pulmonary Function Test, Imaging Test), Disease (TB, Lung Cancer, COPD), End User (Reference Laboratories, Physician Offices) - Global Forecast to 2021The global respiratory diagnostics market is projected to reach USD 7.45 Billion by 2021 from USD 5.24 Billion in 2016, at a CAGR of 7.3% from 2016 to 2021. In this report, the global respiratory diagnostics market is broadly segmented by product and service, test type, disease, end user, and region. |
November 2016 | $ 5650 |
|
Syringes Market by Usability (Sterilizable/reusable (hypodermic, oral) & Disposable Syringes (conventional, safety, prefilled)), Material (Glass & Plastic Syringes), Type (General & Specialized Syringes (insulin, tuberculin) - Global Forecast to 2021The syringes market is expected to reach USD 15.99 Billion by 2021 from USD 10.56 Billion in 2016, at a CAGR of 8.7% during the forecast period. High prevalence of chronic diseases across the globe, rising geriatric population, increasing adoption of safety syringes, technological advancements, and increasing demand for vaccines are supporting the growth of this market. However, high cost of safety syringes and increasing incidence of needle stick injuries are the major challenges in this market. |
November 2016 | $ 5650 |
|
Dermatology Devices Market by Diagnostic Device (Imaging Device, Dermatoscope, Microscope), Treatment Device (Electrosurgical, Cryotherapy, Laser), Application (Skin Cancer Diagnosis, Acne, Psoriasis, Skin Rejuvenation, Warts) - Global Forecasts to 2021The global dermatology devices market is expected to reach USD 14.17 Billion by 2021 from USD 8.22 Billion in 2016, at a CAGR of 11.50%. This market is broadly classified into diagnostic devices (by type and application) and treatment devices (by type and application). The dermatology diagnostic devices market, by type, is segmented into dermatoscopes, microscopes, and imaging devices. |
October 2016 | $ 5650 |
|
Aesthetic/Cosmetic Lasers Market by Type (Standalone (CO2, Er:YAG, Diode, Nd:YAG, Alexandrite, Pulsed-Dye), Multiplatform), Application (Acne, Scars, Tattoo Removal, Varicose Veins), End User (Hospitals, Medical Spa, Private clinics) - Forecasts to 2021The aesthetic/cosmetic lasers market is projected to reach USD 1,132.7 Million by 2021 from USD 697.6 Million in 2016, growing at a CAGR of 10.2% during the forecast period. Major players in the aesthetic/cosmetic lasers market include Aerolase (U.S.), Alma Lasers, Ltd. (Israel), Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), El.En. SpA (Italy), Lumenis Ltd. (Israel), Sciton, Inc. (U.S.), SharpLight Technologies (Israel), Syneron Medical Inc. (Israel), and Solta Medical (U.S.). |
October 2016 | $ 5650 |
|
Phototherapy Equipment Market by Type (Long lamp, CFL, LED, Fiber optic), Application (Skin diseases (psoriasis, vitiligo, eczema), Neonatal Jaundice), End-user, Geography (North America (USA, Canada), Europe, Asia-Pacific) - Global Forecast to 2021The phototherapy equipment market is expected to reach USD 583.4 Million by 2021 from USD 468.2 Million in 2016, growing at a CAGR of 4.5% during the forecast period of 2016 and 2021. This market is primarily driven by the rising incidence of neonatal jaundice in both developed and developing markets, rising number of people suffering from skin diseases, inflow of technologically advanced products, and rising adoption of LED-based phototherapy equipment. However, the high use of alternative treatment modes and stringent regulatory policies for the approval of new devices are limiting the growth of this market. |
October 2016 | $ 5650 |
|
Ophthalmic Lasers Market by Product Type (Femtosecond Lasers, Excimer Lasers, Nd:YAG Lasers, Diode Lasers, and Other Lasers), Application (Refractive Error Correction, Cataract Removal, Glaucoma Treatment, Diabetic Retinopathy Treatment, AMD Treatment, and Other Applications), & End User (Hospitals and Clinics and Ambulatory Surgery Centers (ASCs) - Global Forecast to 2021The ophthalmic lasers market is projected to reach USD 1,245.4 Million by 2021 from USD 970.2 Million in 2016, at a CAGR of 5.1%. Increasing prevalence of ophthalmic disorders, rising prevalence of chronic disorders, rapid growth in geriatric population, and increasing regulatory approvals for ophthalmic lasers are expected to drive the growth of the ophthalmic lasers market. |
October 2016 | $ 5650 |
|
Body Composition Analyzers Market by Product (Bio-impedance analyzer/DEXA/Skinfold calipers/ADP/Hydrostatic weighing), & End-users (Hospitals/Fitness & wellness centers/Academic & Research Center/Home-users) - Analysis & Global Forecasts to 2021The body composition analyzers market is expected to reach USD 668.1 Million in 2021 from USD 366.7 Million in 2016 at a CAGR of 12.7%. The demand for body composition analyzers has been on the rise due to the growing obese population across the globe. Other drivers include growing health and fitness consciousness among people, increasing government initiatives to encourage physical activity and technological advancements. |
October 2016 | $ 5650 |
|
Tumor Ablation Market by Technology (Radiofrequency, Microwave, Cryoablation, IRE, Ultrasound, Laser), Mode of Treatment (Surgical, Laparoscopic, Percutaneous), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecast 2021The global tumor ablation market is estimated to grow at a CAGR of 12.5% to reach USD 580.1 Million by 2021. Technological advancements in the field of tumor ablation coupled with increased procedural safety profile, rising market demand of minimal invasive tumor ablation techniques, increasing prevalence of cancer across the globe, as well as growing number of public-private initiatives & funding to support ongoing research activities related to tumor ablation are propelling the growth of the market. Over the past three years, the company has adopted new product launches, product enhancements, and geographic expansion as its key business strategies to ensure its dominance in this market. Angiodynamics, Inc. (U.S.), Boston Scientific Corporation (U.S.), Galil Medical, Inc. (U.S.), EDAP TMS S.A. (France), Healthtronics, Inc. (U.S.), Medtronic, Plc (U.S.), Mermaid Medical, Inc. (Denmark), Mesonix, Inc. (U.S.), Neuwave Medical, Inc. (U.S.) and Sonacare Medical, LLC (U.S.) are some of the other key players operating in the tumor ablation market. |
October 2016 | $ 5650 |
|
Inorganic Scintillators Market by Scintillation Material (NaI, CsI, LSO & LYSO), Type (Alkali Halides, Rare Earth Metals), & Application (Healthcare, Homeland Security & Defense, Nuclear Power Plants) - Analysis & Global Forecast to 2021The inorganic scintillators market is expected to reach USD 330.7 Million in 2021 from USD 256.1 Million in 2016, growing at a CAGR of 5.2%. Growing safety concerns post the Fukushima disaster, growing security threats, growing security budgets of global sporting events, increasing incidence of cancer, growth in the number of PET/CT scans, and growing threat of nuclear terrorism are expected to drive the growth of the market in the coming years. |
October 2016 | $ 5650 |
|
Cardiac Marker Testing Market by Type (Troponin I & T, CK-MB, Myoglobin, BNP, hsCRP), Product (Reagent, Instrument), Method (Chemiluminescence, ELISA), Disease (Myocardial Infarction, Congestive Heart Failure), Testing (Lab, POC) - Global Forecast to 2021The global cardiac marker testing market is projected to reach USD 3.50 Billion by 2021, at a CAGR of 8.8% in the forecast period (2016–2021). Factors such as growing incidences of cardiovascular diseases, the rapidly increasing geriatric population, growing funding from public–private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are driving the growth of the cardiac marker testing market. However, factors such as technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are some of the key factors hampering the growth of this market. |
October 2016 | $ 5650 |
|
Burn Care Market by Product (Advanced (Alginate, Collagen, Hydrocolloid, Hydrogel), Biologics, Traditional), Depth (Minor, Partial-thickness, Full-thickness Burn), End-Users (Hospitals (Inpatient, Outpatient), Physician Clinics, Homecare) - Forecast to 2021The global burn care market is expected to reach USD 2.33 Billion by 2021 from USD 1.68 Billion in 2016, at a CAGR of 6.8% from 2016 to 2021. In this report, the global burn care market has been broadly classified on the basis of product, depth of burn, end user, and region. |
September 2016 | $ 5650 |
|
Nurse Call Systems Market by Instrument (Buttons, Integrated Communication Systems, Intercom Systems, Mobile Systems), Technology (Wired Systems and Wireless Systems), Application (Emergency Medical Alarms, Workflow Support, Wanderer Control, and Other Applications), End User (Hospitals, Assisted Living Centers and Nursing Homes, Clinics and Physician Offices, Ambulatory Service Centers, and Other End Users) - Global Forecast to 2021The global nurse call systems market is expected to reach USD 1.75 Billion by 2021 from USD 1.12 Billion in 2016, at a CAGR of 9.3%. This market is broadly classified based on instruments, technologies, applications, and end users. On the basis of instruments, the nurse call systems market is segmented into buttons, integrated communication systems, mobile systems, and intercom systems. The integrated communication systems segment is expected to account for the largest share of the global nurse call systems market in 2016. |
September 2016 | $ 5650 |
|
Refurbished Medical Equipment Market (X-Ray, Ultrasound, MRI, CT Scanner, Nuclear Imaging Systems, Heart-Lung Machine, Surgical, CO2 Monitor, Patient Monitor, Pulse Oximeter, AED Defibrillator, Cath Labs, Neonatal, Endoscopy) - Global Forecast to 2021The refurbished medical equipment market is expected to reach USD 11.91 Billion by 2021 from USD 6.55 Billion in 2016, at a CAGR of 12.7% during the forecast period. Increasing privatization in the healthcare sector, poor reimbursement scenario for various medical treatments, large patient population base, and presence of a large number of hospitals/clinics with budget constraints in developing countries are the major factors driving the growth of this market. |
September 2016 | $ 5650 |
|
Latin America Infusion Pump Market by Product (Volumetric, Syringe, Feeding, Insulin, PCA Pump), Application (Chemotherapy, Gastroenterology, Diabetes, Pain Management), Setting (Hospital, Ambulatory Centers), Accessories - Forecast to 2021The Latin American infusion pumps and accessories market is projected to reach USD 671.9 Million by 2021 from USD 487.3 Million in 2016, growing at a CAGR of 6.6% during the forecast period. Market growth can be attributed to the increasing prevalence of chronic diseases owing to the rapidly growing geriatric population, increasing use of infusion products in home care with favorable reimbursement coverage, and technological improvements in infusion products. |
September 2016 | $ 5650 |
|
Antinuclear Antibody Test Market by Product (Reagents & Assay Kits, Systems, Software, Services), Technique (Immunofluorescence, Elisa, Multiplex), Disease (Rheumatoid Arthritis, SLE), End User (Clinical Labs, Hospitals) - Forecast to 2021The global antinuclear antibody (ANA) testing market is expected to reach USD 1,476.1 Million by 2021 from USD 823.5 Million in 2016, at a CAGR of 12.4%. This market is segmented based on products, diseases, techniques, end users, and regions. On the basis of products, the ANA testing market is segmented into assay kits & reagents, systems, and software & services. The assay kits & reagents segment is expected to account for the largest share of the global ANA testing market in 2016, primarily due to the growing number of reagent rental agreements and increasing prevalence of autoimmune diseases worldwide. |
September 2016 | $ 5650 |
|
Medical Holography Market by Product (Holographic Display, Microscope, Print, Software), Application (Medical Imaging, Medical Education, Biomedical Research), End User (Medical Schools, Pharmaceutical Companies, Hospitals) - Global Forecast to 2021The global medical holography market is projected to reach USD 953.9 Million by 2021 from USD 223.1 Million in 2016, at a CAGR of 33.7%. This market is mainly driven by the growing clinical applications of holography in the healthcare sector, rising adoption of holography products in biomedical research and medical education, and increasing investments and funds for R&D in medical holography market. However, high computational cost of processing holograms is hampering the uptake of holography products in medical sector up to certain extent. |
September 2016 | $ 5650 |
|
Laboratory Equipment Services Market by Service (Repair, Calibration, Validation), Equipment (Analytical, Specialty), Service Provider (OEM, Third Party), Service Contracts (Standardized, and Customized), End User - Global Forecast to 2021The global laboratory equipment services market, in terms of value, is projected to reach USD 11.51 Billion by 2021 from USD 6.50 Billion in 2016, at a CAGR of 10.0% during the forecast period. This market is expected to grow faster in terms of volume than value. Growth in this market is mainly driven by increasing research in pharmaceutical and biotechnology industries and the growing need for timely and effective diagnosis of diseases. Furthermore, developing markets such as India and China and the increasing number of asset management companies provides significant growth opportunities for the laboratory equipment services market. |
September 2016 | $ 5650 |
|
Small Animal Imaging (In-Vivo) Market by Modality (Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes) - Global forecast to 2021The global small animal imaging market is expected to reach a value of USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016-2021. A number of factors such as technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches are propelling the growth of the global small animal imaging market. |
September 2016 | $ 5650 |
|
Urology Surgical Instruments Market by Product (Endoscopes, Endovision Systems, Peripheral Instruments, Consumables and Accessories), Application (Chronic Kidney Diseases, Benign Prostatic Hyperplasia, Oncology) - Global Forecast to 2021The global urology surgical instruments market is expected to reach USD 11.48 Billion by 2021 from USD 7.74 Billion in 2016, growing at a CAGR of 8.2% from 2016 to 2021. The growth of the overall urology surgical instruments market can be contributed to rising prevalence of kidney diseases and urinary tract infections; rising number of hospitals and growing hospital investments in surgical infrastructure; availability of investments, funds, and grants from government bodies; and rising geriatric population. |
September 2016 | $ 5650 |
|
Preclinical Imaging (In-VIVO) Market by Modality (Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes) - Global Forecast to 2021The global preclinical imaging market is expected to reach a value of USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016-2021. A number of factors such as technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches are propelling the growth of the global preclinical imaging market. |
August 2016 | $ 5650 |
|
North American Drug Delivery Technologies Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Device), Nasal (Drop), Topical (Solid), Implantable (Active)), End User (Hospital, Home Care) - Global Forecast to 2021The North American drug delivery technologies market is projected to reach USD 758.7 Billion by 2021 from USD 520.0 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is primarily driven by the rising prevalence of chronic diseases, growth in the biologics market, funding initiatives for drug delivery research, and technological advancements. However, risk of needlestick injuries and side effects related to drugs are expected to restrain the growth of this market in the coming years. |
August 2016 | $ 5650 |
|
Medical Radiation Shielding Market by Products (X-Ray, Shields, Booths, Sheet Lead, Bricks, Curtain), Solution (Radiation Therapy, Cyclotron, Multimodality, PET, SPECT, CT, MRI), End User (Hospitals, Diagnostics Center) - Global Forecasts to 2021The reporting segments in this market include products, solutions, end user, and regions. On the basis of products, the medical radiation shielding market is segmented into Shields, Barriers, Booths, X-ray rooms, Sheet Lead, Lead Bricks, Lead Curtains, Lead Lined Doors & Windows, Lead Glass, Lead Lined Drywalls, Lead Lined Plywood, High Density Concrete Blocks, Lead Acrylic, and MRI Shielding Products. The MRI shielding products segment is expected to account for the largest share of the global medical radiation shielding market in 2016. The high market share of this segment is attributed to the higher MRI installation base across the globe. |
August 2016 | $ 5650 |
|
Laparoscopic Instruments Market by Product (Laparoscope, Insufflator, Energy Device), Application (Bariatric Surgery, Colorectal Surgery, General Surgery), End User (Hospitals, Ambulatory Surgical Centers) - Analysis & Global Forecast to 2021Laparoscopic instruments are used during laparoscopy, a type of minimally invasive surgical procedure used for diagnostic and treatment purposes. The global laparoscopic instruments market is projected to reach USD 11.68 Billion by 2021, growing at a CAGR of 8.9 %, during the forecast period of 2016 to 2021. The major players in the laparoscopic instruments market include Karl Storz GmbH & Co.KG (Germany), Olympus Corporation (Japan), Medtronic plc (Ireland), B. Braun Aesculap (Germany), Stryker Corporation (U.S.), Richard Wolf GMBH (Germany), Ethicon, Inc. (U.S.), Smith & Nephew PLC (U.K.), Cook Medical Incorporated (U.S.) and ConMed Corporation (U.S.) among others. |
August 2016 | $ 5650 |
|
Dental Consumables Market by Product (Implants, Prosthetics, Orthodontics, Endodontics, Infection Control, Periodontics, Whitening Products, Prophylaxis, Fluorides, Sealants, Splints), End-User (Hospital & Clinic, Academic, Research) - Global Forecast to 2021The dental consumables market is expected to witness significant growth in the coming years. Factors such as the rapid rise in geriatric population, growing dental tourism in emerging markets, rising incidences of dental caries and other periodontal diseases, growing disposable incomes (resulting in increased willingness to spend out-of-pocket), rising demand for cosmetic dentistry, and increasing dental care expenditure are the major factors driving the growth of the global dental consumables market. The global dental consumables market is projected to reach USD 35.35 Billion by 2021 from USD 25.45 Billion in 2016, at a CAGR of 6.8% from 2016 to 2021. However the high cost and limited reimbursement for dental care and shortage of dental professionals are expected to restrain the growth of this market to certain extent. |
August 2016 | $ 5650 |
|
Urinalysis Market by Product Type (Dipstick, Reagent, Analyzers, POC), Test Type (Biochemical, Sediment, Microscopic, Flow-Cytometric), Application (Diabetes, UTI, Kidney, Liver Disease, Pregnancy), End User (Hospitals, Diagnostic Labs) - Forecast to 2021The global urinalysis market is expected to reach USD 1.91 Billion by 2021 from USD 1.32 Billion in 2016, at a CAGR of 7.6%. The global market is broadly classified into product type, test type, applications, end user, and region. The key players in the urinalysis market include Beckman Coulter (U.S.), Roche Diagnostics (Switzerland), Siemens AG (Germany), Sysmex (Japan) and Arkray, Inc. (Japan). |
July 2016 | $ 5650 |
|
Organ Preservation Market by Preservation Solution(UW/Custodiol HTK/Perfadex), Transportation Technique (Static Cold Storage/Hypothermic Machine Perfusion/Normothermic Machine Perfusion) & Organ Type(Kidneys/liver/lung) - Analysis & Forecasts to 2021The organ preservation market is expected to reach USD 241.2 Million in 2021 from USD 165.9 Million in 2016 at a CAGR of 7.8%. The demand for organ preservation solutions and transport devices has been on the rise due to the growing organ transplants across the globe and better transplant outcomes for end-stage diseases. The technological advancements in the organ preservation technique have enabled better transplant outcomes and spurred the demand for preservation solutions and transport devices for transplantation. |
July 2016 | $ 5650 |
|
U.S. Therapeutic Plasma Exchange Market by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Guillain Barre Syndrome, Multiple Sclerosis, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - Forecasts to 2021The U.S. therapeutic plasma exchange (TPE) market by indication is estimated to reach USD 260.0 million by 2021, growing at a CAGR of 11% to 12% during the forecast period. The growing prevalence of neurological diseases; increasing adoption of TPE procedures in rare disorders such as Guillain-Barré syndrome (GBS), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Neuromylitis Optica, Thrombotic Thrombocytopenic Purpura (TTP), Cryoglobulinaemia; and growing awareness about increasing the clinical response rate of TPE procedures in various diseases in the U.S. are driving the growth of this market. |
July 2016 | $ 5650 |
|
Dental Equipment Market by Product (Dental Radiology Equipment, Digital Sensors, Dental Lasers, Diode Lasers, Dental Chairs, CAD/CAM, Dental Handpieces, Casting Machines ) & End User (Hospitals and Clinics, Dental Laboratories) - Global Forecast to 2021The global dental equipment market is estimated to grow at a CAGR of 4.9% during the forecast period, to reach USD 7.52 Billion by 2021. The rapidly increasing aging population, growing prevalence of dental diseases, technological advancements and growing demand for cosmetic dentistry are the major factors driving the growth of the dental equipment market. However, high cost of equipment, especially advanced equipment, is expected to hinder the growth of this market to a certain extent. |
July 2016 | $ 5650 |
|
Surgical Instrument Tracking Systems Market by Technology (RFID and Barcodes), Components (Hardware, Software, Services), End-User (Hospitals), Geography (North America, Europe, Asia-Pacific and RoW) - Forecast to 2021The global surgical instrument tracking systems market is expected to reach USD 204.8 Million by 2021 from USD 92.2 Million in 2016, growing at a CAGR of 17.3% from 2016 to 2021. Factors such as the UDI regulations by FDA, rising need for inventory management and better patient care, and the need to maximize revenues through operational efficacy are expected to drive market growth in the coming years. |
July 2016 | $ 5650 |
|
Blood Culture Tests Market by Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia) & End User (Hospital Laboratories, Reference Laboratories) - Global Forecast to 2021The blood culture tests market is projected to reach USD 4,768.9 Million by 2021 from USD 3,252.6 Million in 2016, growing at a CAGR of 8.0%. Major factors driving the growth of this market are rapidly rising aging population, increase in product approvals and launches, growing number of sepsis cases and high cost of treatment, high incidence of bloodstream infections, increase in demand for rapid diagnostic techniques, and high prevalence of infectious diseases. On the other hand, factors such as high cost of automated instruments and lack of technically skilled professionals are likely to hinder market growth. |
July 2016 | $ 5650 |
|
Blood Gas Analyzer/Blood Gas and Electrolyte Analyzer Market by Product/Brand (GEM 4000, GEM 3000, i-STAT, ABL900, ABL90, cobas b 221, RAPIDLab), Player/Company (Radiometer, Instrumentation Laboratory, Siemens, Abbott, Alere) - Global Forecasts to 2021The global market for blood gas analyzers was estimated to be USD 506.9 Million in 2016, which would reach USD 636 Million by 2021, growing at a CAGR of 4.6% during 2016 to 2021. Owing to the increasing demand for point of care and automated blood gas analyzers, this market is expected to witness decent growth in the coming years. An increase in number of patients being treated in ICUs, NICUs and emergency departments would further accelerate the pace of growth of blood gas analyzers market. |
July 2016 | $ 5650 |
|
Laboratory Freezers Market by Product (Cryopreservation, Plasma Freezer, Explosion-Proof Freezer, Enzyme Freezer, Ultra-Low Freezer, Blood Bank Refrigerator, Pharmacy Refrigerator, Chromatography Refrigerator) & by End User - Global Forecast to 2021The global laboratory freezers market is projected to reach USD 3.76 Billion by 2021, at a CAGR of 4.6% from 2016 to 2021. The increasing demand for blood & blood components, rising government support for research activities and clinical trials, and technological advancements in freezers & refrigerators are the major factors driving the growth of the laboratory freezers market. |
July 2016 | $ 5650 |
|
Minimally Invasive Surgical Instruments Market by Product (Handheld Instruments, Guiding Devices, Inflation Systems), Application (Cardiothoracic, Vascular, Gastrointestinal), End Users (Private Hospitals, Government Hospitals) - Global Forecast to 2021The minimally invasive surgical instruments market is projected to reach USD 21.47 Billion by 2021 from USD 13.89 Billion in 2016, at a CAGR of 9.1%. Benefits of minimally invasive surgeries over traditional open surgeries; reduction in healthcare costs and time; increasing number of surgeries among the aging population; increasing prevalence of lifestyle disorders; and technological advancements are key factors expected to drive the growth of the minimally invasive surgical instruments market. Increasing awareness of technologically advanced MIS instruments & procedures and emerging markets provide significant growth opportunities for the market. |
June 2016 | $ 5650 |
|
Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends & Global Forecasts to 2021The pen needles market is projected to reach USD 2.81 Billion by 2021 from USD 1.65 Billion in 2016, growing at a CAGR of 11.2% during the forecast period of 2016 to 2021. Growth in the pen needles market can be attributed to the favorable reimbursement environment and government support in selected countries; advantages of insulin pens over syringes and vials; technological advancements to minimize pain and anxiety; growing diabetic population; and conferences, meetings, and congresses that create pen needle awareness. |
June 2016 | $ 5650 |
|
Wound Dressings Market by Type (Advanced Wound Dressings, Traditional Wound Dressings), Application (Surgical Wounds, Ulcers, Burns), End User (Inpatient Facilities, Outpatient Facilities) - Global Forecast to 2021The global wound dressings market is estimated to be valued at USD 6.31 Billion in 2016, and is projected to grow at a CAGR of 6.0% from 2016 to 2021, to reach USD 8.46 Billion by 2021. Advanced wound dressings segment registered the largest market share in 2015 and is expected to grow at a CAGR of 6.9%. Increasing awareness regarding wound care management, high growth potential of emerging economies, and increasing number of acquisitions by key companies have opened an array of opportunities for the growth of wound dressings market in coming years. |
June 2016 | $ 5650 |
|
Dental Bone Graft Substitutes Market by Type (Synthetic Bone Grafts, Xenografts, Allografts, and Demineralized Allografts), Application (Sinus Lift, Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, and Implant Bone Regeneration), Product (Biooss, Osteograf, Grafton, and Others) - Forecast to 2021The global dental bone graft substitutes market is expected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021. Factors such as technological advancements in the field of dental bone grafts and increase in the number of bone grafting procedures are expected to drive the growth of the global dental bone grafts substitutes market. Several insurance providers in the U.S. and various countries in the European region have assisted the medical sector to introduce and encourage the usage of latest synthetic bone grafts and demineralized allografts. |
June 2016 | $ 5650 |
|
Pain Management Devices Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, Migraine, Facial), by Mode of Purchase (OTC, Prescription-Based) - Global Forecasts to 2021This report studies the global pain management devices market over the forecast period of 2016 to 2021. The market is expected to reach ~USD 4.64 Billion by 2021, at CAGR of 8.5% from 2016 to 2021. A number of factors, such as the growing demand for long-term pain management among the geriatric population, large patient population base, adverse effects of pain medications, development of novel pain management devices, established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries, and high proven efficacy of pain management devices for the treatment of chronic pain are driving the growth of the global pain management devices market. |
June 2016 | $ 5650 |
|
Veterinary Reference Laboratory Market by Technology (Clinical Chemistry, Hematology, Immunodiagnostics, Molecular Diagnostics), Application (Pathology, Bacteriology, Virology, Parasitology), Animal (Dog, Cat, Cattle, Pig) - Global Forecast to 2021The veterinary reference laboratories market witnessed healthy growth during the last decade and is expected to grow at a CAGR of 9.8% between 2016 and 2021 to reach 2.76 Billion by 2021. The growth in this market is majorly attributed to factors such as rising animal healthcare expenditure, rising pet adoption, increasing demand for pet insurance, growing demand for animal-derived food products, increasing number of veterinary practitioners and their growing income levels in developed regions, and rising awareness about zoonotic diseases. |
June 2016 | $ 5650 |
|
Electroceuticals/Bioelectric Medicine Market by Product (Pacemakers, Cochlear Implants, Spinal Cord Stimulators), Type of Device (Implantable, Non-Invasive), Application (Arrhythmia, Depression, Migraine), End User (Hospitals) - Global Forecast to 2021The global electroceuticals/bioelectric medicine market is expected to reach USD 25.20 Billion by 2021 from USD 17.20 Billion in 2016, growing at a CAGR of 7.9% from 2016 to 2021. The growth of the overall electroceuticals/bioelectric medicine market can be contributed to rising geriatric population, regulatory approval for new and advanced electroceuticals, growing investments and funds for the development of novel therapies and electroceuticals, rising prevalence of neurological disorders, and growing prevalence of hearing loss. |
June 2016 | $ 5650 |
|
Medical Animation Market by Type (3D, 2D, 4D), Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), Application (Drug MoA, Patient Education), End User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to 2021This report studies the global medical animation market for the forecast period of 2016 to 2021. This market is expected to reach USD 301.3 Million by 2021 from USD 117.3 Million in 2016, at a CAGR of 20.8%. Major players in the medical animation market include Infuse Medical (U.S.), Hybrid Medical Animation, Inc. (U.S.), Ghost Productions, Inc. (U.S.), Scientific Animations, Inc. (U.S.), INVIVO Communications, Inc. (Canada), Random42 Scientific Communication (U.K.), Radius Digital Science (U.S.), Nucleus Medical Media, Inc. (U.S.), AXS Studio, Inc. (Canada), Visible Body (U.S.), Elara Systems, Inc. (U.S.), Animated Biomedical Productions (Australia), XVIVO Scientific Animation (U.S.), Blausen Medical Communications, Inc. (U.S.), Trinsic Medical Animation, LLC. (U.S.), Viscira (U.S.), Understand.com (U.S.), and Medmovie, Inc. (U.S.). |
May 2016 | $ 5650 |
|
Patient Handling Equipment Market by Product (Wheelchair, Scooters, Medical Beds, Bathroom Safety, Mechanical, Ambulatory), Type of Care (Bariatric Care, Critical Care, Wound), Accessories (Lifting, Transfer) & by End User (Home, Hospital) - Forecast to 2021The patient handling equipment market is expected to reach USD 17.18 Billion in 2021 at a CAGR of 10.5%. Factors driving market growth include rising geriatric population, increasing incidence of disabilities, high risk of injuries to caregivers during manual handling of patients, and the implementation of regulations against the manual lifting of heavy loads. The patient handling equipment market is broadly segmented based on product, type of care, end user, accessory, and region. |
May 2016 | $ 5650 |
|
Medical Suction Devices Market by Type (AC-Powered, Battery-Powered, Dual, Manually Operated), Application (Surgical, Airway, R&D), Portability (Handheld, Wall-Mounted), End User (Homecare, Hospitals and Clinics, Prehospitals) - Global Forecast to 2020The medical suction devices market is expected to reach USD 886.3 Million by 2020 from USD 732.0 Million in 2015. Major factors driving the growth of this market the paradigm shift from traditional healthcare settings to home healthcare and the increasing need for compact and portable devices. Moreover, the rising adoption of home care has led to the increased demand of portable suction devices, as they are reliable & easy to use and have high durability & robustness. This helps healthcare providers and patients to use suction devices without any assistance. |
May 2016 | $ 5650 |
|
Craniomaxillofacial Implants Market by Type (Mid Face, Plates, Screws, Mandibular Orthognathic Implants, Neuro, Mesh, Bone Graft, Dural Repair), by Material of Construction (Titanium, Polymer), by Application Site & Property - Global Forecasts to 2021The global CranioMaxillofacial implants market is expected to reach USD 2.49 Billion by 2021 from USD 1.79 Billion in 2016 at a CAGR of 6.9% from 2016 to 2021. The global Craniomaxillofacial implants market is broadly classified into type, application site, material of construction, property and regions. |
May 2016 | $ 5650 |
|
Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021. The swollen, twisted veins that are visible under the skin are termed as varicose veins. |
May 2016 | $ 5650 |
|
Breast Imaging Market by Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, Optical Imaging)) - Forecast to 2021This report studies the breast imaging market over the forecast period of 2016 to 2021. The market is expected to reach USD 4.14 Billion by 2021, at a CAGR of 8.5% from 2016 to 2021. Growing incidence of breast cancer globally, rising government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues are some of the key factors driving the growth of this market. |
May 2016 | $ 5650 |
|
Asia and North Africa Critical Care Equipment Market by Product (Infusion Pumps, Ventilators, & Patient Monitors) - Competitive Analysis & Forecasts to 2021The critical care devices market is expected to reach USD 2.61 Billion by 2021 from USD 1.78 Billion in 2016, at a CAGR of 8.0% during the forecast period. Continuous technological advancements in critical care devices, increasing government support, growing private sector investments in the healthcare industry, and increasing patient population base are key factors fuelling the growth of the critical care devices market in the emerging nations. |
May 2016 | $ 5650 |
|
HLA Typing for Transplant Market by Technology (SSO-PCR, SSP-PCR, NGS, Sanger’s Sequencing), Products & Services (Instruments, Reagents, Software), Application (Diagnostics, Research), End User (Hospitals, Academia, Diagnostic Center) - Forecast to 2021The global HLA typing for transplant market is projected to reach USD 753.9 Million by 2021 from USD 535.0 Million in 2016, growing at a CAGR of 7.1% from 2016 to 2021. Market growth can be attributed to factors such as the rising number of solid organ, soft tissue, and stem cell transplantations; technological advancements in the field of organ transplantations; and increased funding, research grants, and public-private investments. |
May 2016 | $ 5650 |
|
Asia and North Africa Hemodialysis & Peritoneal Dialysis Market by Products (Machine, Dialyzer, Bloodlines, Concentrates, Catheters, & Transfer Sets) and Services (In-Center and Home) - Forecast to 2020The dialysis market in emerging nations is projected to grow at a CAGR of 9.2% during the forecast period, and is expected to reach a value of USD 35.9 Billion by 2020. The rising prevalence of end-stage renal disease (ESRD), diabetes, and hypertension is stimulating the demand for dialysis treatment in the emerging nations. Furthermore, low preference of patients for kidney transplantation, technological advancements, and substantial government healthcare expenditure on the treatment of ESRD are adding to the growth prospects of dialysis products and services market in the emerging nations. |
May 2016 | $ 5650 |
|
Biochips Market by Type (DNA Chip (Genomics, Drug Discovery, Gene Expression) Lab-on-a-chip (IVD & POC, Proteomics), Protein Chips), End user (Academics Institutes, Diagnostics Centers), Fabrication Technology (Microarrays, Microfluidics) - Forecast to 2020The Biochips market is estimated to grow at a CAGR of 18.4% from 2015 to 2020 to reach USD 17.75 Billion by 2020. The base year considered for the study is 2015 and the forecast for the market size is provided for the period between 2015 and 2020. In the current market scenario, biochips are increasingly adopted in various applications in the field of genomics, drug discovery, and proteomics. In addition, the development of targeted and personalized medicines for the treatment of cancer and technological advancements in biochips are also supporting the growth of biochip products. Major players in biochips market include Abbott Laboratories (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer Inc. (U.S.), Fluidigm Corporation (U.S.), Illumina, Inc. (U.S.), GE Healthcare (U.S.), Bio-Rad Laboratories Inc. (U.S.), Cepheid Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.) and F. Hoffmann-La Roche AG (Switzerland). |
May 2016 | $ 5650 |
|
Dental Digital X-ray Market by Product (Digital, Analog), Type (Intraoral, Extraoral (CBCT, Panoramic), Hybrid X-ray), Application (Diagnostic, Therapeutics, Forensic), End User (Dental Clinics, Forensic Laboratories) - Global Forecast to 2020The dental digital X-ray market is projected to reach USD 3,290.6 Million by 2020 from USD 2,154.0 Million in 2015. Major factors driving the growth of this market include technological advancements, growing geriatric population, ability of digital systems to reduce diagnosis time and improve image quality, growing adoption of CBCT systems, increase in dental disorders, and growing demand for cosmetic dentistry. On the other hand, factors such as high cost of dental digital X-rays and lack of reimbursement for dental care are likely to hinder the market growth. |
April 2016 | $ 5650 |
|
Medical Robots Transforming Healthcare: Pricing & Cost-Benefit Assessment (Price Variation (by Product (Surgical Robots, Rehabilitation Robotics, Stereotactic Radiosurgery), by Application, by Geography), Reimbursement, Selection Criteria, Buying CycleMedical robots are devices that are used to improve the quality of care for patients. The major types of medical robots are surgical robots, hospital and pharmacy robots, rehabilitation robots, and non-invasive radiosurgery robots. Each type of robots vary widely in prices, offer varied benefits & cost-saving advantages, and are subject to different reimbursement structures, buying cycle, price wars, and other factors. |
April 2016 | $ 5650 |
|
Bathroom & Toilet Assist Devices Market by Product Type (Chairs & Stools, Bath Lifts, Toilet Seat Raisers, Toilet Aids, Commodes, Handgrips & Grab Bars, Bath Aids), Region (North America, Asia-Pacific, Europe, Row) - Global Forecast to 2020The global bathroom & toilet assist devices market is expected to reach USD 4.68 Billion by 2020, at a CAGR of 5.7% from 2015 to 2020. Factors, such as rise in the aging population, growing rate of awareness about assistive devices, and technological advancement are driving the growth of this market. |
April 2016 | $ 5650 |
|
Breast Lesion Localization Methods Market - Comparative Analysis, Field Force Analysis, Business Models, End User Preference Survey (Selection Criteria, Qualitative Analysis of Replacement Trend), Competitive Product Portfolio and Strategic ConsolidationThe breast lesion localization market is estimated to reach USD 877.9 Million by 2020 from USD 445.9 Million in 2015, at a CAGR of 14.5% from 2015 to 2020. The overall market for breast lesion localization methods is expected to witness rapid growth owing to the increasing number of breast cancer surgeries and implementation of favorable reimbursement guidelines. Furthermore, the rising demand for better quality care, and growing awareness amongst patients about breast cancer screening are the other major factors driving the breast lesion localization methods market. |
April 2016 | $ 5650 |
|
Medical Gases Market by Gases (Oxygen, Nitrogen, Nitrous Oxide, Helium, Gas Mixture), Equipment (Delivery System, Cryogenic Freezer, Oxygen Concentrator), Application (Respiratory Diseases, Anesthesia, Medical Imaging) & by End User - Global Forecast to 2021The global medical gases and equipment market is estimated to reach USD 19.96 Billion by 2021, growing at a CAGR of 8.0% from 2016 to 2021. Factors such as implementation of the U.S. Food and Drug Administration (FDA) Safety and Innovation Act, growing home healthcare market, rising aging population, increasing prevalence of respiratory diseases, rapid urbanization, and high prevalence of tobacco smoking are driving the growth of this market. Some of the prominent players in the global medical gases and equipment market include Air Products and Chemicals, Inc. (U.S.), The Linde Group (Germany), Air Liquide (France), Praxair, Inc. (U.S.), Taiyo Nippon Sanso Corp. (Japan), SOL-SpA (Italy), Airgas, Inc. (U.S.), Atlas Copco (Sweden), Messer Group (Germany), and GCE Holding AB (Sweden). |
April 2016 | $ 7150 |
|
Laboratory Centrifuge Market by Product (Equipment (Microcentrifuge/Ultracentrifuge), Accessories), Rotor Design, Intended Use, Application (Diagnostic/Microbiology/Proteomics/Genomics), End User (Hospital/Biotech/Pharmaceutical) - Global Forecast to 2020The laboratory centrifuges market is expected to reach USD 1.74 Billion by 2020 from USD 1.53 billion in 2015, growing at a CAGR of 2.5 % from 2015 to 2020. Factors such as increasing prevalence and incidence of diseases, increasing focus on research, new product launches, and drug innovation and technological advancements are expected to drive the growth of the market in the coming years. On the other hand, factors such as low sales of laboratory centrifuges due to longer lifespans are hindering the growth of this market. |
April 2016 | $ 5650 |
|
Therapeutic Drug Monitoring Market by Product (Consumables, Equipment), Technology (Immunoassays, Proteomic Technologies), Class of Drug (Antiepileptics, Antibiotics, Immunosuppressants), End User (Hospital Labs, Private Labs) - Global Forecast to 2020The therapeutic drug monitoring market is projected to reach USD 2.55 Billion by 2020 from USD 1.78 Billion in 2015, growing at a CAGR of 7.4% during the forecast period (2015–2020). The technological advances in tests used to monitor therapeutic drugs, increased knowledge of pharmacogenetics and pharmacokinetics of drugs, need for better healthcare in developing countries, and rising prevalence of psychiatric diseases and cancer are the major drivers for the therapeutic drug monitoring market. |
March 2016 | $ 5650 |
|
U.S. In Vitro Diagnostics (IVD) Market by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology), Application (Infectious Diseases, Diabetes, Cancer, Cardiology), End User (Hospitals & Laboratories) & by Region - Forecast to 2020The U.S. IVD market is projected to reach USD 25.99 Billion by 2020 at a CAGR of 4.7% during the forecast period of 2015 to 2020. Some of the key factors driving the growth of this market are the rising incidence of chronic and infectious diseases in the U.S., rapidly aging population, growing preference for point-of-care testing and personalized medicine, implementation of the Affordable Care Act (ACA), increasing adoption of automated instruments, and automation in laboratories. |
March 2016 | $ 12000 |
|
Polymerase Chain Reaction Usage Pattern and Replacement Trends, End User Analysis, Pricing Analysis, Comparative Analysis, Competitive Landscape Comparative Analysis and End User Preference StudyPCR is a well-adopted molecular diagnostics technique, and has a wide range of applications ranging from diagnosis of infectious disease, cancer, personalized medicine, and identification of target therapies for particular disease condition. This report provides qualitative assessment of the PCR technology in terms of pricing, replacement trends, competitors’ portfolio analysis, and selection criteria for adoption of PCR instruments from an end-user perspective. |
March 2016 | $ 5650 |
|
Near Infrared Imaging Market by Product Type (Near Infrared Fluorescence Imaging Devices, Near Infrared Fluorescence & Bioluminescence Imaging Devices, Reagents), Application, End User and Geography - Global Forecast to 2020The global near infrared imaging market is projected to reach USD 471.2 Million by 2020, at a CAGR of 8.8% from 2015 to 2020. Fluorescence and bioluminescence imaging are the two types of optical imaging techniques. Fluorescence imaging is based on the light emitted by the excited flourochromes inside the subject upon excitation from an external light source. However, the recent trend is towards the use of near infrared dyes and infrared fluorescent proteins (700 nm-800 nm), as they are much more feasible for imaging due to much lower autoflourescence of tissue and deeper tissue penetration at these wavelengths. |
March 2016 | $ 5650 |
|
Asian Home Health Care Market by Product (BP & Heart Rate Monitor, Ovulation KIT, HIV Test, ECG, EKG, EEG, Hearing Aids, Ventilator, Cane, Walker, Wheelchairs), Services (Rehabilitation, Skilled, Hospice, Palliative Care), & Telehealth - Forecasts to 2020The Asian home healthcare market is expected to reach USD 62.32 Billion by 2020 from USD 39.07 Billion in 2015, at a CAGR of 9.8% from 2015 to 2020. The major factors driving the growth of this market include the rapidly increasing aging population, increasing incidences of chronic diseases, growing demand for affordable healthcare delivery systems due to increasing healthcare costs, technological advancements, and government initiatives to promote home healthcare. On the other hand, limited insurance coverage, lack of awareness about home healthcare, and patient safety concerns are major factors restricting the growth of this market. |
March 2016 | $ 5650 |
|
Walking Assist Devices Market by Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), and Region (North America, Europe, Asia-Pacific and ROW) - Global Forecast to 2020The global walking assist device market is expected to reach USD 6.57 Billion by 2020, at a CAGR of 3.9% from 2015 to 2020. The report also provides a detailed competitive landscaping of companies operating in this market. Segment and country-specific company shares, new product launch, M&A, and product approvals of the major companies would be detailed. Honda Motor Co., Ltd., Permobil Inc., GF Health Products, Inc., Invacare Corporation, Besco Medical Co., LTD., Betterlifehealthcare Ltd., C.T.M. Homecare Product, Inc., Ottobock, Ossenberg GmbH, Pride Mobility Products Corp., Aetna Inc., Sunrise Medical (US) LLC, and Karma Healthcare Ltd., are some of the key players operating in this market |
February 2016 | $ 5650 |
|
Hemostats Market by Product Type (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), and Geography (Americas, Europe, APAC, MEA) - Global Forecast to 2020The global hemostats market is projected to reach USD 2.76 Billion by 2020 at a CAGR of 6.2% from 2015 to 2020. The Americas market contributed the largest share to the global hemostats market in 2014, wherein the U.S. dominating the Americas market. The report on global hemostats market analyzes and segments the market on the basis of product and region. It analyzes the competitive developments, such as alliances, joint ventures, and mergers & acquisitions in the global hemostats market. This market is also analyzed with an explicit focus on the high-growth applications and fastest-growing market segments. |
February 2016 | $ 5650 |
|
Medical Automation Market by Application (Diagnostics & Monitoring, Therapeutics, Lab & Pharmacy Automation, Medical Logistics & Training), End-User (Hospital, Diagnostic Center, Research Institute, Home/Ambulatory Care) - Global Forecast to 2020The global medical automation market over the forecast period of 2015 to 2020. The market is expected to reach USD 55.03 Billion by 2020, at CAGR of 9.5% from 2015 to 2020. Continuous technological advancements in automation solutions, increasing government financial support for medical automation, rising labour costs, and growing need for reproducibility and accuracy are key factors fuelling the growth of the medical automation market. Increasing demand for automation in laboratories and pharmacies and high potential for early detection and treatment of diseases due to automation are some other prime factors offering growth opportunities for players in the medical automation market. However, high cost of automation is one of the key restraints for this market. |
February 2016 | $ 5650 |
|
HPV Testing & Pap Test Market by Test Type (HPV Testing (Follow-Up, Co-Testing, Primary)), by Application (Pap Test (Cervical Cancer, Vaginal Cancer)), by End User (Laboratories, Hospitals, Physicians’ Offices & Clinics) - Global Forecast to 2020The HPV testing and Pap test market is expected to grow at a CAGR of 6.6% to reach USD 4,523.1 Million by 2020. A number of factors such as increasing number of cervical cancer cases, growing aging population, increasing awareness of cervical cancer screening programs, and government initiative and funding are propelling the growth of the HPV testing and Pap test market. However, changes in regulatory guidelines for cervical cancer screening and HPV vaccination are some major factors restraining the growth of this market. In addition to this, the uncertain reimbursement scenario serves to be a major challenge impacting the growth of the HPV test and Pap test market. |
February 2016 | $ 5650 |
|
Fetal (Labor & Delivery) and Neonatal Care Equipment Market - (Ultrasound, Doppler, Monitors (Intrapartum & Antepartum), Warmer, Incubator, Pulse Oximeter, Phototherapy/Jaundice Management Devices, CPAP, Capnograph, & Resuscitator) - Global Forecast to 2020The global fetal (labor & delivery) and neonatal care equipment market is poised to grow at a CAGR of 6.5% during the forecast period, and is expected to reach a value of USD 8.61 Billion by 2020. Rising awareness among population in developing nations about neonatal and fetal care, growing number of NICU admissions and inflow of technologically advanced products are driving the growth of the fetal and neonatal care equipment market. In addition, factors such as increasing prevalence of hospital acquired infections in newborn babies and huge patient populations of preterm & low weight birth babies in both developed & developing markets demand for neonatal care equipment are further stimulating the growth of the fetal and neonatal care equipment market. |
February 2016 | $ 5650 |
|
Digital X-ray Market by Application (Mammography, Dental, Chest Imaging, Cardiovascular), Technology (Computed, Direct), Portability (Ceiling Mounted, Mobile), Type of System, End User (Diagnostic Center, Hospitals), Price - Global Forecast to 2020The global digital x-ray market is expected to reach USD 10.46 Billion by 2020 from USD 6.15 Billion in 2015, at a CAGR of 11.2%. The major players in the digital x-ray market are Canon Inc. (Japan), Carestream Health Inc. (U.S.), Fujifilm Medical Systems (Japan), GE Healthcare (U.K.), Hitachi Medical Corporation (Japan), Hologic, Inc. (U.S.), Philips Healthcare (Netherlands), Shimadzu Corporation (Japan), Siemens Healthcare (Germany), and Toshiba Medical Systems Corporation (Japan). |
February 2016 | $ 5650 |
|
Optical Imaging Market by Technique (OCT, NIRS, HSI, PAT) by Product (Imaging System, Camera, Lens, Software) by Therapeutic Area (Ophthalmology, Oncology, Neurology, Dermatology), by Application (Pathological, Intra-operative) - Global Forecast to 2020The global optical imaging market is estimated to be worth USD 1.75 Billion in 2020 and is expected to grow at a 12.1% CAGR during the forecast period of 2015 to 2020. This market is mainly driven by rising geriatric population, increase in research and development activities in the life sciences sector, and increasing application of optical imaging techniques in drug discovery processes and preclinical research are fueling the growth of this market However, the market growth is restricted by factors such as high costs of instruments, stringent regulatory approval procedures, dearth of skilled operators, and insufficient reimbursements for optical imaging procedures. |
February 2016 | $ 5650 |
|
Pressure Monitoring Market Product (Device (Blood Pressure, Intracranial Pressure, Intraocular Pressure), Accessory), Procedure (Invasive), Application (Respiratory, Glaucoma, Dialysis), End User (Hospital, ASC, Diagnostic) - Forecast to 2020The pressure monitoring market is expected to reach USD 8.04 Billion by 2020 from USD 6.3 Billion in 2015, at a CAGR of 5.0%. The major factors driving the growth of this market are the increasing urbanization resulting into increased pollution levels, rising prevalence of chronic diseases and acute diseases, changing lifestyle, growing aging population, and technological advancements. On the other hand, high cost of technological development, concerns regarding the accuracy of these devices, short shelf life of devices and accessories, availability of low cost devices from the local market, and lack of training for using the devices may hinder the growth of the market. |
January 2016 | $ 5650 |
|
Operating Room Equipment & Supplies Market by Equipment (Anesthesia Machines, Operating Tables), by Supplies (Surgical Instruments, Disposable Materials), & by End-User (Hospitals, Outpatient Facilities) - Analysis & Global Forecast to 2020The operating room equipment & supplies market is projected to reach USD 29.15 Billion by 2020 from USD 24.31 Billion in 2015, at a CAGR of 3.7% in the next five years (2015 to 2020). The growth of the overall operating room equipment & supplies market can be attributed to the growing investments, funds, and grants by government bodies worldwide, rising number of hospitals, increasing patient preference for minimally invasive surgeries, growing number of regulatory approvals for operating room equipment, and growing number of geriatric population coupled with the increasing number of surgeries globally. |
January 2016 | $ 5650 |
|
HIP Replacement Devices Market by Product (Primary HIP Replacement (Cemented, Cementless), Partial HIP Replacement, Revision HIP Replacement, HIP Resurfacing), Geography (Americas, EU-5, Japan, BRIC, South-East Asia, MEA) - Forecast to 2020The total hip replacement is also referred to as total hip arthroplasty/hip resurfacing. It is a very common surgery that helps to minimize pain and rigidity in the hip joint. The total hip replacement is categorized into four segments, namely, primary hip reconstruction, partial hip reconstruction, hip resurfacing, and revision hip implants. The global hip reconstruction market was valued at USD 4.8 Billion in 2014 and is expected to reach USD 5.9 Billion by 2020, at a CAGR of 3.0% from 2015-2020. |
January 2016 | $ 5650 |
|
Knee Reconstruction Devices Market by Product Type (Primary (Cemented & Cementless), Partial, and Revision Implants), and Geography (U.S., Canada, Eu-5, Japan, Bric, Turkey, Indonesia - Global Analysis and Forecast to 2020The global knee reconstruction devices market is expected to reach USD 7.94 Billion by 2020, at a CAGR of 4.3% from 2015 to 2020. The growth rate of knee reconstruction surgeries is influenced by various factors, such as rise in the aging population and prevalence of arthritis, technological advancements, and well-structured healthcare policies in most of the countries. |
January 2016 | $ 5650 |
|
Disposable Medical Device Sensors Market by Product (Biosensor, Image sensor, Accelerometer), Monitoring (Smart Pill, Pulse Oximeter), Diagnostics (Capsule Endoscope, Blood Glucose Strip), Therapeutics (Insulin Pump, Dialysis) - Global Forecast to 2020The disposable medical device sensors market is poised to reach USD 5,936 Million by 2020, growing at a CAGR of 10.3% during the forecast period of 2015 to 2020. Market growth can be attributed to the growing prevalence of diabetes and other infectious diseases across the globe, government support for research and development activities in medical sensors, various benefits such as faster analysis, low costs, ease of use, and rising needs to curtail escalating healthcare costs. |
December 2015 | $ 5650 |
|
Powered Surgical Instruments Market by Power Source (Electric, Battery, Pneumatic), Product (Drill, Saw, Stapler, Reamer, Battery, Console, Cables, Blade, Burr, Cart) & by Application (Orthopedic, ENT, Oral, Thoracic, Neurology) - Global Forecast to 2020The global powered surgical instruments market is estimated to be worth around USD 1.7 Billion in 2014 and is expected to reach around USD 2.2 Billion to grow at a CAGR of 4.1% during the forecast period of 2015 to 2020. This market is mainly driven by increasing aging population, high prevalence of chronic disorders requiring surgical interventions, and high disposable income among consumers. |
December 2015 | $ 5650 |
|
Atrial Fibrillation Surgery Market by Procedure (Catheter Ablation, Surgical Ablation/Maze), Product (Catheter Ablation, Surgical Ablation), and Geography (Canada, China, France, Germany, India, Japan, U.S., U.K.) - Global Forecast to 2020The global AF surgery product market was worth $791.5 Million in 2014 and is estimated to reach $1.73 Billion by 2020. This market is segmented on the basis of surgical procedures into catheter ablation and surgical ablation. Catheter and surgical ablation procedures are well accepted for the treatment of atrial fibrillation. Catheter ablation holds a larger market share and is poised to grow at a CAGR of 14.5% during the forecast period. |
December 2015 | $ 5650 |
|
Latin America Orthodontic Supplies Market by Removable & Fixed Braces (Brackets (Self Ligating, Lingual), Archwire (Nickel Titanium, Stainless Steel), Anchorage Appliances (Buccal Tube, Band), Ligature (Elastomeric, Wire)) & Adhesives - Forecast to 2020The Latin America orthodontic supplies market is valued at USD 245.0 Million in 2015 and expected to reach USD 320.2 Million by 2020, at a CAGR of 5.5% from 2015 to 2020. A number of factors such as the growing number of patients with malocclusions, lower cost of orthodontic treatment in Latin American countries as compared to other developed nations, higher concentration of orthodontics associations, decreasing trade barriers for medical devices in some Latin American countries, and rising disposable incomes in countries such as Brazil, Mexico, and Chile are propelling the growth of the Latin America orthodontic supplies market. |
December 2015 | $ 5650 |
|
Top 10 Medical Device Technologies Market by Type (IVD, Cardiology, Diagnostic Imaging, Orthopedics, Ophthalmology, Endoscopy, Diabetes Care, Wound Management, Kidney/Dialysis, and Anesthesia & Respiratory Care Devices) - Global Forecast to 2020The global top 10 medical device technologies market is expected to reach USD 428.97 Billion by 2020, at a CAGR of 5.5% from 2015 to 2020. Growth in the global top 10 medical device technologies market is mainly driven by factors such as the rising prevalence of chronic diseases and related increase in disability-adjusted life years (DALYs), technological advancements in medical devices, and growing aging population. Moreover, increasing investments from government bodies and private players in healthcare sectors in emerging economies and increasing focus of key players on emerging countries are creating new growth opportunities for this market. However, uncertainty in reimbursement and excise tax on medical devices in the U.S. are restraining the growth of the market. |
December 2015 | $ 5650 |
|
Smoke Evacuation System Market by Product (Smoke Evacuators (Portable & Stationary), Pencils, Wands, Tubings, Accessories), Application (Laser, Ultrasonic & Electrosurgery Units), End-User (Hospital, Surgical Centers, Clinics) - Global Forecast to 2020This report studies the smoke evacuation system market over the forecast period of 2015 to 2020. The market is expected to reach USD 180 Million by 2020, at CAGR of 5.6% from 2015 to 2020.On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and Rest of the World. In 2015, the global smoke evacuation system market is estimated to be dominated by North America. A number of factors such as the increasing number of surgical procedures, technological advancements, rising demand for minimally invasive surgeries, and favorable reimbursement scenario are driving the growth of the smoke evacuation system market in the North American region. The Asia-Pacific market is expected to grow at the highest CAGR from 2015 to 2020. |
November 2015 | $ 5650 |
|
Dental Lasers Market by Product (Soft Tissue, All Tissue, Dental Welding Lasers), Application (Conservative Dentistry, Endodontic Treatment, Periodontitis), End User (Hospitals, Clinics), and Geography - Global Forecast to 2020The global dental laser market is expected to reach USD 224.7 Million by 2020, at a CAGR of 5.2% during the forecast period from 2015 to 2020. The rising middle class and aging population; increasing awareness for oral hygiene, reduced treatment time, and operating cost; and rising demand for cosmetic dentistry have influenced the growth of the dental lasers market. The increasing technological advancements are further expected to drive the growth of the market. |
November 2015 | $ 5650 |
|
Spine Biologics Market by Product Type (Bone Graft, Bone Graft Substitute, Platelet Rich Plasma, BMAC), Surgery Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), End User, and Geography - Global Forecast to 2020Spinal biologics encompass materials that can be utilized in case of bone fusion surgery, spinal cord injury, and degenerative disk disease. Ten years ago, the spine treatment market constituted 75% traditional rods and plates made of metals and 25% biologics. However, since metals are inert materials, they did not stimulate the bone regeneration process. On the other hand, biological materials are proteins that can attract and stimulate cells, promote fusion, and help in the bone healing process. . The global spine biologics market is expected to reach $2.4 Billion by 2020, at a CAGR of 4.4% during the forecast period from 2015 to 2020. |
November 2015 | $ 5650 |
|
Latin America Medical Gases & Equipment Market by Product (Oxygen, Medical Air, Nitrogen, Carbon Dioxide, Nitrous Oxide, Helium, Ethylene Oxide, Blood-gas Mixture, Cylinder, Hoses, Manifold, Regulator) End User (Hospital, Home Care) - Forecast to 2020The Latin America medical gases & equipment market is estimated to reach around USD 1.8 Billion by 2020 at a CAGR of 10.2% during the forecast period of 2015 to 2020. The Latin America medical gases & equipment market is witnessing considerable growth owing to the high prevalence of respiratory diseases, rising geriatric population, high prevalence of tobacco smoking, urbanization, growing levels of pollution, and changing lifestyles. |
November 2015 | $ 5650 |
|
ENT Devices Market by Product (Diagnostic (Endoscope (Rigid, Flexible), Hearing Screening), Surgical (RF, Handheld (Otology & Laryngeal), Packing Material, Ear Tubes), Hearing Aids, Lasers), & End User (Hospital & Ambulatory) - Global Forecast to 2020The global ENT devices market is expected to reach USD 14,001 Million by 2020 from USD 9,595 Million in 2015, at a CAGR of 6.5% during the forecast period. Growth in this market is mainly driven by the high prevalence of chronic sinusitis, rising geriatric population, favorable reimbursement scenario for ENT procedures in developed countries, rising adoption of minimally invasive ENT procedures, increasing presence of prominent players in the ENT devices market, and technological advancements. In addition the growing adoption of surgical instruments and techniques that are minimally invasive and more accurate than the conventional methods is a key market trend that will drive the ENT devices market during the forecast period. However, changes in the reimbursement policy for Tracheoesophageal Voice Prosthesis (TEP) devices in the U.S., high cost of CO2 lasers, and high cost and lack of reimbursement for hearing aids are factors that are likely to restrict the growth of this market. |
November 2015 | $ 5650 |
|
Veterinary Equipment and Disposables Market by product (Anesthesia Machine, Vaporizer, Ventilator, Patient Monitoring Devices, Oxygen Mask, Infusion Pump), by Animal (Canine, Feline, Equine, Bovine, Zoo Animals & Others) - Global Forecast to 2020The global veterinary equipment and disposables market is estimated to grow at a CAGR of 6.5% to reach around USD 1.7 Billion by 2020 from USD 1.2 Billion in 2015. Factors such as rising animal health expenditure and the growing demand for pet insurance, increasing number of veterinary practitioners and their rising income levels in developed regions, increasing animal research and growing research grants, and growth in the companion animals market are driving the growth of the global veterinary equipment and disposables market. However, a severe shortage of skilled veterinarians and the increasing cost of pet care are expected to restrain the growth of this market to a certain extent. Low animal health awareness in emerging markets poses major challenges for the adoption of veterinary equipment and disposables among hospitals and clinics. |
November 2015 | $ 5650 |
|
Cosmetic Dentistry Market by Product (Dental Implants, Dental Bridges, Dental Crowns, Orthodontic Braces, Dental Lasers, Dental Veneers, Dental Handpieces, Bonding Agents, Dental Lasers, Dental Chairs, CAD/CAM Systems) - Global Forecast to 2020The global cosmetic dentistry market is estimated to grow at a CAGR of 6.8% from 2015 to 2020 to reach USD 22.4 Billion by 2020. Growing consumer awareness, rising focus on dental aesthetics, expanding middle-class population with increasing disposable incomes in developing nations, and rising dental tourism in emerging markets are the major factors driving the growth of the cosmetic dentistry market. |
November 2015 | $ 5650 |
|
Anesthesia Monitoring Devices Market by Product (Basic Anesthesia Monitors, Advanced Anesthesia Monitors, Integrated Anesthesia Workstations), End User (Hospital, Ambulatory Surgery Centers), and Geography - Global Forecast to 2020The requirement of anesthesia monitoring devices basically depends on the types of cases performed in the operating room. The parameters to be considered for anesthesia monitoring devices include continuous assessment by measurement of patient’s oxygenation, ventilation, circulation, and temperature. The global anesthesia monitoring devices market was valued at USD 820.9 Million in 2014 and is expected to reach USD 1,616.0 Million by 2020, at a CAGR of 12.0% from 2015 to 2020. |
October 2015 | $ 5650 |
|
Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020Radioimmunoassay (RIA) is an in-vitro assay technique that is used to measure the concentration of antigens in blood. RIA encompasses the separation of protein from a mixture by using the specificity of antibody- antigen binding and their quantitation by using radioactivity. The global radioimmunoassay (RIA) market was valued at $345.2 Million in 2014 and is expected to reach $428.4 Million in 2020 at a CAGR of 3.5% from 2015-2020. |
October 2015 | $ 5650 |
|
Spirometer Market by Product (Hand-held, Table-top, Desktop), Technology (Volume Measurement, Flow Measurement, Peak Flow Meters), End-user (Hospital, Clinic, Homecare), Application & Geography - Global Forecast to 2020A spirometer is an instrument used to measure the air inhaled into and exhaled out of the lungs. It provides a simple of way of measuring lung volume and capacity, and is used in pulmonary tests. It helps in diagnosing respiratory diseases (such as asthma, bronchitis, emphysema, and COPD), shortness of breath, exposure to chemicals at work, lung function before surgery, effect of medication, and progress in disease treatment. The global spirometer market is expected to reach USD 858.6 Million by 2020, at a CAGR of 9.8% from 2015 to 2020. |
October 2015 | $ 5650 |
|
Anti-snoring Devices and Snoring Surgery Market by Device Type (MADs, TRD, Nasal Dilator, Chin Strap, Position Control, Pillows, TSD, EPAP), Surgical Procedure (UP3, LAUP, RFA, Sclerotherapy, Pillar, Others (Septoplasty, ESS)) - Global Trends & Forecast to 2020The anti-snoring treatment market is poised to reach USD 1,232.6 Million by 2020 from USD 744.7 Million in 2015, growing at a CAGR of 10.6% from 2015 to 2020. Major factors driving the growth of this market include the growing awareness regarding the ill effects of snoring, availability and benefits of anti-snoring treatments, growing geriatric and obese population, presence of a large number of cigarette smokers and alcoholics, and a large pool of untapped snoring population. However, poor efficacy of current anti-snoring treatments available in the market, high cost of some of the anti-snoring treatments, and lack of reimbursement are major factors restraining the growth of this market. |
September 2015 | $ 5650 |
|
Foot and Ankle Devices Market by Product (Orthopedic Implants (External Fixation, Internal Fixation), Prostheses, Bracing) & by Cause of Injury (Diabetes, Rheumatoid Arthritis, Osteoporosis, Osteoarthritis, Trauma, Bunions) - Trends & Global Forecasts to 2020Foot and ankle devices are used for the treatment of injuries caused by orthopedic disorders, such as diabetic foot, bunions, arthritis, and hammertoes with the help of surgical procedures. These devices also replace the foot lost/ damaged due to amputation, trauma, or congenital conditions. Technological advancements have made these devices lighter and stronger, restricting the additional amount of energy to be applied by the organ; this is driving the market for these devices. This market is expected to reach USD 5.4 Billion by 2020 from USD 3.8 Billion in 2015 at a CAGR of 7.2% during the forecast period. |
September 2015 | $ 5650 |
|
Nuclear Medicine Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), hybrid PET, & Planar Scintigraphy), Application (Cardiology, Oncology & Neurology) & by End user (Hospitals, Imaging Centers) - Global Forecasts to 2020Nuclear medicine equipment makes use of radioactive substances (also called as nuclear medicine or radiopharmaceuticals) that are inserted into the body orally or intravenously. These systems capture the radiations emitted by radiopharmaceuticals to create images of the structures and activities inside the human body. These images enable physicians to look inside a human body to help determine the cause of an illness or injury and provide an accurate diagnosis. The nuclear medicine equipment market is expected to grow at a single-digit CAGR in the next five years. This market is poised to reach USD 2.13 Billion by 2020 from USD 1.78 Billion in 2015, at a CAGR of 3.6% during the forecast period. |
September 2015 | $ 5650 |
|
Antimicrobial Coatings for Medical Devices Market by Type of Material (Metallic Coatings (Silver Coatings), Non-metallic Coatings (Polymeric Coatings) & Device Type (Catheters, Implantable Devices, Surgical Instruments) - Global Forecast to 2020The antimicrobial coatings for medical devices market is segmented on the basis of type of material, device types, and regions. The global antimicrobial coatings for medical devices market is expected to grow at a CAGR of 14.2% from 2015 to 2020 to reach USD 1.17 Billion by 2020 from USD 0.61 Billion in 2015. Factors such as rising awareness about hospital-acquired infections, favorable research and funding environment, technological advancements in antimicrobial coatings, growing implantable devices market, increasing research and development activities for antimicrobial coated cardiovascular devices, high growth in geriatric population, and increasing burden of cardiovascular diseases across the globe are driving the growth of this market. |
September 2015 | $ 5650 |
|
Medical Lifting Sling Market by Product (Transfer, Hammock, Toilet, Seating, Universal, Standing, Bariatric), by Material (Nylon, Padded, Canvas), by Usage Type (Disposable, Reusable), End User (Home, Hospital, Elderly) -Forecast to 2020In this report, the medical lifting sling market is broadly segmented on the basis of product, usage type, material, end user and region. On the basis of products, the medical lifting sling market is broadly segmented into standing slings, seating slings, universal slings, hammock slings, transfer slings, toilet slings, bariatric slings, and others (such as positioning and pivot slings). The transfer sling segment is expected to be the largest segment and will also be the fastest growing segment in the forecast period. This growth can be attributed to the multi-purpose application of the sling. The medical lifting sling market is estimated to grow at a CAGR of 11.4% to reach USD 706.0 Million by 2020. |
August 2015 | $ 5650 |
|
Diabetes Care Devices Market In Brazil, Russia, India & China (BRIC) by Product (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes) - Forecast to 2020The BRIC diabetes care devices market is estimated to be valued at USD 1.7 Billion in 2015 and is poised to reach USD 2.3 Billion by 2020, growing at a CAGR of 6.3% during the forecast period. Increasing diabetic population, growing research on diabetes, and lifestyle changes (driving the prevalence of diabetes among urban population) are the main factors driving the growth of this market. Rising obese population associated with diabetes and increasing international collaborations are further expected to contribute to the growth of this market. On the other hand, high cost of devices, emergence of alternative therapies, disparity in reimbursement, and lack of awareness may restrict the growth of this market to a certain extent. |
August 2015 | $ 5650 |
|
Medical Waste Management Market by Type of Waste (Non-Hazardous, Infectious, Sharps, Pharmaceuticals), Service (Treatment, Disposal, Recycling), Treatment Type (Incineration, Autoclaving), Treatment Site (Offsite, Onsite) - Global Forecast to 2020The global medical waste management market is expected to reach USD 13.3 Billion by 2020 from USD 10.3 Billion in 2015 at a CAGR of 5.2%. On the basis of type of waste, the market is segmented into nonhazardous and hazardous waste. The hazardous waste segment is projected to grow at the highest CAGR from 2015 to 2020 owing to increasing investments by public and private organizations. |
August 2015 | $ 5650 |
|
Breast Biopsy Market by Product (Table, Needle, Localization wire, Guidance System), Type (Open Biopsy- Excisional, Incisional, Needle- Core Needle Aspiration, Vacuum Assisted) & by Guidance system (Ultrasound, Stereotactic, MRI) - Forecast to 2020The global breast biopsy market is poised to reach $728.8 Million by 2020 from $436.4 Million in 2015, at a CAGR of 10.8% from 2015 to 2020. Based on type, the breast biopsy market is categorized into needle breast biopsy and open surgical breast biopsy market. The needle breast biopsy is further subsegmented into core needle biopsy (CNB), fine needle aspiration biopsy (FNAB), and vacuum-assisted biopsy (VAB). Among these, VAB is expected to be fastest-growing segment owing to the growing demand for less-invasive breast biopsy procedures worldwide. Open surgical breast biopsy is further segmented into excisional and incisional breast biopsy. |
July 2015 | $ 5650 |
|
Catheter Stabilization Device /Catheter Securement Devices Market by Product (Portal, Epidural, Peripheral, Femoral, Nasogastric, Endotracheal), Application (Cardiovascular, Respiratory, Urological, Gastric, Radiology), End User – Global Forecast to 2020The global catheter stabilization device market is expected to reach $1,372.35 Million by 2020 from $957.26 Million in 2015, growing at a CAGR of 7.47% between 2015 and 2020. Securement devices are used to secure catheters and infusion or drainage devices and to facilitate their operations. They can be repositioned upon initial application unlike normal dressing tapes, and are water-resistant devices made of latex-free, soft-cloth materials and are water resistant. The scope of the securement devices market includes securement devices used in surgeries and home healthcare settings. |
June 2015 | $ 5650 |
|
Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) - Forecast to 2020According to the CDC, cancer is the second leading cause of mortality, causing 584,881 deaths worldwide in 2013. Early diagnosis is the key to prevent the rising number of cancer-related deaths. The global cancer diagnostics market is witnessing a rapid transformation owing to several technological advancements in diagnostic platforms such as next-generation sequencing, DNA microarrays, and polymerase chain reaction (PCR). Moreover, the market has seen the advent of hybrid imaging instruments with enhanced accuracy, such as PET/CT and SPECT/CT. These advancements have augmented the growth of the cancer diagnostics market. The global cancer diagnostics market is expected to reach $13.1 Billion in 2020 from an estimated $7.1 Billion in 2015, growing at a CAGR of 12.9%. |
June 2015 | $ 5650 |
|
Electrophysiology Market by Product {Diagnostic Catheter (Conventional, Advanced, Ultrasound)), Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices (Mapping, Recording, Generator, ICE, X-ray)) & Indication (AF, VT, WPW) - Global Forecasts to 2019The global electrophysiology market is estimated to grow at a significant CAGR of 10.3% in the forecast period. Factors such as development of technologically advanced electrophysiology devices, rapid growth in aging population with high risk of target diseases, increasing incidence of arrhythmia cases across the globe, and growing focus of key market players to expand their geographic presence are fuelling the growth of the global electrophysiology market. This report studies the global electrophysiology market over the forecast period of 2014 to 2019. The market is expected to reach $4.73 billion by 2019 at CAGR of 10.3% from 2014 to 2019. |
May 2015 | $ 5650 |
|
Medical Videoscope Market by Scope [Rigid (Laparoscope, Ureteroscope), Flexible (Colonoscope, Gastroscope)], Visualization Systems (Monitors, HD Camera, 3D Camera, Light Source), by Application (Colonoscopy, Laparoscopy, Arthroscopy) - Global Forecasts to 2019Medical videoscope have huge demand across the globe owing to their wide application areas as well as their flexibility in terms of specification of instruments, which fits in with the various requirements of different procedures. The market has seen an extraordinary amount of technological advancements and breakthroughs in the last few years, as companies have focused on developing products capable of reducing pain, curtailing the number of sick days, and reducing the overall cost of treatment. The global medical videoscopes market was valued at $13.6 Billion in 2014 and is expected to reach $19.0 Billion by 2019, growing at a CAGR of 7.0% from 2014 to 2019. |
April 2015 | $ 5650 |
|
Cannula Market by Product (Nasal, Arterial, Arthroscopy, Ophthalmic, Cardioplegia, Suction, Femoral, Injector, Infusion, Venous, Microcannula), Material (Plastic, Metal) & End User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2020The cannula market is estimated to grow at a CAGR of 5.6% from 2015 to 2020 to reach $135.5 million by 2020.The report segments the global cannula market by product, by material, by application, by end-users and region. On the basis of material, the market is divided into plastic, metal and silicone. The silicone material is estimated to be the fastest growing segment during the forecast period. On the basis of end users, the cannulas market is divided into hospitals, ambulatory surgical centers, and others (blood banks and home healthcare facilities). |
April 2015 | $ 5650 |
|
Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Stomach, Small Intestine, Large Intestine) & Geography - Global Forecast to 2024The global smart pills market is segmented on the basis of applications and regions. The market by applications is categorized into capsule endoscopy, drug delivery, and patient monitoring. On the basis of regions, the market is divided into North America, Europe, Asia, and Rest of the World (RoW: Pacific countries, Africa, and Latin America). The Smart pills market in 2014 is valued at $1.56 billion. It is forecasted to reach $3.83 billion in the year 2020, growing at a CAGR of 16.16% (2014 – 2020). This will continue to reach $8.98 billion by the year 2024, growing at a CAGR of 23.7% (2020 – 2024). |
March 2015 | $ 5650 |
|
Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) - Global Forecast to 2020Based on protein type, the market is categorized into monoclonal antibodies, insulin, erythropoietins, interferons, colony stimulating factor, growth hormones, coagulation factor, vaccines and others (interleukins, follicle stimulating hormones, enzyme replacement). Monoclonal antibodies is the largest as well as fastest growing segment of the protein engineering protein type market. This growth is attributed to the increase in adoption of them for various therapies such as cancer and autoimmune diseases. The protein engineering market is estimated to grow at a CAGR of 15.7% to reach $1,463.0 million by 2020. |
March 2015 | $ 5650 |
|
Fetal Monitoring Market by Product (Ultrasound, Electronic Fetal Monitors, Electrodes, Doppler, Uterine Contraction, Telemetry), Portability, Method (Invasive), Application (Antepartum, Intrapartum), End User (Hospital, Clinics) - Forecast to 2019The fetal monitoring market is expected to reach $2,346.4 million by 2019 from $1,688.7 million in 2014, at a CAGR of 6.8%. Major factors driving the growth of this market include increasing initiatives from government and non-government bodies for improving maternal/fetal health across the globe, rising company investments in the development of fetal monitors, increasing number of conferences and symposia, and technological advancements. |
March 2015 | $ 5650 |
|
Metabolic Testing Market by Product (CPET, Body Composition Analysis, ECG, Portable System), by Application (Critical Care, Lifestyle Diseases), by Technology (REE, Body Composition Analysis), by End User (Gym, Sports, Hospital) - Global Forecast to 2019The global metabolic testing market is expected to reach $475.75 million by 2019 from $332.78 million in 2014, growing at a CAGR of 7.41% between 2014 and 2019. Rising prevalence of lifestyle diseases is the primary growth driver for this market during the forecast period (2014–2019). Moreover, technological advancements and increasing healthcare expenditure are also expected to drive market growth. However, high cost of equipment and software and reimbursement issues may hinder the growth of this market. |
March 2015 | $ 5650 |
|
Nanotechnology in Medical Devices Market by Product (Biochip, Implant Materials, Medical Textiles, Wound Dressing, Cardiac Rhythm Management Devices, Hearing Aid), Application (Therapeutic, Diagnostic, Research) - Global Forecast to 2019The global nanotechnology-based medical devices market is expected to grow at a significant CAGR of around 11-12% during the forecast period (2014–2019). The market is mainly driven by the growth in aging population, rising adoption of nanotechnology-based medical devices, and increased nanotechnology R&D expenditure. In addition, the governments of several nations are investing heavily in developing and commercializing new nanotechnology products. However, safety issues regarding nanotechnology-based medical devices, stringent regulatory guidelines, and time-consuming approval processes for these devices are hampering the growth of this market to a certain extent. The global nanotechnology-based medical devices market was valued at around $5 billion in 2014 and is poised to grow at a CAGR of around 11-12% during the forecast period (2014 to 2019). |
March 2015 | $ 5650 |
|
Lab Accessories Market by Type (Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station) & End User (OEM/Biotechnology & Pharmaceutical Companies/Hospital/Private Labs/Research Institute) - Global Forecast to 2020The laboratory accessories market is valued at $327.0 million in 2014. It is expected to reach $504.7 million by 2020, growing at a CAGR of 7.5% from 2014 to 2020. The laboratory accessories market is dominated by North America, it is followed by Europe, Asia and Rest of the world. The Asian market is the fastest growing in the forecast period (2014-2020). Reagent reservoirs is the fastest-growing segment of this market. |
March 2015 | $ 5650 |
|
Soft Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments) by Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global Forecast to 2019The global soft tissue repair market is estimated to grow at a CAGR of 7.5% from 2014 to 2019 to reach $14.7 billion in 2019. The increasing incidence of soft tissue injuries among the active aging population, increasing participation in sports, increasing obesity rate, and increasing healthcare expenditure & lack of substitutes for soft tissue repair surgery are the major factors driving market growth. |
March 2015 | $ 5650 |
|
European Patient Handling Equipment Market by Product (Wheelchair, Scooters, Bathroom Safety Supply, Mechanical, Ambulatory), by Type of Care (Bariatric, Critical, Wound, Fall), by Accessories (Lifting, Transfer), by End User (Hospital, Elderly) - Forecast to 2019The European patient handling equipment market is estimated to grow at a CAGR of 11.4% to reach $5,150.2 million by 2019. The nonmechanical equipment product segment is expected to witness the fastest growth during the forecast period. The European patient handling equipment market by region is segmented into Germany, the U.K., France, Sweden, Denmark, Spain, the Netherlands, Italy, and Rest of Europe (RoE). |
January 2015 | $ 5650 |
|
Breath Analyzers Market by Technology (Fuel Cell, Semiconductor, Infrared, Crystal), by Application (Alcohol, Drug Abuse, Tuberculosis, Asthma, Cancer), by End User (Law Enforcement, Enterprises, Individuals) - Analysis & Global Forecast to 2019This report studies the breath analyzers market over the forecast period of 2014 to 2019. This market is expected to reach $1,539.1 million in 2019 from $479.3 million in 2014 at a CAGR of 26.3%. The breath analyzers solutions market is categorized into four broad segments, namely, technology, applications, end users, and regions. The breath analyzers market, by technology, comprises fuel cell technology, semiconductor oxide sensor technology, and others. |
January 2015 | $ 5650 |
|
Diagnostic Imaging Equipment Market by Modality [Digital X-ray Imaging, Ultrasound (Color Doppler, Portable), Magnetic Resonance Imaging, CT Scanner (Low-, Mid-, & High-end), Mammography, PET, SPECT] - Emerging Markets (BRIC - Brazil, Russia, India, and China) - 2011-2018The BRIC diagnostic imaging equipment market has been divided into six segments based on type of modality, namely, ultrasound systems, X-ray imaging systems, computed tomography (CT) systems, magnetic resonance imaging (MRI) systems, nuclear imaging systems, and mammography systems. Each segment is further sub segmented based on product type. BRIC diagnostic imaging equipment market at an estimated $1.6 billion in 2013. This is due to the high usage of ultrasound systems for various diagnostic applications as compared to other costly imaging equipment, and the presence of large number of domestic ultrasound systems manufacturers in these countries. |
November 2014 | $ 5650 |
|
Clinical Chemistry Analyzer Market by Product (Systems & Reagents), Test Type (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals), End User (Hospitals, Laboratories, Academic Research) - Global Forecast to 2019The global clinical chemistry analyzers market was valued at $8,965.00 million in 2014and is poised to grow at a CAGR of 5.52% between 2014and 2019, to reach $11,728.01 million in 2018.Rapid growth in the diagnostics market, increase in the healthcare spending, and increasing incidence in lifestyle disease will drive the growth of the clinical chemistry analyzers market. Furthermore, increasing awareness for preventative healthcare, increase in aging population, increase in reagent rental agreements and increasing demand for laboratory automation will aid the demand for clinical chemistry analyzers products. |
October 2014 | $ 5650 |
|
Single Tooth Implants and Dental Bridges Market by Product (Single Tooth Implants, Dental Bridges), by Type (3-unit, 4-unit, Maryland, Cantilever, Partial), by Material (PFM, All Ceramics and Metal Alloys) - Global Forecasts to 2019The global single-tooth implants and dental bridges market is valued at $3,297.6 million in 2014 and is poised to grow at a CAGR of 7.3% during the forecast period of 2014 to 2019. Rising incidences of dental caries and other periodontal diseases among the aging baby-booming populationand growing aging population who are more prone to tooth loss are the major factors driving the growth of this market. In addition, better hygiene and aesthetics associated with the usage of single-tooth implants is expected to drive the growth of the single-tooth implants, as opposed to dental bridges. |
October 2014 | $ 5650 |
|
Dental Imaging Market by Technology (X-ray, CBCT, Intraoral Camera, Optical Imaging), Method (Extraoral, Intraoral), Application (Diagnostic, Therapeutic, Cosmetic, Forensic), End User (Dental Clinic, Dental Labs) – Global Trends & Forecasts to 2019The global dental imaging market is expected to reach $2,686.5 million by 2019 from $1,691.1 million in 2014, growing at a CAGR of 9.7% from 2014 to 2019. Major factors driving growth of this market include technological advancements such as CBCT, increasing aging populations leading to growth in oral diseases, rising oral care awareness and increasing disposable income in emerging economies, growth impetus of cosmetic dentistry, and shift towards digital dental imaging systems. However, high cost of instruments, lack of reimbursement especially in emerging economies, and lack of dental laboratory technicians are expected to restrain the growth of this market. |
October 2014 | $ 5650 |
|
Physiotherapy Equipment Market by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, Exercise Ball), Applications (Pediatric, Musculoskeletal) & by End Users (Hospitals), Advanced technologies - Global Forecast to 2019The physiotherapy equipment marketis expected to grow at a single–digit CAGR of 6.8% to reach $19,786.3 million by 2019 from $14,240.0 million in 2014. Major factors fuelinggrowth of this market are rapidly aging population, increasing inclination towards active lifestyles, and government support in the form of incentives. However, lack of skilled physiotherapists, highmaintenance expenses, and stringent regulations are restricting the growth of the physiotherapy equipment market. |
September 2014 | $ 5650 |
|
NewBorn Screening Market by Test Type (Dried Blood Spot, Hearing Screening, CCHD), Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit – Global Forecast to 2019The global newborn screening market was valued at an estimated $438.9 million in 2013 and is expected to grow at a CAGR of 11.0% in the next five years. This high growth is mainly attributed to the benefits offered by newborn screening programs, legislations and mandates, technological advancements, government support, and expanding panel of newborn diseases, and conferences and symposiums related to the usage of new technologies. Furthermore, various awareness programs and conferences are being organized across the globe, which is likely to drive the market growth. However, factors such as lack of trained professional infrastructure and socio-economic barriers are expected to hinder the market growth. |
June 2014 | $ 5650 |
|
Diagnostic Electrocardiograph (ECG) Market by Product (Resting, Stress, Holter Monitor), End-user (Hospitals, Home/Ambulatory, Research Center, Physician Office, Nursing Homes) & by Lead Type (Single, 3-6, 12) - Global Forecast to 2020The global diagnostic ECG market is estimated to reach $4,875 million by 2018 at a high CAGR during the forecast period. The factors driving this market include the increasing geriatric population, rising incidences of lifestyle diseases, technological advancements in diagnostic ECG devices, and high growth rate in developing countries. |
June 2014 | $ 5650 |
|
North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon (Plain/Old, Cutting), Stent (Bioabsorbable, Drug-Eluting), Catheter (IVUS, OCT), IVC Filter (Retrievable), Endovascular Stent Graft - Forecast to 2018The North American interventional cardiology and peripheral vascular devices market is expected to reach $5,947.5 million by 2018, at a meager CAGR of 2.9%. The slow growth of this market can be attributed to the declining growth in the coronary angioplasty procedural volume (decreasing at a CAGR of around 3.0% during the forecast period) in the U.S. |
June 2014 | $ 5650 |
|
Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures – Global Forecasts to 2018The global pediatric interventional cardiology market is segmented on the basis of type of devices and geography. Based on the type of device, the market is further segmented into congenital heart defect closure devices, transcatheter heart valves, and others (catheters, guidewires, balloons, and stents). Based on geography, this market is divided into four geographic regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). This report also includes the number of pediatric interventional cardiology procedures performed across different regions. |
March 2014 | $ 5650 |
|
European Home Healthcare Market By Products (Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit), Services (Respiratory Therapy, Rehabilitation Therapy) & Telehealth – Forecasts to 2017The Europe home healthcare market is segmented as products, services, telehealth, and geography. The products market is further classified into homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, and nutrition and fitness. The home healthcare services market is further segmented into unskilled care, rehabilitation therapy, infusion therapy and respiratory therapy, while the telehealth market includes monitoring devices, services, and managed equipment services. The total market is divided into seven major countries, i.e. Germany, France, U.K., Italy Spain, Russia, and Rest of Europe (RoE). |
July 2013 | $ 5650 |
|
North American Home Healthcare Market, By Product [Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit], Services [Respiratory Therapy, Rehabilitation Therapy] & Telehealth - Forecasts To 2017The North America home health care market was valued at $90.9 billion in 2012; it is poised to grow at a CAGR of 7.5% to reach $130.4 billion by 2017. Home healthcare market includes products, services, and telehealth. The home care product category comprises homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, fitness, and nutrition products. Services include unskilled care, rehabilitation therapy, infusion therapy, and respiratory therapy, while telehealth includes home telehealth monitoring devices and telehealth services. |
May 2013 | $ 5650 |
|
Additive Manufacturing Market , By Application (Medical Devices, Automotives, & Aerospace) and Technology (3D Printing, Laser Sintering, Stereolithography, Fused Deposition Modeling, Electron Beam Melting, & Tissue Engineering) - Forecast (2012 - 2017)According to the American Society for Testing and Materials (ASTM), ’additive manufacturing’ is the “process of joining materials to make objects from 3D model data, usually layer upon layer”. Various synonyms generally used for AM are additive fabrication, additive processes, additive techniques, additive layer manufacturing, layer manufacturing, and freeform fabrication. The AM market can be applied in various industries such as motor vehicles, consumer products, business machines, medical, academic, aerospace, government/military, and others (architecture, paleontology, and forensic pathology). In this report, we are mainly focusing on the medical applications of AM. |
April 2013 | $ 5650 |
|
Medical Bionic Implant /Artificial Organs Market - (Vision Bionics/Bionic Eye, Brain Bionics, Heart Bionics/Artificial Heart, Orthopedic Bionics and Ear Bionics) – Trends and Global Forecasts to 2017Bionics is mechanical/electronic replacement or enhancement of organs/parts of living organisms. The medical bionic implants market is a potentially growing one with a global market of $12.67 billion in 2012. It is expected to grow at a CAGR of 7.1% to reach $17.82 billion in 2017. |
November 2012 | $ 5650 |
|
Bio-Implants Market - by Type (Cardiovascular, Spine, Orthopedics, Trauma, Dental), by ROA (Surgical/Injectable), by Origin (Allo/Auto/Xenograft, Synthetic) & Materials (Ceramics, Biomaterial, Alloys, Polymers) - Global Trends &, Forecasts till 2017Bio-implants can be defined as prostheses used to regularize physiological functions. They are made up of biosynthetic materials like collagen, and tissue-engineered products like artificial skin or tissues. Most bioengineered products like cardiac pacemakers and orthopedic artificial implants are also covered under bio-implants, since they are implanted entirely in the patient’s body. |
September 2012 | $ 5650 |
|
Ophthalmology Drugs & Devices Market (Contact Lens, Optical Coherence Tomography (OCT) Scanner, IOL, Dry Eye, AMD, Glaucoma & Phacoemulsification) – Competitive Landscape & Global Forecasts To 2017The global ophthalmology market witnessed a dip during the economic downturn in 2008 and 2009; however, it is poised to grow at a stable rate mainly due to an increasing aging population, large pool of patients with eye diseases, changing demographics and geographical trends, and increased focus on combination therapies of drugs. Moreover, incidences of glaucoma and cataract are increasing every year. |
August 2012 | $ 5650 |
|
Minimally Invasive Medical Robotics, Imaging & Visualization Systems & Surgical Instruments Market Forecasts to 2016 (DA VINCI, Robodoc, Spine Assist, Neuromate, Ultrasound, CT, MRI, X-RAY Imaging, Electrosurgical Devices, Handheld Instruments, Guiding Devices, Inflation Systems & Auxiliary Devices) Global Trends & Competitive AnalysisA minimally invasive surgical (MIS) procedure refers to the surgery performed with minute incisions in the body; for instance, plaque blockages in the arteries of the heart and other vessel walls of peripheral organs, such as lower extremities, neck, kidneys, and brain. The principal advantage of these procedures over surgery is short recovery time, small scars, low risk of infection, less bleeding, and shorter hospital stays. |
July 2012 | $ 5650 |
|
Dental Diagnostic & Surgical Equipment Market - (Radiology, Laser, CAD/CAM Devices & Chairs) – Current Trends, Opportunities and Global Forecasts (2011 - 2016)The market for dental diagnostic and surgical equipment consists of devices used in diagnosing dental diseases/conditions and treating the same. These include dental chairs, hand pieces, CAD/CAM systems, scaling units, instrument delivery systems, dental lasers, intra oral and extra oral radiology equipment, and CBCT scanners. The global market for these equipments was valued at $4.5 billion in 2011 and is expected to grow at a CAGR of 5.8% from 2011-2016. |
March 2012 | $ 5650 |
|
In-Vitro Diagnostic (IVD) Market (Applications, End-users & Types) Trends & Global Forecasts (Major & Emerging Markets – G7, Japan & BRIC) (2011 - 2016)The Asian region is expected to be ruled by the emerging economies such as China and India, show the highest CAGR by the year 2016. The Chinese IVD market is taking frog leap amongst the emerging nations, followed by India, Russia, and Brazil. The major driving factor for the IVD industry to boom in the emerging countries is the government funding and improved healthcare facilities. |
January 2012 | $ 5650 |
|
Orthopedic Devices Market (Forecast to 2016)The orthopedic devices market is witnessing major growth sue to increasing patient awareness about the advantages of advanced treatments and technologies such as orthobiologics. |
October 2011 | $ 5650 |
|
Top 10 Medical Devices Market – (Point of Care Diagnostics, Hemodialysis, Minimally Invasive Surgery, Cataract & Ocular Lens, Patient Monitors) – Global Trends, Developments and Forecasts up till 2015The global top 10 medical devices market was expected to be worth $164 billion in the year 2010 and is estimated to reach $228 billion by 2015, growing at a CAGR of 6.8% from 2010 to 2015. The cardiovascular devices, orthopedic devices, and diagnostic imaging devices markets are the major revenue generators for the medical devices industry |
June 2011 | $ 5650 |
|
Microscopy Market in Latin America (2010 - 2015)Microscopes have been in use since the 17th century and since then, technical advances have greatly widened the scope of microscopy. Digitization has led to greater precision of the images. The development of confocal microscopes and new technologies in electron microscopes is boosting the growth of the microscopy market. |
March 2011 | $ 5650 |
|
Global Anesthesia and Respiratory Devices Market (2010-2015)The global anesthesia and respiratory devices market is expected to witness moderate growth in the coming five years. Respiratory devices account for the largest share (about 57%) in this market; primarily due to their wide usage among the three consumer segments (healthcare institutions, home healthcare and transport) as compared to anesthesia devices; which have limited usage amongst the end-users. |
February 2011 | $ 5650 |
|
Global Minimally Invasive Surgery Market 2010 - 2015The global minimally invasive surgery market is witnessing steady growth due to rapid technological advancements changing demographics and rising awareness amongst the patient population for less invasive procedures or single incision procedures. |
October 2010 | $ 5650 |
|
Global Dental Devices and Consumables Market (2010 - 2015)The dental devices report forecasts the size of global dental devices and consumables market over the period 2010 – 2015. The report analyses the key trends of the market, and segments the global dental equipment and consumables market by components and into various geographic regions (with the market size for each of these regions). Further, it discusses the key market drivers, restraints and opportunities of the global dental equipment and consumables market. |
September 2010 | $ 5650 |
|
Patient Monitoring Devices - Emerging Markets BRIC(Brazil, Russia, India, China) 2010-2015The Emerging Markets: BRIC (Brazil, Russia, India and China) Patient Monitors witnesses significant growth opportunities due to rapidly aging population, high incidence of chronic diseases, and government initiatives such as reform in healthcare delivery systems. Despite the impact of economic slowdown, BRIC nations are expected to grow at a CAGR of around 10 - 12% from 2009 – 2014. |
July 2010 | $ 5650 |
|
Global Dental Implants Market (2010 -2015)The global dental implants market is estimated to be $ 4 billion by 2014, growing at a CAGR of 6 %.this is the most promising and dynamic market within dental device market with 18% of market share. The market is expected to grow because of the tremendous demand for cosmetic dentistry and effective treatment for edentulism. The European and North American markets are the top two markets with most promising outlook for the future. The developing economies in Asian and South American regions are also expected to contribute to the growth of the market in the coming years. |
July 2010 | $ 5650 |
|
Global Ophthalmology Drugs & Devices MarketGlobal ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders. |
May 2010 | $ 5650 |
|
Global Ophthalmology Devices Market (2009 - 2014)This market report will enable strategic understanding on the ophthalmology devices & drugs market. Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass more than 40 company profiles. |
April 2010 | $ 5650 |
|
Home Healthcare Market (2009-2014)In this report, we have analyzed how the home care and self care market is evolving. The increasing population above the age group of 65 years covers about 70% of the entire market, while the elderly support population (population between 20-64 years of age) is declining. The lack of family members to support and care for the elderly at home generates a high demand for home care products and services. Along with this, the increased cost of hospital care services presents the largest opportunity for this market. Thus, many companies are eagerly approaching this segment with several customized products and services. |
February 2010 | $ 5650 |
|
Global Dental Consumables MarketDental consumables form the largest segment of the dental industry, and also hold significant potential for further growth due to the increasing incidence of oral disease and growing awareness about oral care. The growth of the dental consumables market is also driven by the demand from the increasing population of aging people across the globe, as well as from the younger generation focusing on dental aesthetics. |
December 2009 | $ 5650 |
|
Global Services Outsourcing Opportunities in Medical DevicesThis report will provide market estimates and forecast for outsourcing oppportunities within medical equipment and pharma industry. The market segmentation for the same will include products, services, applications, and technologies. |
November 2009 | $ 5650 |
|
Drug - Device Combination (2009 - 2014)This report analyzes the basic structure of the drug-device combination market and its various submarkets. Individual markets for major products such as anti-microbial catheters, wound-care products, bone-graft substitutes, bone cement, drug-eluting stents, photodynamic therapy, artificial pancreas, and steroid eluting electrodes are further broken down into their respective sub-segments based on products, technology and applications. |
November 2009 | $ 5650 |
|
Neurostimulation Market by Product & Applications (2012-2017) (Spinal Cord, Deep Brain, Sacral Nerve, Vagus Nerve, Transcranial Magnetic, Gastric, TENS) Global Trends, Emerging Applications & Competitive LandscapeThis report provides an in-depth review of the numerous significant developments in neurostimulation technology, and the markets for this technology. It also provides in detail the competitive landscape, profiles of key players and over 100 market related tables on the neurostimulation sector. |
September 2009 | $ 5650 |
|
Dental Equipment Market (2009 - 2014)The report provides market data on the latest and future equipment and technologies in the market. It also analyzes the key market trends, strategies of the key players and provides market data for the next five years. The focus is on the patented equipment and technologies being developed across the globe. |
September 2009 | $ 5650 |
|
Minimally Invasive and Non Invasive Product and Service Market (2009 - 2014)This report will analyze the market potential for minimally invasive/non-invasive surgery. The target segment (end-users) of the minimal invasive/non-invasive surgery products are mainly hospital surgical departments, outpatient surgery centers, group medical practices, individual surgeons, and medical schools. The number of outpatient centers is set to rise, as a low cost alternative for hospitals. |
July 2009 | $ 5650 |
|
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.
Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement
Connect With Us
Live Chat Support
Search reports
Medical Devices ›
Information and Communications Technology ›
Semiconductor and Electronics ›
Chemicals ›
Advanced Materials ›
Energy and Power ›
Food and Beverage ›
Biotechnology ›
Aerospace and Defence ›
Healthcare IT ›
Automotive and Transportation ›
Automation and Process Control ›
Agriculture Industry ›
Packaging ›
Pharmaceuticals ›
Building and Construction ›
Mining, Minerals and Metals ›
Analytical and Scientific Instrumentation ›
Engineering Equipment and Devices ›
'Connect With Us
